[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 4033
1. Yokoyama KK, Murata T, Pan J, Nakade K, Kishikawa S, Ugai H, Kimura M, Kujime Y, Hirose M, Masuzaki S, Yamasaki T, Kurihara C, Okubo M, Nakano Y, Kusa Y, Yoshikawa A, Inabe K, Ueno K, Obata Y: Genetic materials at the gene engineering division, RIKEN BioResource Center. Exp Anim; 2010;59(2):115-24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The genetic resources include cloned DNAs, gene libraries (e.g., cDNA and genomic DNA cloned into phage, cosmid, BAC, phosmid, and YAC), vectors, hosts, recombinant viruses, and ordered library sets derived from animal cells, including human and mouse cells, microorganisms, and viruses.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20484845.001).
  • [ISSN] 1881-7122
  • [Journal-full-title] Experimental animals
  • [ISO-abbreviation] Exp. Anim.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Japan
  • [Number-of-references] 34
  •  go-up   go-down


2. Palti Y, Rodriguez MF, Gahr SA, Purcell MK, Rexroad CE 3rd, Wiens GD: Identification, characterization and genetic mapping of TLR1 loci in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol; 2010 May-Jun;28(5-6):918-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two TLR1 loci were identified from a rainbow trout bacterial artificial chromosome (BAC) library using DNA sequencing and genetic linkage analyses.
  • Full length cDNA clone and direct sequencing of four BACs revealed an intact omTLR1 open reading frame (ORF) located on chromosome 14 and a second locus on chromosome 25 that contains a TLR1 pseudogene.
  • However, due to the lack of TLR6 and 10 genes in teleost genomes and up-regulation of TLR1 mRNA in response to LPS and bacterial infection in other fish species we hypothesize an important role for omTLR1 in anti-microbial immunity.
  • Therefore, the identification of a TLR2 ortholog in rainbow trout and the development of assays to measure ligand binding and downstream signaling are critical for future elucidation of omTLR1 functions.

  • COS Scholar Universe. author profiles.
  • ZFIN. ZFIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Ltd.
  • (PMID = 20153434.001).
  • [ISSN] 1095-9947
  • [Journal-full-title] Fish & shellfish immunology
  • [ISO-abbreviation] Fish Shellfish Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Toll-Like Receptor 1
  •  go-up   go-down


3. Saul SM, Brzezinski JA 4th, Altschuler RA, Shore SE, Rudolph DD, Kabara LL, Halsey KE, Hufnagel RB, Zhou J, Dolan DF, Glaser T: Math5 expression and function in the central auditory system. Mol Cell Neurosci; 2008 Jan;37(1):153-69
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The basic helix-loop-helix (bHLH) transcription factor Math5 (Atoh7) is required for retinal ganglion cell (RGC) and optic nerve development.
  • Math5 expression in the CN was verified by mRNA in situ hybridization, and the identity of positive neurons was confirmed morphologically using a Math5-Cre BAC transgene with an alkaline phosphatase reporter.
  • These temporal changes are consistent with a higher-level auditory processing disorder involving the CN, potentially affecting the integration of binaural sensory information.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. BROMODEOXYURIDINE .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Evol Dev. 2003 Sep-Oct;5(5):532-41 [12950631.001]
  • [Cites] Nat Neurosci. 2003 Oct;6(10):1091-100 [14513037.001]
  • [Cites] J Neurosci. 2003 Oct 8;23(27):9199-207 [14534254.001]
  • [Cites] Exp Brain Res. 1966;1(3):220-35 [5920550.001]
  • [Cites] J Neurophysiol. 1990 May;63(5):1169-90 [2358868.001]
  • [Cites] Hear Res. 1990 Nov;49(1-3):363-90 [2292507.001]
  • [Cites] J Comp Neurol. 1991 Feb 15;304(3):387-407 [2022755.001]
  • [Cites] J Comp Neurol. 1991 Dec 22;314(4):684-706 [1816271.001]
  • [Cites] Science. 1999 Jun 11;284(5421):1837-41 [10364557.001]
  • [Cites] Curr Opin Neurobiol. 1999 Aug;9(4):389-93 [10448164.001]
  • [Cites] Science. 1962 Nov 23;138(3543):893-5 [13952991.001]
  • [Cites] Hear Res. 2005 Jan;199(1-2):57-70 [15574300.001]
  • [Cites] J Assoc Res Otolaryngol. 2004 Dec;5(4):411-26 [15675004.001]
  • [Cites] Neurol Res. 2005 Jun;27(4):436-40 [15949244.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2540-51 [15980246.001]
  • [Cites] Nat Neurosci. 2005 Oct;8(10):1335-42 [16136041.001]
  • [Cites] Neuron. 2005 Oct 6;48(1):17-24 [16202705.001]
  • [Cites] Neuron. 2005 Oct 6;48(1):31-43 [16202707.001]
  • [Cites] Am J Anat. 1982 Feb;163(2):103-30 [7072613.001]
  • [Cites] J Neurophysiol. 1982 Jun;47(6):987-1016 [7108581.001]
  • [Cites] J Comp Neurol. 1982 Aug 20;209(4):409-24 [7130465.001]
  • [Cites] J Comp Neurol. 1983 Feb 1;213(4):448-63 [6300200.001]
  • [Cites] J Mol Appl Genet. 1983;2(1):101-9 [6302193.001]
  • [Cites] J Acoust Soc Am. 1985 Jul;78(1 Pt 2):328-33 [2993393.001]
  • [Cites] J Comp Neurol. 1986 May 22;247(4):457-76 [3722446.001]
  • [Cites] Brain Res. 1986 Jul 2;377(1):147-54 [2425899.001]
  • [Cites] J Neurophysiol. 1986 Aug;56(2):261-86 [3760921.001]
  • [Cites] Brain Res. 1988 May 16;468(2):233-42 [3260120.001]
  • [Cites] Brain. 1988 Dec;111 ( Pt 6):1453-74 [3208066.001]
  • [Cites] J Neurocytol. 1988 Oct;17(5):711-25 [2463341.001]
  • [Cites] Exp Brain Res. 1988;73(2):263-84 [3215304.001]
  • [Cites] J Comp Neurol. 1989 Apr 22;282(4):595-616 [2723154.001]
  • [Cites] J Comp Neurol. 1989 May 22;283(4):474-80 [2745750.001]
  • [Cites] J Comp Neurol. 1990 May 1;295(1):136-54 [2341631.001]
  • [Cites] J Comp Neurol. 2006 Mar 1;495(1):100-12 [16432905.001]
  • [Cites] Anat Rec A Discov Mol Cell Evol Biol. 2006 Apr;288(4):358-69 [16550576.001]
  • [Cites] Neuron. 2006 Apr 20;50(2):205-18 [16630833.001]
  • [Cites] J Neurosci Methods. 2006 Jun 15;153(2):214-20 [16406043.001]
  • [Cites] J Comp Neurol. 1967 May;130(1):77-86 [4962091.001]
  • [Cites] J Comp Neurol. 1967 Sep;131(1):27-54 [6069501.001]
  • [Cites] J Comp Neurol. 1969 Aug;136(4):453-84 [5801446.001]
  • [Cites] J Comp Neurol. 1974 Jun 1;155(3):251-300 [4134212.001]
  • [Cites] J Am Aud Soc. 1979 Mar-Apr;4(5):173-8 [511644.001]
  • [Cites] J Comp Neurol. 1980 Aug 15;192(4):687-702 [7419749.001]
  • [Cites] J Comp Neurol. 1980 Dec 15;194(4):877-904 [7204645.001]
  • [Cites] J Comp Neurol. 1981 Mar 20;197(1):141-52 [6164700.001]
  • [Cites] J Comp Neurol. 1981 Mar 20;197(1):169-84 [7229124.001]
  • [Cites] Neurosci Lett. 1981 Oct 23;26(2):143-9 [7301202.001]
  • [Cites] J Comp Neurol. 1993 Feb 8;328(2):161-84 [8423239.001]
  • [Cites] J Comp Neurol. 1993 May 8;331(2):245-60 [8509501.001]
  • [Cites] J Neurosci Res. 1993 Sep 1;36(1):88-98 [8230324.001]
  • [Cites] Cell Tissue Res. 1993 Dec;274(3):487-92 [8293446.001]
  • [Cites] J Neurophysiol. 1994 Mar;71(3):1022-36 [8201399.001]
  • [Cites] Hear Res. 1994 Apr;74(1-2):1-21 [8040081.001]
  • [Cites] J Comp Neurol. 1994 Jun 1;344(1):83-100 [7520457.001]
  • [Cites] Brain. 1994 Oct;117 ( Pt 5):1127-41 [7953594.001]
  • [Cites] Cell. 1994 Dec 16;79(6):1025-34 [8001130.001]
  • [Cites] Hear Res. 1995 Jan;82(1):109-24 [7744707.001]
  • [Cites] Development. 1995 Jul;121(7):2019-30 [7635049.001]
  • [Cites] Hear Res. 1995 Jun;86(1-2):77-81 [8567424.001]
  • [Cites] J Neurosci. 1995 Dec;15(12):8011-22 [8613738.001]
  • [Cites] J Neurosci. 1996 Jun 1;16(11):3775-89 [8642420.001]
  • [Cites] Hear Res. 1996 Apr;93(1-2):28-51 [8735067.001]
  • [Cites] Hear Res. 1996 Apr;93(1-2):52-71 [8735068.001]
  • [Cites] Scand Audiol. 1996;25(2):133-41 [8738639.001]
  • [Cites] Hear Res. 1996 Dec 1;102(1-2):1-14 [8951445.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):628-31 [8971114.001]
  • [Cites] Nature. 1997 May 8;387(6629):176-8 [9144287.001]
  • [Cites] Mech Dev. 1997 Jul;65(1-2):111-22 [9256349.001]
  • [Cites] Curr Opin Neurobiol. 1997 Aug;7(4):487-92 [9287194.001]
  • [Cites] J Comp Neurol. 1997 Sep 22;386(2):178-202 [9295146.001]
  • [Cites] Nature. 1997 Nov 13;390(6656):169-72 [9367153.001]
  • [Cites] Hear Res. 1998 Jan;115(1-2):61-81 [9472736.001]
  • [Cites] Hear Res. 1998 Jan;115(1-2):162-74 [9472745.001]
  • [Cites] Development. 1998 Feb;125(3):381-91 [9425134.001]
  • [Cites] J Physiol. 1998 May 15;509 ( Pt 1):183-94 [9547392.001]
  • [Cites] Development. 1998 Dec;125(23):4821-33 [9806930.001]
  • [Cites] Neuroreport. 1998 Oct 26;9(15):3383-6 [9855285.001]
  • [Cites] Annu Rev Physiol. 1999;61:477-96 [10099698.001]
  • [Cites] Genetics. 1999 Apr;151(4):1531-45 [10101175.001]
  • [Cites] Dev Biol. 1999 Apr 15;208(2):281-92 [10191045.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5251-6 [10220452.001]
  • [Cites] Brain Res. 2006 May 26;1091(1):217-23 [16574081.001]
  • [Cites] J Comp Neurol. 2007 Oct 10;504(5):533-49 [17701984.001]
  • [Cites] Mol Cell Neurosci. 2007 Dec;36(4):435-48 [17900924.001]
  • [Cites] Annu Rev Physiol. 1999;61:497-519 [10099699.001]
  • [Cites] Trends Neurosci. 1999 Nov;22(11):497-504 [10529817.001]
  • [Cites] J Comp Neurol. 1999 Dec 13;415(2):160-74 [10545157.001]
  • [Cites] J Neurocytol. 1998 Nov;27(11):841-64 [10644202.001]
  • [Cites] Development. 2000 Mar;127(5):1039-48 [10662643.001]
  • [Cites] Hear Res. 2000 Feb;140(1-2):77-90 [10675636.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4333-8 [10760300.001]
  • [Cites] Dev Dyn. 2000 Apr;217(4):361-7 [10767080.001]
  • [Cites] Neuron. 2000 Mar;25(3):549-61 [10774724.001]
  • [Cites] Genes Dev. 2000 Aug 1;14(15):1852-65 [10921900.001]
  • [Cites] J Neurosci. 2000 Dec 15;20(24):9162-73 [11124994.001]
  • [Cites] Genes Dev. 2001 Jan 1;15(1):24-9 [11156601.001]
  • [Cites] Curr Opin Neurobiol. 2001 Feb;11(1):82-8 [11179876.001]
  • [Cites] Development. 2001 Jul;128(13):2497-508 [11493566.001]
  • [Cites] Nat Genet. 2001 Sep;29(1):61-5 [11528393.001]
  • [Cites] Neuroscience. 2001;106(1):79-88 [11564418.001]
  • [Cites] J Neurophysiol. 2001 Nov;86(5):2299-311 [11698520.001]
  • [Cites] Nat Rev Neurosci. 2002 Jan;3(1):53-64 [11823805.001]
  • [Cites] Methods. 2001 Dec;25(4):402-8 [11846609.001]
  • [Cites] Mamm Genome. 2002 Feb;13(2):95-101 [11889557.001]
  • [Cites] J Neurophysiol. 2002 May;87(5):2262-70 [11976365.001]
  • [Cites] Nat Rev Neurosci. 2002 Jul;3(7):517-30 [12094208.001]
  • [Cites] J Neurosci. 2003 Mar 15;23(6):2314-22 [12657690.001]
  • [Cites] Neuroscientist. 2003 Apr;9(2):127-43 [12708617.001]
  • [Cites] Brain Res Bull. 2003 Jun 15;60(5-6):457-74 [12787867.001]
  • [Cites] Nat Rev Neurosci. 2003 Jul;4(7):540-50 [12838329.001]
  • [Cites] Ear Hear. 2003 Aug;24(4):332-41 [12923424.001]
  • (PMID = 17977745.001).
  • [ISSN] 1044-7431
  • [Journal-full-title] Molecular and cellular neurosciences
  • [ISO-abbreviation] Mol. Cell. Neurosci.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM067840-04; United States / NIDDK NIH HHS / DK / P60 DK20572; United States / NIDCD NIH HHS / DC / R01 DC04825; United States / NEI NIH HHS / EY / T32 EY013934; United States / NIGMS NIH HHS / GM / T32 GM07544; United States / NIDCD NIH HHS / DC / P30 DC005188; United States / NIGMS NIH HHS / GM / R01 GM067840; United States / NIDDK NIH HHS / DK / P60 DK020572; United States / NEI NIH HHS / EY / R01 EY14259; United States / NEI NIH HHS / EY / R01 EY014259-03; United States / NEI NIH HHS / EY / EY014259-03; United States / NIGMS NIH HHS / GM / GM067840-04; United States / NIDCD NIH HHS / DC / T32 DC00011; United States / NIGMS NIH HHS / GM / T32 GM007544; United States / NEI NIH HHS / EY / R01 EY014259; United States / NIDCD NIH HHS / DC / P30 DC05188; United States / NIDCD NIH HHS / DC / T32 DC000011; United States / NIDCD NIH HHS / DC / R01 DC004825
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; 0 / Atoh7 protein, mouse; 0 / Basic Helix-Loop-Helix Transcription Factors; 0 / Nerve Tissue Proteins; 0 / RNA, Messenger; 0 / Stilbamidines; EC 3.2.1.23 / beta-Galactosidase; G34N38R2N1 / Bromodeoxyuridine
  • [Other-IDs] NLM/ NIHMS38894; NLM/ PMC2266824
  •  go-up   go-down


Advertisement
4. Wester U, Bondeson ML, Edeby C, Annerén G: Clinical and molecular characterization of individuals with 18p deletion: a genotype-phenotype correlation. Am J Med Genet A; 2006 Jun 1;140(11):1164-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aims of present study were to clinically and molecularly characterize the syndrome further in seven subjects with de novo 18p deletions and to perform genotype-phenotype correlation.
  • All seven subjects had terminal deletions and no interstitial deletion was observed with subtelomeric FISH analyses.
  • To define the extent of the 18p deletions and the parental origin of the deletion microsatellite- and FISH analyses were performed on genomic DNA and on lymphoblastoid cell lines of the study participants.
  • Totally 19 chromosomes, 18 specific polymorphic microsatellite markers, and 5 BAC clones were used.

  • Genetics Home Reference. consumer health - chromosome 18.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Wiley-Liss, Inc.
  • (PMID = 16691587.001).
  • [ISSN] 1552-4825
  • [Journal-full-title] American journal of medical genetics. Part A
  • [ISO-abbreviation] Am. J. Med. Genet. A
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


5. Owonikoko TK, Ramalingam SS, Kanterewicz B, Balius TE, Belani CP, Hershberger PA: Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells. Int J Cancer; 2010 Feb 1;126(3):743-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.
  • We observed a 53% response rate in non-small cell lung cancer (NSCLC) patients treated with vorinostat plus paclitaxel/carboplatin in a Phase I trial.
  • Vorinostat addition to carboplatin or paclitaxel led to significantly greater growth inhibition than chemotherapy alone in all 4 cell lines.

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Vorinostat .
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oncol Rep. 2006 Jan;15(1):187-91 [16328054.001]
  • [Cites] Cancer Chemother Pharmacol. 2006 Jan;57(2):257-67 [16028101.001]
  • [Cites] Cancer Res. 2006 May 15;66(10):5409-18 [16707469.001]
  • [Cites] BMC Cancer. 2006;6:183 [16834771.001]
  • [Cites] Mol Cancer Ther. 2006 Aug;5(8):1967-74 [16928817.001]
  • [Cites] Mol Cancer Ther. 2006 Aug;5(8):2086-95 [16928830.001]
  • [Cites] Cancer Res. 2006 Sep 1;66(17):8838-46 [16951201.001]
  • [Cites] Nat Rev Drug Discov. 2006 Sep;5(9):769-84 [16955068.001]
  • [Cites] J Cell Biol. 1981 Nov;91(2 Pt 1):479-87 [6118377.001]
  • [Cites] Biochemistry. 1995 Jul 4;34(26):8474-80 [7599137.001]
  • [Cites] Am J Physiol. 1995 Jun;268(6 Pt 1):L1012-20 [7611423.001]
  • [Cites] Cancer Res. 1998 Aug 15;58(16):3620-6 [9721870.001]
  • [Cites] Clin Cancer Res. 1997 Mar;3(3):449-54 [9815704.001]
  • [Cites] Nat Rev Drug Discov. 2005 Apr;4(4):307-20 [15789122.001]
  • [Cites] Mol Cell. 2005 Jun 10;18(6):617-22 [15949437.001]
  • [Cites] Mol Cell Biol. 2005 Aug;25(16):7158-69 [16055725.001]
  • [Cites] Clin Cancer Res. 2006 Sep 15;12(18):5570-7 [17000694.001]
  • [Cites] Mol Cancer Ther. 2006 Nov;5(11):2767-76 [17121923.001]
  • [Cites] Cancer Res. 2006 Dec 1;66(23):11298-304 [17145876.001]
  • [Cites] N Engl J Med. 2006 Dec 14;355(24):2542-50 [17167137.001]
  • [Cites] Scand J Gastroenterol. 2007 Jan;42(1):103-16 [17190770.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 May 8;104(19):8071-6 [17470784.001]
  • [Cites] Clin Cancer Res. 2007 Jun 15;13(12):3605-10 [17510206.001]
  • [Cites] Biochem Pharmacol. 2007 Sep 1;74(5):659-71 [17498667.001]
  • [Cites] Oncologist. 2007 Oct;12(10):1247-52 [17962618.001]
  • [Cites] Pulm Pharmacol Ther. 1999;12(5):291-302 [10545285.001]
  • [Cites] J Natl Cancer Inst. 2000 Aug 2;92(15):1210-6 [10922406.001]
  • [Cites] Cancer Chemother Pharmacol. 2001 May;47(5):429-36 [11391859.001]
  • [Cites] Nature. 2002 May 23;417(6887):455-8 [12024216.001]
  • [Cites] Anticancer Res. 2002 May-Jun;22(3):1497-504 [12168829.001]
  • [Cites] Curr Cancer Drug Targets. 2002 Dec;2(4):337-53 [12470210.001]
  • [Cites] EMBO J. 2003 Mar 3;22(5):1168-79 [12606581.001]
  • [Cites] Anticancer Res. 2003 Jan-Feb;23(1A):499-503 [12680257.001]
  • [Cites] Oncol Rep. 2003 Nov-Dec;10(6):1663-82 [14534679.001]
  • [Cites] Cancer Res. 2003 Nov 1;63(21):7291-300 [14612526.001]
  • [Cites] Cancer Res. 2003 Nov 15;63(22):7891-9 [14633718.001]
  • [Cites] Cancer Res. 2004 Jan 1;64(1):316-21 [14729640.001]
  • [Cites] Semin Oncol. 2004 Feb;31(1 Suppl 1):68-74 [14981583.001]
  • [Cites] Cytometry A. 2004 Apr;58(2):99-110 [15057963.001]
  • (PMID = 19621389.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA090440-08; United States / NCI NIH HHS / CA / P50 CA090440; United States / NCI NIH HHS / CA / R01 CA132844-01A2; United States / NCI NIH HHS / CA / P50 CA90440; United States / NCI NIH HHS / CA / CA132844-01A2; United States / NCI NIH HHS / CA / P50 CA090440-08; United States / NCI NIH HHS / CA / R01 CA132844
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Histone Deacetylase Inhibitors; 0 / Histones; 0 / Hydroxamic Acids; 0 / Neoplasm Proteins; 0 / Tubulin; 58IFB293JI / vorinostat; BG3F62OND5 / Carboplatin; P88XT4IS4D / Paclitaxel
  • [Other-IDs] NLM/ NIHMS137936; NLM/ PMC2795066
  •  go-up   go-down


6. Wislez M, Antoine M, Baudrin L, Poulot V, Neuville A, Pradere M, Longchampt E, Isaac-Sibille S, Lebitasy MP, Cadranel J: Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib. Lung Cancer; 2010 May;68(2):185-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.
  • There is no optimal established therapy for treating advanced or recurrent adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC), and it remains unclear whether chemotherapy achieves therapeutic results comparable to those seen in the more common non-small lung carcinoma subtypes.
  • In order to improve the decisions made during the treatment of advanced ADC-BAC, we attempted to better characterize the mucinous and non-mucinous ADC-BAC subtypes.
  • Fifty pathological samples were obtained from 62 patients included in a multicenter prospective phase II trial (IFCT0401) conducted to evaluate gefitinib as a first-line therapy for non-resectable ADC-BAC.
  • We demonstrated that demographic data, clinical characteristics and stage at presentation (extrathoracic versus lung metastasis, as well as TNM staging) did not distinguish between the two subtypes.
  • In contrast, three biological markers (PAS staining, TTF-1 expression and EGFR genomic gain combined with mutation analysis) enabled us to independently segregate all but 2 of the 50 patients into the mucinous and non-mucinous ADC-BAC subtypes.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / diagnosis. Adenocarcinoma, Mucinous / diagnosis. DNA-Binding Proteins / metabolism. Lung Neoplasms / diagnosis. Receptor, Epidermal Growth Factor / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Biomarkers, Tumor / genetics. Biomarkers, Tumor / metabolism. DNA Mutational Analysis. Disease Progression. Drug Resistance, Neoplasm. Female. Humans. Male. Middle Aged. Quinazolines / therapeutic use

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 19581016.001).
  • [ISSN] 1872-8332
  • [Journal-full-title] Lung cancer (Amsterdam, Netherlands)
  • [ISO-abbreviation] Lung Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA-Binding Proteins; 0 / Quinazolines; 0 / TTF1 protein, human; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; S65743JHBS / gefitinib
  •  go-up   go-down


7. Venkatraman L, Kalangutkar A, Russell CF: Primary hyperparathyroidism and metastatic carcinoma within parathyroid gland. J Clin Pathol; 2007 Sep;60(9):1058-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary hyperparathyroidism and metastatic carcinoma within parathyroid gland.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / secondary. Hyperparathyroidism, Primary / complications. Lung Neoplasms. Parathyroid Neoplasms / secondary


8. Lin W, Huang YW, Zhou XD, Ma Y: In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol; 2006 Dec 15;217(3):252-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In vitro toxicity of silica nanoparticles in human lung cancer cells.
  • The cytotoxicity of 15-nm and 46-nm silica nanoparticles was investigated by using crystalline silica (Min-U-Sil 5) as a positive control in cultured human bronchoalveolar carcinoma-derived cells.
  • Exposure to 15-nm or 46-nm SiO(2) nanoparticles for 48 h at dosage levels between 10 and 100 microg/ml decreased cell viability in a dose-dependent manner.
  • Cell viability decreased significantly as a function of both nanoparticle dosage (10-100 microg/ml) and exposure time (24 h, 48 h, and 72 h).
  • In summary, exposure to SiO(2) nanoparticles results in a dose-dependent cytotoxicity in cultural human bronchoalveolar carcinoma-derived cells that is closely correlated to increased oxidative stress.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / drug therapy. Lung Neoplasms / drug therapy. Nanoparticles / toxicity. Silicon Dioxide / toxicity
  • [MeSH-minor] Cell Line, Tumor. Cell Survival / drug effects. Chromatography, High Pressure Liquid. Dose-Response Relationship, Drug. Glutathione / metabolism. Humans. L-Lactate Dehydrogenase / metabolism. Lipid Peroxidation / drug effects. Malondialdehyde / metabolism. Oxidative Stress / drug effects. Particle Size. Reactive Oxygen Species / metabolism

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MALONALDEHYDE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Toxicol Appl Pharmacol. 2007 Apr 15;220(2):225; author reply 226 [17350663.001]
  • (PMID = 17112558.001).
  • [ISSN] 0041-008X
  • [Journal-full-title] Toxicology and applied pharmacology
  • [ISO-abbreviation] Toxicol. Appl. Pharmacol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Reactive Oxygen Species; 4Y8F71G49Q / Malondialdehyde; 7631-86-9 / Silicon Dioxide; EC 1.1.1.27 / L-Lactate Dehydrogenase; GAN16C9B8O / Glutathione
  •  go-up   go-down


9. Conner JA, Goel S, Gunawan G, Cordonnier-Pratt MM, Johnson VE, Liang C, Wang H, Pratt LH, Mullet JE, DeBarry J, Yang L, Bennetzen JL, Klein PE, Ozias-Akins P: Sequence analysis of bacterial artificial chromosome clones from the apospory-specific genomic region of Pennisetum and Cenchrus. Plant Physiol; 2008 Jul;147(3):1396-411
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sequence analysis of bacterial artificial chromosome clones from the apospory-specific genomic region of Pennisetum and Cenchrus.
  • Thirty-two ASGR bacterial artificial chromosomes (BACs) isolated from both species and one ASGR-recombining BAC from P. squamulatum, which together cover approximately 2.7 Mb of DNA, were used to investigate the genomic structure of this region.
  • Phrap assembly of 4,521 high-quality reads generated 1,341 contiguous sequences (contigs; 730 from the ASGR and 30 from the ASGR-recombining BAC in P. squamulatum, plus 580 from the C. ciliaris ASGR).
  • These putative coding regions were further analyzed in silico with reference to the rice (Oryza sativa) and sorghum (Sorghum bicolor) genomes using the resources at Gramene (www.gramene.org) and Phytozome (www.phytozome.net) and by hybridization against sorghum BAC filters.
  • [MeSH-minor] Arabidopsis Proteins / genetics. Chromosomes, Artificial, Bacterial. Cloning, Molecular. DNA Transposable Elements. Gene Duplication. Genome, Plant. Molecular Sequence Data. Oryza / genetics. Sequence Analysis, DNA. Sorghum / genetics. Synteny. Transcription Factors / genetics

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 2000 Dec 15;290(5499):2114-7 [11118139.001]
  • [Cites] Planta. 2007 Nov;226(6):1353-62 [17628826.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8714-9 [11447285.001]
  • [Cites] Plant Mol Biol. 2002 Mar-Apr;48(5-6):821-7 [11999852.001]
  • [Cites] Hereditas. 2001;135(1):19-25 [12035611.001]
  • [Cites] Plant Cell. 2002 Aug;14(8):1737-49 [12172019.001]
  • [Cites] Nature. 2003 Mar 27;422(6930):433-8 [12660784.001]
  • [Cites] Genetics. 2003 Mar;163(3):1069-82 [12663545.001]
  • [Cites] Curr Opin Plant Biol. 2003 Apr;6(2):128-33 [12667868.001]
  • [Cites] Plant J. 2003 Jun;34(5):605-21 [12787243.001]
  • [Cites] Heredity (Edinb). 1999 Dec;83 ( Pt 6):715-21 [10651916.001]
  • [Cites] Genetics. 2000 May;155(1):379-90 [10790411.001]
  • [Cites] Plant Cell. 2000 May;12(5):637-46 [10810140.001]
  • [Cites] Genetics. 2003 Sep;165(1):367-86 [14504243.001]
  • [Cites] Nucleic Acids Res. 2004 Jan 1;32(Database issue):D360-3 [14681434.001]
  • [Cites] Mol Genet Genomics. 2004 Jan;270(6):539-48 [14648202.001]
  • [Cites] Plant Physiol. 2004 Apr;134(4):1733-41 [15064383.001]
  • [Cites] Mol Genet Genomics. 2004 May;271(4):377-86 [15014981.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14349-54 [15388850.001]
  • [Cites] Biochim Biophys Acta. 1979 Apr 26;562(2):192-206 [444525.001]
  • [Cites] Hoppe Seylers Z Physiol Chem. 1980 Aug;361(8):1223-33 [7409756.001]
  • [Cites] Curr Biol. 1995 Jul 1;5(7):737-9 [7583118.001]
  • [Cites] Heredity (Edinb). 1998 Jan;80 ( Pt 1):33-9 [9474774.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5127-32 [9560240.001]
  • [Cites] Genetics. 2005 Feb;169(2):1169-73 [15489512.001]
  • [Cites] Curr Opin Plant Biol. 2005 Apr;8(2):135-41 [15752992.001]
  • [Cites] Bioinformatics. 2005 Aug 15;21(16):3422-3 [15976072.001]
  • [Cites] Nature. 2005 Aug 11;436(7052):793-800 [16100779.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13206-11 [16141333.001]
  • [Cites] Plant Physiol. 2005 Aug;138(4):1898-902 [16172096.001]
  • [Cites] Theor Appl Genet. 2005 Oct;111(6):1042-51 [16133318.001]
  • [Cites] Plant Physiol. 2005 Oct;139(2):869-84 [16169961.001]
  • [Cites] Curr Opin Genet Dev. 2005 Dec;15(6):621-7 [16219458.001]
  • [Cites] Plant Physiol. 2006 Mar;140(3):963-71 [16415213.001]
  • [Cites] Theor Appl Genet. 2006 Apr;112(6):1179-91 [16463157.001]
  • [Cites] BMC Bioinformatics. 2006;7:115 [16522212.001]
  • [Cites] Genetics. 2006 May;173(1):389-400 [16547108.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17638-43 [17101966.001]
  • [Cites] Nature. 2000 Dec 14;408(6814):796-815 [11130711.001]
  • (PMID = 18508959.001).
  • [ISSN] 0032-0889
  • [Journal-full-title] Plant physiology
  • [ISO-abbreviation] Plant Physiol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ ED544199/ ED548719/ EU559277/ EU559280
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Arabidopsis Proteins; 0 / BABY BOOM protein, Arabidopsis; 0 / DNA Transposable Elements; 0 / Transcription Factors
  • [Other-IDs] NLM/ PMC2442526
  •  go-up   go-down


10. van Duin M, van Marion R, Watson JE, Paris PL, Lapuk A, Brown N, Oseroff VV, Albertson DG, Pinkel D, de Jong P, Nacheva EP, Dinjens W, van Dekken H, Collins C: Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization. Cytometry A; 2005;63(1):10-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization.
  • METHODS: A minimal tiling path contig of 702 8q-specific bacterial artificial chromosome (BAC) clones was generated with a novel computational tool (BAC Contig Assembler).
  • BAC clones were amplified by degenerative oligonucleotide primer (DOP) polymerase chain reaction and subsequently printed onto glass slides.
  • For validation of the array DNA samples of gastroesophageal and prostate cancer cell lines, and chronic myeloid leukemia specimens were used, which were previously characterized by multicolor fluorescence in situ hybridization and conventional CGH.
  • The 8q array was further tested with paraffin-embedded prostate cancer specimens.
  • In comparison with conventional CGH, the resolution of the detected changes was much improved, which was demonstrated by an amplicon of 0.7 Mb and a deletion of 0.6 Mb, both spanned by only six BAC clones.
  • [MeSH-minor] Adenocarcinoma / genetics. Cardia. Chromosome Aberrations. Fixatives. Formaldehyde. Humans. In Situ Hybridization, Fluorescence. Male. Nucleic Acid Hybridization. Oligonucleotide Array Sequence Analysis. Prostatic Neoplasms / genetics. Stomach Neoplasms / genetics. Tumor Cells, Cultured

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FORMALDEHYDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15619731.001).
  • [ISSN] 1552-4922
  • [Journal-full-title] Cytometry. Part A : the journal of the International Society for Analytical Cytology
  • [ISO-abbreviation] Cytometry A
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA89520
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fixatives; 1HG84L3525 / Formaldehyde
  •  go-up   go-down


11. Xie SG, Shi DW, Wen DH, Wang R, Xi DL: Control of bromate and THM precursors using ozonation combined system. Biomed Environ Sci; 2007 Jun;20(3):217-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The biological activated carbon (BAC) filter could effectively reduce CHCl3FP and CHCl2BrFP, but increase CHClBr2FP.

  • MedlinePlus Health Information. consumer health - Ozone.
  • Hazardous Substances Data Bank. OZONE .
  • Hazardous Substances Data Bank. CHLORINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17672213.001).
  • [ISSN] 0895-3988
  • [Journal-full-title] Biomedical and environmental sciences : BES
  • [ISO-abbreviation] Biomed. Environ. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bromates; 0 / Trihalomethanes; 4R7X1O2820 / Chlorine; 66H7ZZK23N / Ozone
  •  go-up   go-down


12. Boross P, Breukel C, van Loo PF, van der Kaa J, Claassens JW, Bujard H, Schönig K, Verbeek JS: Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector. Genesis; 2009 Nov;47(11):729-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
  • The generation of cell type specific inducible Cre transgenic mice is the most challenging and limiting part in the development of spatio-temporally controlled knockout mouse models.
  • Here we report the generation and characterization of a B lymphocyte-specific tamoxifen-inducible Cre transgenic mouse strain, LC-1-hCD19-CreER(T2).
  • [MeSH-major] B-Lymphocytes / metabolism. Chromosomes, Artificial, Bacterial. Gene Expression Regulation / drug effects. Integrases / genetics. Tamoxifen / pharmacology. Transgenes

  • Hazardous Substances Data Bank. TAMOXIFEN .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • SciCrunch. Marmoset Gene list: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 Wiley-Liss, Inc.
  • (PMID = 19621440.001).
  • [ISSN] 1526-968X
  • [Journal-full-title] Genesis (New York, N.Y. : 2000)
  • [ISO-abbreviation] Genesis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD19; 0 / DNA Primers; 094ZI81Y45 / Tamoxifen; EC 2.7.7.- / Cre recombinase; EC 2.7.7.- / Integrases
  •  go-up   go-down


13. Shintani Y, Ohta M, Iwasaki T, Ikeda N, Tomita E, Nagano T, Kawahara K: A case of micronodular pneumocyte hyperplasia diagnosed through surgical resection. Ann Thorac Cardiovasc Surg; 2010 Aug;16(1):45-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Micronodular pneumocyte hyperplasia (MNPH) is often associated with tuberous sclerosis complex and/or lymphangioleiomyomatosis.
  • We present the case of a 45-year-old woman with MNPH without evidence of either.
  • A preoperative high-resolution chest computed topographic scan demonstrated a ground-glass opacity 8 mm in diameter that revealed the possibility of atypical adenomatous hyperplasia (AAH) or bronchioloalveolar carcinoma (BAC).
  • Therefore an S3 segmentectomy of the right lung was performed, and the specimens revealed the characteristic histological and immunohistological features of MNPH.
  • Solitary MNPH is extremely rare and requires to be distinguished from AAH or BAC on a computed tomographic scan; therefore surgical resection may be required to definitely rule out malignancy.
  • [MeSH-major] Pneumocytes / pathology. Solitary Pulmonary Nodule / diagnosis
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Female. Humans. Hyperplasia. Immunohistochemistry. Middle Aged. Predictive Value of Tests. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20190710.001).
  • [ISSN] 2186-1005
  • [Journal-full-title] Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
  • [ISO-abbreviation] Ann Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


14. Jain D, Joshi K, Jindal SK: Precursor lesions of adenocarcinoma lung--two case reports. Indian J Pathol Microbiol; 2005 Jul;48(3):399-402
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Precursor lesions of adenocarcinoma lung--two case reports.
  • Although precursor lesions of bronchogenic squamous cell carcinoma are well documented, the preinvasive lesions of pulmonary adenocarcinoma are seen very rarely.
  • It has been hypothesized that there is a stepwise progression of alveolar epithelial hyperplasia to atypical alveolar hyperplasia and subsequently to malignancy in the pathogenesis of peripheral adenocarcinoma of the lung.
  • In the present paper we would like to share our experience of two cases of pulmonary adenocarcinoma with their precursor lesions in the form of atypical alveolar hyperplasia.
  • [MeSH-major] Adenocarcinoma / pathology. Lung Diseases, Interstitial / pathology. Lung Neoplasms / pathology. Precancerous Conditions / pathology. Pulmonary Alveoli / pathology

  • MedlinePlus Health Information. consumer health - Interstitial Lung Diseases.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16761769.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


15. Findley SD, Cannon S, Varala K, Du J, Ma J, Hudson ME, Birchler JA, Stacey G: A fluorescence in situ hybridization system for karyotyping soybean. Genetics; 2010 Jul;185(3):727-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The development of a universal soybean (Glycine max [L.
  • We used genetically anchored BAC clones both to identify individual chromosomes in metaphase spreads and to complete a FISH-based karyotyping cocktail that permitted simultaneous identification of all 20 chromosome pairs.
  • These studies led to the identification and characterization of a reciprocal chromosome translocation between chromosomes 11 and 13 in two accessions of wild soybean.
  • [MeSH-minor] Base Sequence. Chromosomes, Artificial, Bacterial. DNA, Plant. Molecular Sequence Data. Nucleic Acid Hybridization

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Plant Cell. 2002 Aug;14(8):1691-704 [12172016.001]
  • [Cites] Science. 2001 Aug 10;293(5532):1098-102 [11498581.001]
  • [Cites] Plant Physiol. 2004 May;135(1):59-70 [15141067.001]
  • [Cites] Theor Appl Genet. 2004 Jun;109(1):122-8 [14991109.001]
  • [Cites] Plant Cell. 2004 Jul;16(7):1667-78 [15208399.001]
  • [Cites] Genome. 2004 Aug;47(4):764-8 [15284882.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13554-9 [15342909.001]
  • [Cites] Biochem Genet. 1978 Feb;16(1-2):45-68 [565635.001]
  • [Cites] Biochim Biophys Acta. 1979 Jan 26;561(1):167-83 [570420.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Dec;86(23):9394-8 [2594775.001]
  • [Cites] J Mol Biol. 1990 Oct 5;215(3):403-10 [2231712.001]
  • [Cites] Plant Mol Biol. 1991 Jul;17(1):101-9 [1868210.001]
  • [Cites] Plant Mol Biol. 1995 Nov;29(4):857-62 [8541510.001]
  • [Cites] Chromosome Res. 1997 Sep;5(6):363-73 [9364938.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13073-8 [9789043.001]
  • [Cites] Biotech Histochem. 1999 May;74(3):160-6 [10416789.001]
  • [Cites] Genetics. 2005 Feb;169(2):1169-73 [15489512.001]
  • [Cites] Genetics. 2005 Jul;170(3):1221-30 [15879505.001]
  • [Cites] Plant J. 2006 Mar;45(5):857-62 [16460517.001]
  • [Cites] Curr Opin Plant Biol. 2006 Apr;9(2):104-9 [16458041.001]
  • [Cites] Genetics. 2006 Mar;172(3):1893-900 [16361231.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16666-71 [17068128.001]
  • [Cites] Curr Opin Plant Biol. 2007 Apr;10(2):109-15 [17289425.001]
  • [Cites] Genetics. 2007 May;176(1):685-96 [17339218.001]
  • [Cites] BMC Genomics. 2007;8:132 [17524145.001]
  • [Cites] BMC Genomics. 2007;8:330 [17880721.001]
  • [Cites] BMC Genomics. 2007;8:427 [18031571.001]
  • [Cites] Genome. 2008 Apr;51(4):294-302 [18356965.001]
  • [Cites] Theor Appl Genet. 2008 Apr;116(6):745-53 [18214422.001]
  • [Cites] Cytogenet Genome Res. 2008;120(3-4):351-7 [18504364.001]
  • [Cites] Genetics. 1948 Jan;33(1):131 [18933709.001]
  • [Cites] Plant Physiol. 2009 Nov;151(3):1167-74 [19605552.001]
  • [Cites] J Hered. 2009 Nov-Dec;100(6):798-801 [19451208.001]
  • [Cites] Nature. 2010 Jan 14;463(7278):178-83 [20075913.001]
  • [Cites] BMC Genomics. 2010;11:38 [20078886.001]
  • [Cites] BMC Genomics. 2010;11:113 [20163715.001]
  • [Cites] Theor Appl Genet. 2003 Aug;107(4):745-50 [12783169.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3672-8 [12824391.001]
  • (PMID = 20421607.001).
  • [ISSN] 1943-2631
  • [Journal-full-title] Genetics
  • [ISO-abbreviation] Genetics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Plant
  • [Other-IDs] NLM/ PMC2907198
  •  go-up   go-down


16. Buchanan W, Roddick F, Porter N: Removal of VUV pre-treated natural organic matter by biologically activated carbon columns. Water Res; 2008 Jul;42(13):3335-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The system uses sufficient VUV radiation (16J cm(-2)) to significantly enhance the production of biologically degradable moieties prior to treatment with biologically activated carbon (BAC).
  • The VUV-BAC process decreased the overall dissolved organic carbon (DOC) concentration of a natural water sample by 54% and 44% for the virgin carbon and previously used BAC, respectively.
  • Furthermore, VUV-BAC treatment decreased the trihalomethane (THM) formation potential (THMFP) by 60-70% and the haloacetic acid (HAA) formation potential (HAAFP) by 74%.
  • The BAC systems effectively removed the hydrogen peroxide residual produced by VUV irradiation.
  • Although nitrite formation can result from VUV treatment of natural organic matter (NOM), none was detected before or after BAC treatment.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CARBON .
  • Hazardous Substances Data Bank. HYDROGEN PEROXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18502470.001).
  • [ISSN] 0043-1354
  • [Journal-full-title] Water research
  • [ISO-abbreviation] Water Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biological Products; 0 / Nitrates; 0 / Organic Chemicals; 7440-44-0 / Carbon; BBX060AN9V / Hydrogen Peroxide
  •  go-up   go-down


17. Ou SH, Zell JA: Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol; 2008 Mar;3(3):216-27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
  • BACKGROUND: We performed a validation study of the proposed International Association for the Study of Lung Cancer (IASLC) tumor, node, metastasis (TNM) and stage grouping revisions on advanced nonbronchioloalveolar carcinoma (non-BAC) non-small cell lung cancer (NSCLC).
  • METHODS: Twenty-three thousand five hundred eighty-three patients from the California Cancer Registry between 1999 and 2003 with histologically confirmed non-BAC NSCLC and complete TNM staging were identified and reclassified according to the IASLC proposed TNM revisions and new stage groupings.
  • Surveillance, Epidemiology, and End Results extent of disease codes were used to identify various T4 and M descriptors.
  • T4 due to additional nodules had significant survival advantage over other T4 and M descriptors among non-BAC NSCLC and individual histology and warrants down-staging to T3.
  • CONCLUSIONS: IASLC has greatly improved the T4 and M descriptors allowing better prognostication of advanced non-BAC NSCLC.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / secondary. Heart Neoplasms / secondary. Lung Neoplasms / pathology. Neoplasm Staging / methods. Pleural Neoplasms / secondary. Registries / statistics & numerical data

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18317063.001).
  • [ISSN] 1556-1380
  • [Journal-full-title] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • [ISO-abbreviation] J Thorac Oncol
  • [Language] eng
  • [Grant] United States / NCCDPHP CDC HHS / DP / 1U58DP00807-01; United States / NCI NIH HHS / PC / N01-PC-35136; United States / NCI NIH HHS / PC / N01-PC-35139; United States / NCI NIH HHS / PC / N01-PC-54404
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Validation Studies
  • [Publication-country] United States
  •  go-up   go-down


18. Devillard E, McIntosh FM, Newbold CJ, Wallace RJ: Rumen ciliate protozoa contain high concentrations of conjugated linoleic acids and vaccenic acid, yet do not hydrogenate linoleic acid or desaturate stearic acid. Br J Nutr; 2006 Oct;96(4):697-704
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In incubations with ruminal microbial fractions (bacterial fraction (BAC), protozoal fraction (PRO)), LA metabolism was very similar in strained ruminal fluid (SRF) and in the BAC, while the PRO had LA-metabolising activity an order of magnitude lower.
  • The absence of an alternative route of VA/CLA formation via desaturation of stearate was confirmed by incubations of SRF, BAC or PRO with [14C]stearate.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. STEARIC ACID .
  • Hazardous Substances Data Bank. LINOLEIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17010229.001).
  • [ISSN] 0007-1145
  • [Journal-full-title] The British journal of nutrition
  • [ISO-abbreviation] Br. J. Nutr.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Linoleic Acids, Conjugated; 0 / Oleic Acids; 0 / Stearic Acids; 143-25-9 / 11-octadecenoic acid; 4ELV7Z65AP / stearic acid; 9KJL21T0QJ / Linoleic Acid
  •  go-up   go-down


19. Toonkel RL, Borczuk AC, Powell CA: Tgf-beta signaling pathway in lung adenocarcinoma invasion. J Thorac Oncol; 2010 Feb;5(2):153-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tgf-beta signaling pathway in lung adenocarcinoma invasion.
  • The histologic distinction between bronchioloalveolar carcinoma and other adenocarcinomas is tissue invasion.
  • The clinical importance of lung adenocarcinoma invasion is supported by several recent studies indicating that the risk of death in nonmucinous bronchioloalveolar carcinoma is significantly lower than that of pure invasive tumors and in tumors with greater than 0.5 cm of fibrosis or linear invasion.
  • Subsequent studies showed that the CC chemokine regulated on activation, normal T cell expressed, and presumably secreted was up-regulated in invasive tumors and was required for invasion in cells with repressed levels of the transforming growth factor-beta type II receptor.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2002 Jun;109(12):1607-15 [12070308.001]
  • [Cites] Nat Med. 2002 Aug;8(8):816-24 [12118244.001]
  • [Cites] Lung Cancer. 2002 Nov;38(2):143-7 [12399125.001]
  • [Cites] Cancer. 2002 Dec 15;95(12):2546-54 [12467069.001]
  • [Cites] Eur J Cardiothorac Surg. 2003 Mar;23(3):409-14 [12614815.001]
  • [Cites] Nat Rev Cancer. 2003 Jun;3(6):453-8 [12778135.001]
  • [Cites] Lung Cancer. 2003 Jun;40(3):281-7 [12781426.001]
  • [Cites] Am J Surg Pathol. 2003 Jul;27(7):937-51 [12826886.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8430-5 [12808151.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8621-3 [12861075.001]
  • [Cites] J Clin Invest. 2003 Oct;112(7):1116-24 [14523048.001]
  • [Cites] Ann Thorac Cardiovasc Surg. 2003 Oct;9(5):295-300 [14672525.001]
  • [Cites] Cancer Res. 2003 Dec 1;63(23):8284-92 [14678987.001]
  • [Cites] Nat Rev Cancer. 2003 Nov;3(11):807-21 [14557817.001]
  • [Cites] Am J Surg Pathol. 2004 Feb;28(2):198-206 [15043309.001]
  • [Cites] Clin Cancer Res. 2004 Apr 1;10(7):2359-67 [15073112.001]
  • [Cites] J Immunol. 2004 Jun 15;172(12):7335-40 [15187109.001]
  • [Cites] Cancer Res. 2004 Jul 1;64(13):4523-30 [15231662.001]
  • [Cites] Cancer Res. 2004 Jul 15;64(14):4687-92 [15256431.001]
  • [Cites] Br J Cancer. 1993 May;67(5):1015-21 [8388229.001]
  • [Cites] Cancer Genet Cytogenet. 2006 Aug;169(1):39-44 [16875935.001]
  • [Cites] Cancer Res. 2006 Oct 15;66(20):9837-44 [17047044.001]
  • [Cites] Genes Dev. 2006 Nov 15;20(22):3147-60 [17114585.001]
  • [Cites] Cancer Cell. 2007 Feb;11(2):147-60 [17292826.001]
  • [Cites] Mod Pathol. 2007 Feb;20(2):233-41 [17192789.001]
  • [Cites] J Clin Invest. 2007 May;117(5):1305-13 [17415413.001]
  • [Cites] Ann Thorac Surg. 2007 Nov;84(5):1675-9 [17954084.001]
  • [Cites] Cancer Cell. 2008 Jan;13(1):23-35 [18167337.001]
  • [Cites] Oncogene. 2008 Jan 17;27(4):557-64 [17653092.001]
  • [Cites] Cancer Res. 2008 May 15;68(10):3835-43 [18483268.001]
  • [Cites] Am J Surg Pathol. 2008 Jun;32(6):810-27 [18391747.001]
  • [Cites] J Cancer Res Clin Oncol. 2008 Aug;134(8):919-25 [18421475.001]
  • [Cites] Nat Med. 2008 Aug;14(8):822-7 [18641660.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18758-63 [19022904.001]
  • [Cites] Am J Surg Pathol. 2009 Mar;33(3):462-9 [19092635.001]
  • [Cites] Proc Am Thorac Soc. 2009 Apr 15;6(2):152-8 [19349483.001]
  • [Cites] Biochim Biophys Acta. 2009 Jul;1793(7):1165-73 [19339207.001]
  • [Cites] Cancer. 1999 Oct 15;86(8):1455-62 [10526273.001]
  • [Cites] J Natl Cancer Inst. 1999 Dec 15;91(24):2096-101 [10601380.001]
  • [Cites] Oncogene. 1999 Dec 2;18(51):7280-6 [10602482.001]
  • [Cites] Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):159-68 [10708963.001]
  • [Cites] Ann Thorac Surg. 2000 Mar;69(3):893-7 [10750779.001]
  • [Cites] Anticancer Res. 2000 May-Jun;20(3A):1499-502 [10928062.001]
  • [Cites] Lung Cancer. 2000 Sep;29(3):179-88 [10996420.001]
  • [Cites] Exp Lung Res. 2000 Dec;26(8):685-707 [11195465.001]
  • [Cites] Lung Cancer. 2001 Feb-Mar;31(2-3):181-91 [11165397.001]
  • [Cites] Exp Cell Res. 2001 Mar 10;264(1):169-84 [11237532.001]
  • [Cites] Nat Rev Mol Cell Biol. 2000 Dec;1(3):169-78 [11252892.001]
  • [Cites] Cancer. 2001 Mar 1;91(5):964-71 [11251948.001]
  • [Cites] Nat Genet. 2001 Oct;29(2):117-29 [11586292.001]
  • [Cites] J Biol Chem. 2001 Dec 14;276(50):46707-13 [11590169.001]
  • [Cites] Am J Pathol. 2002 Jan;160(1):347-55 [11786428.001]
  • [Cites] Eur Respir J. 2001 Dec;18(6):1059-68 [11829087.001]
  • [Cites] Am J Respir Crit Care Med. 2002 Feb 15;165(4):508-13 [11850344.001]
  • [Cites] Eur J Clin Invest. 2002 Mar;32(3):193-8 [11895471.001]
  • [Cites] Nat Rev Cancer. 2001 Oct;1(1):46-54 [11900251.001]
  • [Cites] Science. 1995 Jun 2;268(5215):1336-8 [7761852.001]
  • [Cites] Gastroenterology. 1996 Feb;110(2):375-82 [8566583.001]
  • [Cites] Oncol Res. 1997;9(2):89-98 [9167190.001]
  • [Cites] Cancer Res. 1998 Jul 15;58(14):3101-4 [9679977.001]
  • [Cites] Prostate. 1998 Sep 15;37(1):19-29 [9721065.001]
  • [Cites] Curr Biol. 1998 Nov 19;8(23):1243-52 [9822576.001]
  • [Cites] Br J Cancer. 1999 Mar;79(7-8):1005-11 [10098728.001]
  • [Cites] Lancet. 1999 Jul 10;354(9173):99-105 [10408484.001]
  • [Cites] AIDS Res Hum Retroviruses. 1999 Jul 1;15(10):869-74 [10408723.001]
  • [Cites] Cancer Res. 2004 Dec 15;64(24):9002-11 [15604265.001]
  • [Cites] J Clin Oncol. 2005 Mar 20;23(9):2078-93 [15774796.001]
  • [Cites] Cancer Res. 2005 Mar 15;65(6):2296-302 [15781643.001]
  • [Cites] Cancer Res. 2005 Apr 15;65(8):3374-9 [15833871.001]
  • [Cites] Am J Respir Crit Care Med. 2005 Sep 15;172(6):729-37 [15976377.001]
  • [Cites] Br J Cancer. 2005 Nov 14;93(10):1157-67 [16251876.001]
  • [Cites] Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):29-40 [16289860.001]
  • [Cites] Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):41-58 [16310402.001]
  • [Cites] Cancer Res. 2006 Feb 15;66(4):2202-9 [16489022.001]
  • [Cites] Lung Cancer. 2006 Apr;52(1):1-7 [16499994.001]
  • [Cites] J Immunol. 2006 Apr 15;176(8):4968-78 [16585593.001]
  • [Cites] J Clin Oncol. 2006 Apr 10;24(11):1679-88 [16549822.001]
  • [Cites] Arch Immunol Ther Exp (Warsz). 2006 Mar-Apr;54(2):143-7 [16648974.001]
  • [Cites] Genes Dev. 2006 May 15;20(10):1331-42 [16702406.001]
  • [Cites] Oncogene. 2006 Jun 8;25(24):3408-23 [16186809.001]
  • [Cites] Cancer Res. 2006 Jul 1;66(13):6714-21 [16818646.001]
  • (PMID = 20101143.001).
  • [ISSN] 1556-1380
  • [Journal-full-title] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • [ISO-abbreviation] J Thorac Oncol
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA120174-04; United States / NCI NIH HHS / CA / R01 CA120174; United States / NCI NIH HHS / CA / R01 CA120174-04
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chemokine CCL5; 0 / Transforming Growth Factor beta
  • [Number-of-references] 81
  • [Other-IDs] NLM/ NIHMS251531; NLM/ PMC2992959
  •  go-up   go-down


20. Yue W, Miao Y, Li X, Wu X, Zhao A, Nakagaki M: Cloning and expression of manganese superoxide dismutase of the silkworm, Bombyx mori by Bac-to-Bac/BmNPV Baculovirus expression system. Appl Microbiol Biotechnol; 2006 Nov;73(1):181-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cloning and expression of manganese superoxide dismutase of the silkworm, Bombyx mori by Bac-to-Bac/BmNPV Baculovirus expression system.
  • In this paper, we used the total fat body RNA of silkworm, Bombyx mori L. to clone and sequence a 648-bp Mn-SOD cDNA fragment through RT-PCR.
  • Furthermore, a newly established Bac-to-Bac/BmNPV Baculovirus expression system was used to overexpress the recombinant Mn-SOD enzyme in silkworm larvae.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16804693.001).
  • [ISSN] 0175-7598
  • [Journal-full-title] Applied microbiology and biotechnology
  • [ISO-abbreviation] Appl. Microbiol. Biotechnol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA, Complementary; 63231-63-0 / RNA; EC 1.15.1.1 / Superoxide Dismutase
  •  go-up   go-down


21. Výborný P, Sejcková L: [Antiglaucoma drugs--content of preservatives and the patient's compliance]. Cesk Slov Oftalmol; 2006 Jul;62(4):270-2, 274
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The authors compare the benzalconium chloride (BAC) concentrations in individual drug used for glaucoma treating.
  • The daily dose of BAC was calculated according to the drop's size and BAC concentration.
  • The daily dose of BAC differs depending on the selected therapy markedly--doses in the range from 0 to 10 micrograms were found.
  • The BAC concentration is one of important factors affecting the patient's compliance in the treatment of the primary open angle glaucoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16895060.001).
  • [ISSN] 1211-9059
  • [Journal-full-title] Ceská a slovenská oftalmologie : casopis Ceské oftalmologické spolecnosti a Slovenské oftalmologické spolecnosti
  • [ISO-abbreviation] Cesk Slov Oftalmol
  • [Language] cze
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Czech Republic
  • [Chemical-registry-number] 0 / Benzalkonium Compounds; 0 / Ophthalmic Solutions; 0 / Preservatives, Pharmaceutical
  •  go-up   go-down


22. Dar M, Giesler T, Richardson R, Cai C, Cooper M, Lavasani S, Kille P, Voet T, Vermeesch J: Development of a novel ozone- and photo-stable HyPer5 red fluorescent dye for array CGH and microarray gene expression analysis with consistent performance irrespective of environmental conditions. BMC Biotechnol; 2008;8:86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of a novel ozone- and photo-stable HyPer5 red fluorescent dye for array CGH and microarray gene expression analysis with consistent performance irrespective of environmental conditions.
  • In high resolution array CGH experiments, HyPer5 is demonstrated to detect chromosomal aberrations at loci 2p21-16.3 and 15q26.3-26.2 from three patient sample using bacterial artificial chromosome (BAC) arrays.

  • MedlinePlus Health Information. consumer health - Ozone.
  • Hazardous Substances Data Bank. OZONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biotechniques. 2002 Sep;33(3):620-8, 630 [12238772.001]
  • [Cites] Nucleic Acids Res. 2003 Oct 1;31(19):5676-84 [14500831.001]
  • [Cites] Anal Chem. 2003 Sep 1;75(17):4672-5 [14632079.001]
  • [Cites] Bioconjug Chem. 1993 Mar-Apr;4(2):105-11 [7873641.001]
  • [Cites] Mol Biotechnol. 2007 Jul;36(3):175-83 [17873405.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5814-9 [15827123.001]
  • [Cites] BMC Genomics. 2006;7:260 [17042939.001]
  • [Cites] BMC Biotechnol. 2007;7:8 [17295919.001]
  • [Cites] Nat Genet. 2007 Jul;39(7 Suppl):S16-21 [17597776.001]
  • [Cites] Science. 1997 Oct 24;278(5338):680-6 [9381177.001]
  • (PMID = 19014508.001).
  • [ISSN] 1472-6750
  • [Journal-full-title] BMC biotechnology
  • [ISO-abbreviation] BMC Biotechnol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carbocyanines; 0 / DNA, Complementary; 0 / Fluorescent Dyes; 66H7ZZK23N / Ozone
  • [Other-IDs] NLM/ PMC2613886
  •  go-up   go-down


23. Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, Finkbeiner S, Steffan JS, Thompson LM, Wetzel R, Yang XW: Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron; 2009 Dec 24;64(6):828-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.
  • The N-terminal 17 amino acids of huntingtin (NT17) can be phosphorylated on serines 13 and 16; however, the significance of these modifications in Huntington's disease pathogenesis remains unknown.
  • In this study, we developed BAC transgenic mice expressing full-length mutant huntingtin (fl-mhtt) with serines 13 and 16 mutated to either aspartate (phosphomimetic or SD) or alanine (phosphoresistant or SA).
  • However, fl-mhtt-induced disease pathogenesis, including motor and psychiatric-like behavioral deficits, mhtt aggregation, and selective neurodegeneration are abolished in SD but preserved in SA mice.
  • Together, our findings demonstrate that serines 13 and 16 are critical determinants of fl-mhtt-induced disease pathogenesis in vivo, supporting the targeting of huntingtin NT17 domain and its modifications in HD therapy.


24. Yamamoto R, Uenishi H, Yasue H, Takagaki Y, Sato E: The genomic structure and a novel alternatively spliced form of porcine pTalpha chain. Mol Immunol; 2007 Jan;44(4):591-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A complete genomic nucleotide sequence for porcine pTalpha gene was obtained from a BAC clone, which revealed a novel exon 2 missing in human and murine counterparts.
  • Using thymocyte RNA and RT-PCR, three types of porcine pTalpha-chain cDNA sequences, pTalpha1, pTalpha2 and pTalpha3, were obtained.
  • Using RT-PCR, pTalpha3 appeared expressed predominantly in the thymocyte RNA.
  • [MeSH-major] Alternative Splicing. Genome. Membrane Glycoproteins / genetics. Receptors, Antigen, T-Cell, alpha-beta / genetics. Swine / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16712934.001).
  • [ISSN] 0161-5890
  • [Journal-full-title] Molecular immunology
  • [ISO-abbreviation] Mol. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Membrane Glycoproteins; 0 / Receptors, Antigen, T-Cell, alpha-beta; 0 / pre-T cell receptor alpha
  •  go-up   go-down


25. Qiao Y, Liu X, Harvard C, Nolin SL, Brown WT, Koochek M, Holden JJ, Lewis ME, Rajcan-Separovic E: Large-scale copy number variants (CNVs): distribution in normal subjects and FISH/real-time qPCR analysis. BMC Genomics; 2007;8:167
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In order to understand their potential significance and to facilitate interpretation of array-CGH findings in constitutional disorders and cancers, we studied 27 normal individuals (9 Caucasian; 9 African American; 9 Hispanic) using commercially available 1 Mb resolution BAC array (Spectral Genomics).
  • A selection of CNVs was further analyzed by FISH and real-time quantitative PCR (RT-qPCR).
  • FISH analysis of 6 CNVs (4 previously reported and 2 novel CNVs) in normal subjects resulted in the confirmation of copy number changes for 1 of 2 novel CNVs and 2 of 4 known CNvs. Three CNVs tested by FISH were further validated by RT-qPCR and comparable data were obtained.
  • This included the lack of copy number change by both RT-qPCR and FISH for clone RP11-100C24, one of the most common known copy number variants, as well as confirmation of deletions for clones RP11-89M16 and RP5-1011O17.
  • Further study of a small selection of CNVs indicated concordant and discordant array vs. FISH/RT-qPCR results.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Biol Clin (Paris). 2004 Mar-Apr;62(2):203-12 [15047473.001]
  • [Cites] Am J Hum Genet. 2007 Jan;80(1):91-104 [17160897.001]
  • [Cites] Nat Genet. 2004 Sep;36(9):949-51 [15286789.001]
  • [Cites] Nat Genet. 2004 Sep;36(9):931-2 [15340426.001]
  • [Cites] Cytogenet Cell Genet. 1996;75(4):243-7 [9067434.001]
  • [Cites] Science. 1998 May 15;280(5366):1077-82 [9582121.001]
  • [Cites] Eur J Hum Genet. 2005 Feb;13(2):260-3 [15494738.001]
  • [Cites] Science. 2005 Mar 4;307(5714):1434-40 [15637236.001]
  • [Cites] Am J Hum Genet. 2005 Jul;77(1):78-88 [15918152.001]
  • [Cites] Nat Genet. 2005 Jul;37(7):727-32 [15895083.001]
  • [Cites] J Med Genet. 2005 Sep;42(9):699-705 [16141005.001]
  • [Cites] Am J Hum Genet. 2005 Oct;77(4):606-16 [16175506.001]
  • [Cites] Am J Med Genet A. 2005 Dec 15;139(3):173-85 [16283669.001]
  • [Cites] Nat Genet. 2006 Jan;38(1):75-81 [16327808.001]
  • [Cites] Nat Genet. 2006 Jan;38(1):82-5 [16327809.001]
  • [Cites] Nat Genet. 2006 Jan;38(1):9-11 [16380720.001]
  • [Cites] BMC Genomics. 2005;6:180 [16351727.001]
  • [Cites] Nat Rev Genet. 2006 Feb;7(2):85-97 [16418744.001]
  • [Cites] Nat Genet. 2006 Jan;38(1):86-92 [16468122.001]
  • [Cites] Nature. 2006 Feb 16;439(7078):851-5 [16482158.001]
  • [Cites] Genome Res. 2006 Aug;16(8):949-61 [16809666.001]
  • [Cites] Nature. 2006 Nov 23;444(7118):444-54 [17122850.001]
  • [Cites] Science. 2004 Jul 23;305(5683):525-8 [15273396.001]
  • (PMID = 17565693.001).
  • [ISSN] 1471-2164
  • [Journal-full-title] BMC genomics
  • [ISO-abbreviation] BMC Genomics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1920519
  •  go-up   go-down


26. Kerstens HH, Kollers S, Kommadath A, Del Rosario M, Dibbits B, Kinders SM, Crooijmans RP, Groenen MA: Mining for single nucleotide polymorphisms in pig genome sequence data. BMC Genomics; 2009;10:4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Available BAC and BAC-end sequences and their naming and mapping information, all obtained from SangerInstitute FTP site, served as a rough assembly of a reference genome.
  • [MeSH-minor] Animals. Chromosomes, Artificial, Bacterial. Cluster Analysis. Genetic Markers. Sequence Alignment. Sequence Analysis, DNA / methods

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Genome Res. 1999 Feb;9(2):167-74 [10022981.001]
  • [Cites] J Mol Biol. 1990 Oct 5;215(3):403-10 [2231712.001]
  • [Cites] Genome Res. 1999 Sep;9(9):868-77 [10508846.001]
  • [Cites] Anim Biotechnol. 2005;16(1):41-54 [15926262.001]
  • [Cites] Genomics. 1996 Jan 1;31(1):123-6 [8808290.001]
  • [Cites] Nucleic Acids Res. 1997 Jul 15;25(14):2745-51 [9207020.001]
  • [Cites] Nucleic Acids Res. 1998 Feb 15;26(4):967-73 [9461455.001]
  • [Cites] Genome Res. 1998 Mar;8(3):175-85 [9521921.001]
  • [Cites] Genome Res. 1998 Mar;8(3):186-94 [9521922.001]
  • [Cites] Nat Genet. 1998 Jul;19(3):233-40 [9662394.001]
  • [Cites] Genome Res. 1998 Jul;8(7):748-54 [9685323.001]
  • [Cites] Hum Mutat. 1998;12(4):221-5 [9744471.001]
  • [Cites] BMC Genomics. 2005;6:70 [15885146.001]
  • [Cites] Am J Hum Genet. 2005 Sep;77(3):454-67 [16080120.001]
  • [Cites] Nat Genet. 2006 Mar;38(3):375-81 [16493422.001]
  • [Cites] Genes Immun. 2006 Jul;7(5):384-92 [16738668.001]
  • [Cites] Nucleic Acids Res. 2007 Jan;35(Database issue):D650-3 [17145712.001]
  • [Cites] Anim Genet. 2007 Jun;38(3):253-8 [17433014.001]
  • [Cites] Bioinformatics. 2007 Jul 1;23(13):i387-91 [17646321.001]
  • [Cites] Genome Res. 2007 Oct;17(10):1414-9 [17673700.001]
  • [Cites] Nature. 2007 Oct 18;449(7164):851-61 [17943122.001]
  • [Cites] Nat Genet. 2007 Nov;39(11):1329-37 [17952073.001]
  • [Cites] Nucleic Acids Res. 2008 Jan;36(Database issue):D707-14 [18000006.001]
  • [Cites] Genome Biol. 2007;8(7):R139 [17625002.001]
  • [Cites] Science. 1998 May 15;280(5366):1077-82 [9582121.001]
  • [Cites] Genome Res. 1999 Nov;9(11):1087-92 [10568748.001]
  • [Cites] Nat Genet. 1999 Dec;23(4):452-6 [10581034.001]
  • [Cites] J Comput Biol. 2000 Feb-Apr;7(1-2):203-14 [10890397.001]
  • [Cites] Genome Res. 2002 Apr;12(4):627-39 [11932247.001]
  • [Cites] Genome Res. 2002 Apr;12(4):656-64 [11932250.001]
  • [Cites] Anim Genet. 2002 Jun;33(3):186-95 [12030921.001]
  • [Cites] Comput Appl Biosci. 1988 Mar;4(1):11-7 [3382986.001]
  • [Cites] Genome Res. 1999 Aug;9(8):677-9 [10447503.001]
  • (PMID = 19126189.001).
  • [ISSN] 1471-2164
  • [Journal-full-title] BMC genomics
  • [ISO-abbreviation] BMC Genomics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Genetic Markers
  • [Other-IDs] NLM/ PMC2637895
  •  go-up   go-down


27. Song J, Dong H, Ma C, Zhao B, Shang G: Construction and functional characterization of an integrative form lambda Red recombineering Escherichia coli strain. FEMS Microbiol Lett; 2010 Aug 1;309(2):178-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • LS-GR shows high recombination efficiency for medium copy number vector and single copy number BAC vector modifications.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20618864.001).
  • [ISSN] 1574-6968
  • [Journal-full-title] FEMS microbiology letters
  • [ISO-abbreviation] FEMS Microbiol. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Recombinases; 0 / Viral Proteins
  •  go-up   go-down


28. Cheung SW, Shaw CA, Scott DA, Patel A, Sahoo T, Bacino CA, Pursley A, Li J, Erickson R, Gropman AL, Miller DT, Seashore MR, Summers AM, Stankiewicz P, Chinault AC, Lupski JR, Beaudet AL, Sutton VR: Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics. Am J Med Genet A; 2007 Aug 1;143A(15):1679-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have developed a clinically validated, targeted BAC clone array as a platform for comparative genomic hybridization (aCGH) to enable detection of a wide range of pathologic copy number changes in DNA.
  • This enhanced ability of aCGH to detect mosaicism missed by routine chromosome analysis may be due to some combination of testing multiple cell lineages and/or failure of cytogenetically abnormal T lymphocytes to respond to mitogens.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17607705.001).
  • [ISSN] 1552-4833
  • [Journal-full-title] American journal of medical genetics. Part A
  • [ISO-abbreviation] Am. J. Med. Genet. A
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Eggermann T, Krause-Plonka I, Wollmann HA, Zerres K, Dai G, Meyer E, Bartsch O: Supernumerary marker chromosome 7 and maternal uniparental disomy 7 in a boy with growth retardation and triangular face. Clin Dysmorphol; 2006 Jan;15(1):9-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Using fluorescence in situ hybridization and BAC clones, the supernumerary marker chromosome was found to be a highly deleted chromosome 7 with breakpoints within the pericentric euchromatin (partial trisomy 7).
  • Considering that the SMC(7) contributed very little, if any, to the phenotype of this boy, we propose that UPD7 studies should be carried out in children with pre- and postnatal growth retardation of unknown cause even in the absence of a SMC.

  • MedlinePlus Health Information. consumer health - Growth Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16317300.001).
  • [ISSN] 0962-8827
  • [Journal-full-title] Clinical dysmorphology
  • [ISO-abbreviation] Clin. Dysmorphol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Euchromatin
  •  go-up   go-down


30. Swiercz R, Hałatek T, Majcherek W, Grzelińiska Z, Wasowicz W: [Toxic effect of benzalkonium chloride on animals and humans]. Med Pr; 2007;58(2):139-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Benzalkonium chloride (BAC) exerts toxic effects on microorganisms.
  • Various BAC-containing preparations used by people may induce a number of adverse effects on the human body.
  • Bearing in mind that BAC is widely used in different branches of the national economy, its toxic effect may cause a health problem of significant importance to humans.
  • The authors describe BAC toxic effects exerted on humans and laboratory animals as well as relevant hazards resulting from the use of BAC-contained preparations.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17926503.001).
  • [ISSN] 0465-5893
  • [Journal-full-title] Medycyna pracy
  • [ISO-abbreviation] Med Pr
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Benzalkonium Compounds; 0 / Preservatives, Pharmaceutical
  • [Number-of-references] 25
  •  go-up   go-down


31. Summers RJ, Shehata BM, Bleacher JC, Stockwell C, Rapkin L: Mucinous adenocarcinoma of the lung in association with congenital pulmonary airway malformation. J Pediatr Surg; 2010 Nov;45(11):2256-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous adenocarcinoma of the lung in association with congenital pulmonary airway malformation.
  • Congenital pulmonary airway malformation (CPAM) is a rare developmental abnormality of the lung that has been associated with the presence of rhabdomyosarcoma, pleuropulmonary blastoma, and most commonly bronchioalveolar carcinoma (BAC) of the lung.
  • Here, we report the case of an 8-year-old patient who developed KRAS mutation positive stage IV mucinous adenocarcinoma of the lung in association with CPAM.
  • This case reflects the previously recognized progression of CPAM to malignancy and suggests that BAC arising in CPAM may take a more aggressive course than previously recognized.
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Cystic Adenomatoid Malformation of Lung, Congenital / diagnosis. Lung Neoplasms / diagnosis. Precancerous Conditions
  • [MeSH-minor] Bronchoscopy. Child. Diagnosis, Differential. Female. Humans. Pneumonectomy / methods. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 21034957.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Dunnick WA, Collins JT, Shi J, Westfield G, Fontaine C, Hakimpour P, Papavasiliou FN: Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region. J Exp Med; 2009 Nov 23;206(12):2613-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Both class switch recombination (CSR) and somatic hypermutation (SHM) require transcription and the trans-acting factor activation-induced cytidine deaminase (AID), and must be up-regulated during antigen-dependent differentiation of B lymphocytes.
  • To test the role of the heavy chain 3' enhancers in both CSR and SHM, we used a BAC transgene of the entire heavy chain constant region locus.
  • Using Cre-loxP recombination to delete a 28-kb region that contains the four known 3' heavy chain enhancers, we isolated lines of BAC transgenic mice with an intact heavy chain locus and paired lines in the same chromosomal insertion site lacking the 3' enhancers.

  • COS Scholar Universe. author profiles.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell. 1994 Jun 3;77(5):737-47 [8205622.001]
  • [Cites] J Exp Med. 1983 Apr 1;157(4):1116-36 [6403653.001]
  • [Cites] J Immunol. 1995 Jul 15;155(2):684-91 [7608545.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5860-5 [8650183.001]
  • [Cites] J Immunol. 1996 Jul 1;157(1):176-82 [8683112.001]
  • [Cites] Nat Biotechnol. 1997 Sep;15(9):859-65 [9306400.001]
  • [Cites] Int Immunol. 1998 Jun;10(6):799-806 [9678761.001]
  • [Cites] J Exp Med. 1998 Oct 19;188(8):1421-31 [9782119.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3000-5 [10077626.001]
  • [Cites] Int Immunol. 1999 Oct;11(10):1709-13 [10508189.001]
  • [Cites] Mol Cell Biol. 2005 Feb;25(4):1511-25 [15684400.001]
  • [Cites] J Immunol. 2005 Apr 1;174(7):4113-9 [15778370.001]
  • [Cites] J Exp Med. 2005 May 2;201(9):1459-66 [15851486.001]
  • [Cites] J Immunol. 2005 May 15;174(10):6176-83 [15879114.001]
  • [Cites] Blood. 2007 Jan 1;109(1):159-67 [16968901.001]
  • [Cites] Science. 2007 Aug 31;317(5842):1227-30 [17761884.001]
  • [Cites] Immunity. 2007 Nov;27(5):711-22 [17980632.001]
  • [Cites] J Immunol. 2008 Feb 15;180(4):2019-23 [18250404.001]
  • [Cites] PLoS Genet. 2009 Jan;5(1):e1000332 [19132090.001]
  • [Cites] J Immunol. 2009 Jun 1;182(11):6926-32 [19454689.001]
  • [Cites] Curr Top Microbiol Immunol. 2000;245(2):127-68 [10533321.001]
  • [Cites] J Immunol. 1999 Dec 1;163(11):5758-62 [10570257.001]
  • [Cites] EMBO J. 2000 May 15;19(10):2315-22 [10811622.001]
  • [Cites] Cell. 2000 Sep 1;102(5):553-63 [11007474.001]
  • [Cites] Cell. 2000 Sep 1;102(5):565-75 [11007475.001]
  • [Cites] J Immunol. 2001 Mar 15;166(6):3659-62 [11238604.001]
  • [Cites] J Immunol. 2001 Jul 15;167(2):811-20 [11441087.001]
  • [Cites] Int Immunol. 2001 Aug;13(8):1003-12 [11470770.001]
  • [Cites] Immunity. 2001 Aug;15(2):187-99 [11520455.001]
  • [Cites] Trends Immunol. 2002 Jan;23(1):31-9 [11801452.001]
  • [Cites] EMBO J. 1986 Jan;5(1):95-102 [3007121.001]
  • [Cites] EMBO J. 1986 Dec 1;5(12):3259-66 [3028778.001]
  • [Cites] J Immunol. 1987 May 15;138(10):3539-48 [3106486.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Apr;86(7):2346-50 [2494666.001]
  • [Cites] Gene. 1989 Apr 15;77(1):51-9 [2744487.001]
  • [Cites] Cell. 1990 Nov 2;63(3):537-48 [2121365.001]
  • [Cites] EMBO J. 1992 Jan;11(1):145-55 [1740102.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6978-82 [1495989.001]
  • [Cites] J Exp Med. 1993 Mar 1;177(3):797-809 [8436910.001]
  • [Cites] Curr Biol. 2002 Oct 29;12(21):R725-7 [12419200.001]
  • [Cites] Eur J Immunol. 2003 Aug;33(8):2108-13 [12884284.001]
  • [Cites] Blood. 2003 Aug 15;102(4):1421-7 [12714490.001]
  • [Cites] J Immunol. 2004 Nov 1;173(9):5531-9 [15494502.001]
  • [Cites] Eur J Immunol. 1976 Aug;6(8):588-90 [789096.001]
  • [Cites] Int Immunol. 1994 Apr;6(4):491-7 [8018590.001]
  • (PMID = 19887393.001).
  • [ISSN] 1540-9538
  • [Journal-full-title] The Journal of experimental medicine
  • [ISO-abbreviation] J. Exp. Med.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P30 CA046592; United States / NIAID NIH HHS / AI / AI076057; United States / NCI NIH HHS / CA / CA46592; United States / NCI NIH HHS / CA / R01 CA098495; United States / NIAID NIH HHS / AI / R01 AI076057; United States / NCI NIH HHS / CA / CA098495
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 3' Untranslated Regions; 0 / Immunoglobulin Heavy Chains; EC 2.7.7.- / Cre recombinase; EC 2.7.7.- / Integrases; EC 3.5.4.5 / Cytidine Deaminase
  • [Other-IDs] NLM/ PMC2806627
  •  go-up   go-down


33. Liu H, Jiang H, Haltli B, Kulowski K, Muszynska E, Feng X, Summers M, Young M, Graziani E, Koehn F, Carter GT, He M: Rapid cloning and heterologous expression of the meridamycin biosynthetic gene cluster using a versatile Escherichia coli-streptomyces artificial chromosome vector, pSBAC. J Nat Prod; 2009 Mar 27;72(3):389-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Herein we describe the development of a versatile Escherichia coli-Streptomyces shuttle Bacterial Artificial Chromosomal (BAC) conjugation vector, pSBAC, to facilitate the cloning, genetic manipulation, and heterologous expression of actinomycetes secondary metabolite biosynthetic gene clusters.
  • The success of heterologous expression of such a giant gene cluster demonstrates the versatility of BAC cloning technology and paves the road for future exploration of expression of the meridamycin biosynthetic pathway in various hosts, including strains that have been optimized for polyketide production.
  • [MeSH-major] Escherichia coli / genetics. Genes, Bacterial / genetics. Macrolides / chemical synthesis. Macrolides / metabolism. Polyketide Synthases / metabolism. Streptomyces / genetics
  • [MeSH-minor] Chromosomes, Artificial. Chromosomes, Artificial, Bacterial / metabolism. Cloning, Molecular. Genetic Vectors / chemical synthesis. Genetic Vectors / genetics. Molecular Structure

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19191550.001).
  • [ISSN] 1520-6025
  • [Journal-full-title] Journal of natural products
  • [ISO-abbreviation] J. Nat. Prod.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 3-normeridamycin; 0 / Macrolides; 0 / meridamycin; 79956-01-7 / Polyketide Synthases
  •  go-up   go-down


34. Petersohn JD, Conquergood LR, Leung M: Acute histologic effects and thermal distribution profile of disc biacuplasty using a novel water-cooled bipolar electrode system in an in vivo porcine model. Pain Med; 2008 Jan-Feb;9(1):26-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Disc biacuplasty (D-BAC) is a novel procedure that uses two water-cooled radiofrequency electrodes in a bipolar configuration to heat a large volume of the posterior annulus fibrosus.
  • METHODS: Seven porcine lumbar discs were treated with D-BAC to assess acute effects on the treated tissue in a "worst-case"in vivo model.

  • MedlinePlus Health Information. consumer health - Herniated Disk.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18254764.001).
  • [ISSN] 1526-2375
  • [Journal-full-title] Pain medicine (Malden, Mass.)
  • [ISO-abbreviation] Pain Med
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


35. Duchesne A, Eggen A: Radiation hybrid mapping of genes and newly identified microsatellites in candidate regions for bovine arthrogryposis-palatoschisis and progressive ataxia based on comparative data from man, mouse and rat. J Anim Breed Genet; 2005 Apr;122 Suppl 1:28-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primer pairs were designed for 15 loci around each candidate gene, in a region of about 20 megabases and were used to screen a bovine Bacterial Artificial Chromosome (BAC) library.
  • Eighteen microsatellites were found in the identified BAC clones, 11 on BTA24 and seven on BTA16.
  • [MeSH-major] Arthrogryposis / veterinary. Ataxia / veterinary. Cattle Diseases / genetics. Cattle Diseases / pathology. Genetic Predisposition to Disease / genetics
  • [MeSH-minor] Animals. Cattle. Chromosomes, Artificial, Bacterial. DNA Primers. Humans. Mice. Microsatellite Repeats / genetics. Radiation Hybrid Mapping / veterinary. Rats


36. Dziadziuszko R, Siemiatkowska A, Limon J, Rzyman W, Jassem J, Bunn PA Jr, Varella-Garcia M, Hirsch FR: Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report. J Thorac Oncol; 2007 Jan;2(1):91-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report.
  • Bronchioalveolar carcinoma of the lung represents increasingly recognized clinical entity with relatively high probability of response to epidermal growth factor receptor tyrosine kinase inhibitors.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / drug therapy. Antineoplastic Agents / therapeutic use. Lung Neoplasms / drug therapy. Protein Kinase Inhibitors / therapeutic use. Quinazolines / therapeutic use. Receptor, Epidermal Growth Factor / genetics
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. Disease Progression. Female. Humans

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17410018.001).
  • [ISSN] 1556-1380
  • [Journal-full-title] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • [ISO-abbreviation] J Thorac Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Protein Kinase Inhibitors; 0 / Quinazolines; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; S65743JHBS / gefitinib
  •  go-up   go-down


37. Chen YP, Tseng CP, Liaw LL, Wang CL, Chen IC, Wu WJ, Wu MD, Yuan GF: Cloning and characterization of monacolin K biosynthetic gene cluster from Monascus pilosus. J Agric Food Chem; 2008 Jul 23;56(14):5639-46
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present study, a bacterial artificial chromosome (BAC) clone, mps01, was screened from the BAC library constructed from Monascus pilosus BCRC38072 genomic DNA.
  • [MeSH-minor] Amino Acid Sequence. Chromosomes, Artificial, Bacterial. Molecular Sequence Data. Phylogeny. Polyketide Synthases / genetics. Polyketide Synthases / metabolism

  • Hazardous Substances Data Bank. LOVASTATIN .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18578535.001).
  • [ISSN] 1520-5118
  • [Journal-full-title] Journal of agricultural and food chemistry
  • [ISO-abbreviation] J. Agric. Food Chem.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 79956-01-7 / Polyketide Synthases; 9LHU78OQFD / Lovastatin
  •  go-up   go-down


38. Chattoo JP, Stevens MP, Nair V: Rapid identification of non-essential genes for in vitro replication of Marek's disease virus by random transposon mutagenesis. J Virol Methods; 2006 Aug;135(2):288-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rapid identification of non-essential genes for in vitro replication of Marek's disease virus by random transposon mutagenesis.
  • Marek's disease virus (MDV) is a highly oncogenic alphaherpesvirus that induces rapid-onset T-cell lymphomas in poultry.
  • The construction of an infectious bacterial artificial chromosome (BAC) clone of the highly oncogenic RB-1B strain of MDV has been described previously.
  • Virus reconstituted from the BAC clone induced rapid-onset lymphomas in chickens very similar to the wildtype viruses.
  • In this paper, the construction of a high-density random transposon-insertion mutant library of the RB-1B BAC clone using a high throughput in vitro transposon mutagenesis technique is described.
  • [MeSH-minor] Chromosomes, Artificial, Bacterial. Open Reading Frames

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16650486.001).
  • [ISSN] 0166-0934
  • [Journal-full-title] Journal of virological methods
  • [ISO-abbreviation] J. Virol. Methods
  • [Language] eng
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / BBS/B/10544
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / DNA Transposable Elements
  •  go-up   go-down


39. Park EJ, Kim H, Kim Y, Yi J, Choi K, Park K: Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice. Toxicology; 2010 Sep 10;275(1-3):65-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Magnetite iron nanoparticles have been widely used as contrast agents and in thermal therapy for cancer.
  • When mice were treated with iron oxide nanoparticles (250 microg/kg, 500 microg/kg, and 1mg/kg) by a single intratracheal instillation, the level of intracellular reduced glutathione (GSH) was decreased in the cells of bronchoalveolar lavage (BAL) fluid.
  • The arrest of cell cycles in G1 phase was observed, but S-phase was significantly decreased.
  • Formation of microgranuloma, which is one of the indicators for chronic inflammatory response, was observed in the alveolar space.
  • In addition, distribution of B cell and CD8+ T cell in blood lymphocytes was increased at day 28.
  • [MeSH-major] Ferric Compounds / toxicity. Inflammation Mediators / toxicity. Lung / drug effects. Lung / metabolism. Nanoparticles / toxicity. Trachea / drug effects

  • Hazardous Substances Data Bank. FERRIC OXIDE .
  • Hazardous Substances Data Bank. HEMATITE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20540983.001).
  • [ISSN] 1879-3185
  • [Journal-full-title] Toxicology
  • [ISO-abbreviation] Toxicology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Ferric Compounds; 0 / Inflammation Mediators; 1K09F3G675 / ferric oxide
  •  go-up   go-down


40. Maver A, Medica I, Salobir B, Tercelj-Zorman M, Sabovic M, Petrovic D, Peterlin B: Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep;25(1):29-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND AIM OF THE WORK: Reduced expression and activity of the peroxisome proliferator-activated receptor gamma (PPARG) have been measured in cells of bronchoalveolar lavage fluid in sarcoidosis patients.

  • Genetic Alliance. consumer health - Sarcoidosis.
  • Genetic Alliance. consumer health - Sarcoidosis 1.
  • MedlinePlus Health Information. consumer health - Sarcoidosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19070258.001).
  • [ISSN] 1124-0490
  • [Journal-full-title] Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
  • [ISO-abbreviation] Sarcoidosis Vasc Diffuse Lung Dis
  • [Language] ENG
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Heat-Shock Proteins; 0 / PPAR gamma; 0 / PPARGC1A protein, human; 0 / Transcription Factors; 9007-49-2 / DNA
  •  go-up   go-down


41. Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC 3rd, Deschamps C, Pairolero PC: Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg; 2006 Oct;82(4):1175-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection.
  • BACKGROUND: Predictors of morbidity and mortality after pulmonary resection for lung cancer in patients 80 years of age or older are unknown.
  • METHODS: The medical records of all patients 80 years of age or older who had pulmonary resection for lung cancer from January 1985 through September 2004 were reviewed.
  • The cancer was squamous cell carcinoma in 143 patients (37.7%), adenocarcinoma in 166 (43.8%), bronchoalveolar cell carcinoma in 47 (12.4%), and other in 23 (6.1%).
  • CONCLUSIONS: Pulmonary resection for lung cancer in octogenarians is feasible.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Squamous Cell / surgery. Lung Neoplasms / surgery. Pneumonectomy / statistics & numerical data

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16996903.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


42. Hahn C, Islamian AP, Renz H, Nockher WA: Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. J Allergy Clin Immunol; 2006 Apr;117(4):787-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Eosinophil-epithelial cell interactions make a major contribution to asthmatic airway inflammation.
  • Neurotrophin levels are increased in bronchoalveolar lavage fluid during allergic asthma.
  • OBJECTIVE: We sought to investigate the role of neurotrophins as inflammatory mediators in eosinophil-epithelial cell interactions during the allergic immune response.
  • METHODS: Neurotrophin expression in the lung was investigated by means of immunohistochemistry and ELISA in a mouse model of chronic experimental asthma.
  • Coculture experiments were performed with airway epithelial cells and bronchoalveolar lavage fluid eosinophils.
  • RESULTS: Neurotrophin levels increased continuously during chronic allergic airway inflammation, and airway epithelial cells were the major source of NGF and BDNF within the inflamed lung.
  • Lung eosinophils expressed the BDNF and NGF receptors tropomyosin-related kinase (Trk) A and TrkB, and coculture with airway epithelial cells resulted in enhanced epithelial neurotrophin production, as well as in prolonged survival of eosinophils.
  • [MeSH-minor] Animals. Asthma / etiology. Asthma / pathology. Asthma / physiopathology. Base Sequence. Brain-Derived Neurotrophic Factor / biosynthesis. Cell Survival. Cytokines / pharmacology. Epithelial Cells / drug effects. Epithelial Cells / physiology. Female. Inflammation Mediators / metabolism. Mice. Mice, Inbred BALB C. Models, Biological. RNA, Messenger / genetics. RNA, Messenger / metabolism. Receptor, trkA / biosynthesis. Receptor, trkB / biosynthesis

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16630935.001).
  • [ISSN] 0091-6749
  • [Journal-full-title] The Journal of allergy and clinical immunology
  • [ISO-abbreviation] J. Allergy Clin. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Brain-Derived Neurotrophic Factor; 0 / Cytokines; 0 / Inflammation Mediators; 0 / Nerve Growth Factors; 0 / RNA, Messenger; EC 2.7.10.1 / Receptor, trkA; EC 2.7.10.1 / Receptor, trkB
  •  go-up   go-down


43. Boukakis G, Patrinou-Georgoula M, Lekarakou M, Valavanis C, Guialis A: Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues. BMC Cancer; 2010;10:434
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
  • The altered expression pattern of hnRNP A2/B1 and/or splicing variant B1 alone in human lung cancer and their potential to serve as molecular markers for early diagnosis remain issues of intense investigation.
  • The main objective of the present study was to use paired tumour/non-tumour biopsies from patients with non-small cell lung cancer (NSCLC) to investigate the expression profiles of hnRNP A1, A2/B1 and A3 in conjunction with ASF/SF2.
  • METHODS: We combined western blotting of tissue homogenates with immunohistochemical examination of fixed tissue sections and quantification of mRNA expression levels in tumour versus adjacent normal-looking areas of the lung in the same patient.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / genetics. Carcinoma, Non-Small-Cell Lung / metabolism. Heterogeneous-Nuclear Ribonucleoprotein Group A-B / metabolism. Lung / metabolism. RNA, Messenger / genetics
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / metabolism. Adenocarcinoma / secondary. Adenocarcinoma, Bronchiolo-Alveolar / genetics. Adenocarcinoma, Bronchiolo-Alveolar / metabolism. Adenocarcinoma, Bronchiolo-Alveolar / secondary. Aged. Blotting, Western. Carcinoma, Large Cell / genetics. Carcinoma, Large Cell / metabolism. Carcinoma, Large Cell / secondary. Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / metabolism. Carcinoma, Squamous Cell / secondary. Female. Humans. Immunoenzyme Techniques. Lung Neoplasms / genetics. Lung Neoplasms / metabolism. Lung Neoplasms / pathology. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Nuclear Proteins / genetics. Nuclear Proteins / metabolism. RNA-Binding Proteins / genetics. RNA-Binding Proteins / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Serine-Arginine Splicing Factors. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Oncol. 2000 Apr;16(4):763-7 [10717246.001]
  • [Cites] Clin Cancer Res. 1999 Dec;5(12):4048-52 [10632338.001]
  • [Cites] Cancer Res. 2001 Mar 1;61(5):1896-902 [11280744.001]
  • [Cites] Anticancer Res. 2001 Mar-Apr;21(2A):979-84 [11396191.001]
  • [Cites] Lung Cancer. 2001 Dec;34(3):341-50 [11714531.001]
  • [Cites] Nat Rev Mol Cell Biol. 2002 Mar;3(3):195-205 [11994740.001]
  • [Cites] Cancer Lett. 2002 Sep 26;183(2):215-20 [12065097.001]
  • [Cites] Lung Cancer. 2003 Apr;40(1):45-53 [12660006.001]
  • [Cites] J Pathol. 2003 May;200(1):88-94 [12692846.001]
  • [Cites] Lung Cancer. 2003 Aug;41(2):131-43 [12871776.001]
  • [Cites] Lung Cancer. 2003 Aug;41(2):179-86 [12871781.001]
  • [Cites] Br J Cancer. 2003 Oct 20;89(8):1493-501 [14562022.001]
  • [Cites] Cancer Res. 2003 Nov 15;63(22):7679-88 [14633690.001]
  • [Cites] Mol Carcinog. 2004 Dec;41(4):187-96 [15390079.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Dec;86(24):9788-92 [2557628.001]
  • [Cites] Annu Rev Biochem. 1993;62:289-321 [8352591.001]
  • [Cites] Science. 1994 Jul 29;265(5172):615-21 [8036511.001]
  • [Cites] Genomics. 1995 Jan 20;25(2):365-71 [7789969.001]
  • [Cites] Exp Cell Res. 1995 Nov;221(1):187-96 [7589244.001]
  • [Cites] J Biol Chem. 1996 May 3;271(18):10760-6 [8631886.001]
  • [Cites] RNA. 1998 Apr;4(4):430-44 [9630249.001]
  • [Cites] Clin Cancer Res. 1998 Jul;4(7):1631-40 [9676837.001]
  • [Cites] Am J Respir Cell Mol Biol. 1998 Oct;19(4):554-62 [9761751.001]
  • [Cites] Cancer Res. 1998 Dec 15;58(24):5818-24 [9865741.001]
  • [Cites] Clin Cancer Res. 1997 Dec;3(12 Pt 1):2237-46 [9815620.001]
  • [Cites] Exp Cell Res. 1999 Feb 1;246(2):399-411 [9925756.001]
  • [Cites] Mol Cell Biol. 1999 Mar;19(3):1720-30 [10022859.001]
  • [Cites] Cancer Res. 1999 Apr 1;59(7):1404-7 [10197602.001]
  • [Cites] Curr Opin Cell Biol. 1999 Jun;11(3):363-71 [10395553.001]
  • [Cites] Int J Oncol. 2005 Mar;26(3):635-40 [15703818.001]
  • [Cites] Genes Dev. 2005 Mar 15;19(6):643-64 [15769940.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Aug 5;333(3):888-95 [15964549.001]
  • [Cites] J Cell Sci. 2005 Jul 15;118(Pt 14):3173-83 [16014382.001]
  • [Cites] Biochim Biophys Acta. 2006 Apr;1765(2):85-100 [16378690.001]
  • [Cites] Cancer Detect Prev. 2006;30(5):395-402 [17067748.001]
  • [Cites] Clin Cancer Res. 2007 Mar 15;13(6):1638-42 [17363515.001]
  • [Cites] Cancer Genomics Proteomics. 2007 May-Jun;4(3):233-9 [17878526.001]
  • [Cites] Mol Carcinog. 2007 Nov;46(11):887-900 [17477362.001]
  • [Cites] FEBS Lett. 2008 Jun 18;582(14):1977-86 [18342629.001]
  • [Cites] Curr Med Chem. 2009;16(9):1047-61 [19275611.001]
  • [Cites] Anticancer Res. 2009 Apr;29(4):1373-82 [19414390.001]
  • [Cites] Am J Respir Cell Mol Biol. 2000 Nov;23(5):636-45 [11062142.001]
  • (PMID = 20716340.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / HNRNPA3 protein, human; 0 / Heterogeneous-Nuclear Ribonucleoprotein Group A-B; 0 / Nuclear Proteins; 0 / RNA, Messenger; 0 / RNA-Binding Proteins; 0 / hnRNP A1; 170974-22-8 / Serine-Arginine Splicing Factors
  • [Other-IDs] NLM/ PMC2933625
  •  go-up   go-down


44. Bruno AC, Baffa O, Carneiro AO: Hybrid system for magnetic and acoustic measurement. Conf Proc IEEE Eng Med Biol Soc; 2009;2009:761-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In order to improve the spatial resolution of Biosusceptometry of Alternate Current (BAC), we are suggesting the coupling of a Doppler ultrasonic transducer with the BAC system.

  • MedlinePlus Health Information. consumer health - Ultrasound.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19964487.001).
  • [ISSN] 1557-170X
  • [Journal-full-title] Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference
  • [ISO-abbreviation] Conf Proc IEEE Eng Med Biol Soc
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


45. Liu HZ, Yang HZ, Mi S, Cui B, Hua F, Hu ZW: Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice. Yao Xue Xue Bao; 2010 Aug;45(8):976-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice.
  • Anti-cancer drug bleomycin (BLM) can cause acute lung injury (ALI) which often results in pulmonary fibrosis due to a failure of resolving acute inflammatory response.
  • TLR2 inhibition attenuated BLM-induced increase of inflammatory cells in bronchoalveolar lavage fluid (BALF), and reversed the immunosuppressive microenvironment by enhancing TH1 response (P<0.05) and inhibiting TH2 (P<0.001), Treg (P<0.01) and TH17 (P<0.01) responses.
  • [MeSH-major] Acute Lung Injury / metabolism. Cytokines / secretion. Inflammation / metabolism. Pulmonary Fibrosis / metabolism. Toll-Like Receptor 2 / metabolism
  • [MeSH-minor] Animals. Bleomycin / toxicity. Bronchoalveolar Lavage Fluid. Cells, Cultured. Dendritic Cells / cytology. Dendritic Cells / metabolism. Interleukin-17 / secretion. Interleukin-23 / secretion. Interleukin-6 / secretion. Lung / metabolism. MAP Kinase Signaling System. Male. Mice. Mice, Inbred C57BL. T-Lymphocytes, Regulatory / drug effects. Th1 Cells / drug effects. Th2 Cells / drug effects

  • MedlinePlus Health Information. consumer health - Pulmonary Fibrosis.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21348427.001).
  • [ISSN] 0513-4870
  • [Journal-full-title] Yao xue xue bao = Acta pharmaceutica Sinica
  • [ISO-abbreviation] Yao Xue Xue Bao
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Cytokines; 0 / Interleukin-17; 0 / Interleukin-23; 0 / Interleukin-6; 0 / Tlr2 protein, mouse; 0 / Toll-Like Receptor 2; 11056-06-7 / Bleomycin
  •  go-up   go-down


46. Honey D, Caylor C, Luthi R, Kerrigan S: Comparative alcohol concentrations in blood and vitreous fluid with illustrative case studies. J Anal Toxicol; 2005 Jul-Aug;29(5):365-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The vitreous alcohol concentration (VAC) exceeded the blood alcohol concentration (BAC) in 209 cases (71%).
  • In casework where the VAC > BAC, linear regression analysis indicated an R2 value of 0.958 (n = 209) and a VAC approximately 16% higher than the BAC.
  • The VAC/BAC ratio was more variable at lower BACs (< 0.1 g/100 mL).
  • Although VAC/BAC ratios were more consistent at concentrations of 0.1 g/100 mL and above, the overall ratio ranged from 1.01 to 2.20.
  • Of the 81 cases where BAC > VAC, a total of 24 cases indicated no vitreous alcohol.
  • Unlike the VAC/BAC data set which consisted of 97% femoral blood, the source of blood in the BAC > VAC data set was slightly more variable.
  • Of the 81 cases where BAC > VAC the blood source consisted of femoral (n = 68), heart (n = 8), pleural cavity (n = 2), carotid (n = 1), jugular (n = 1), and chest blood (n = 1).

  • Hazardous Substances Data Bank. ETHANOL .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16105262.001).
  • [ISSN] 0146-4760
  • [Journal-full-title] Journal of analytical toxicology
  • [ISO-abbreviation] J Anal Toxicol
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 3K9958V90M / Ethanol
  •  go-up   go-down


47. Xu F, Cheng DH, Di YF, Tan K, Li LY, Lu GX, Tan YQ: [Identification of a cryptic 1p36.3 microdeletion in a patient with Prader-Willi-like syndrome features]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct;27(5):524-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Identification of a cryptic 1p36.3 microdeletion in a patient with Prader-Willi-like syndrome features].
  • OBJECTIVE: To determine the karyotype of a patient with Prader-Willi-like syndrome features.
  • RESULTS: No abnormality was discovered by high resolution karyotype analysis and methylation-specific PCR studies.
  • The deleted region was shown within a 4.2 Mb in the distal 1p by 3 BAC FISH probes of 1p36 combined with real-time PCR technique.
  • Family pedigree investigation showed the chromosome abnormality was de novo.

  • Genetic Alliance. consumer health - Prader-Willi syndrome.
  • MedlinePlus Health Information. consumer health - Prader-Willi Syndrome.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20931530.001).
  • [ISSN] 1003-9406
  • [Journal-full-title] Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
  • [ISO-abbreviation] Zhonghua Yi Xue Yi Chuan Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


48. Reddy S, Dolzhanskaya N, Krogh J, Velinov M: A novel 1.4 Mb de novo microdeletion of chromosome 1q21.3 in a child with microcephaly, dysmorphic features and mental retardation. Eur J Med Genet; 2009 Nov-Dec;52(6):443-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A novel 1.4 Mb de novo microdeletion of chromosome 1q21.3 in a child with microcephaly, dysmorphic features and mental retardation.
  • About 1 Mb deletion in the chromosomal region 1q21.3 was identified using BAC array CGH analysis.

  • Genetic Alliance. consumer health - Mental Retardation.
  • Genetic Alliance. consumer health - Microcephaly.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19772933.001).
  • [ISSN] 1878-0849
  • [Journal-full-title] European journal of medical genetics
  • [ISO-abbreviation] Eur J Med Genet
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] Netherlands
  •  go-up   go-down


49. Burtey S, Riera M, Ribe E, Pennekamp P, Passage E, Rance R, Dworniczak B, Fontés M: Overexpression of PKD2 in the mouse is associated with renal tubulopathy. Nephrol Dial Transplant; 2008 Apr;23(4):1157-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Polycystin-2 (PC-2), a cation channel of the Trp family, is involved in autosomal dominant polycystic kidney disease (ADPKD) type 2 (ADPKD2).
  • In the present paper, we describe a mouse model for human PC-2 overexpression, obtained by inserting a human bacterial artificial chromosome (BAC) containing the PKD2 gene.
  • [MeSH-minor] Animals. Blotting, Western. Disease Models, Animal. Extracellular Matrix Proteins / biosynthesis. Extracellular Matrix Proteins / genetics. Female. Humans. In Situ Hybridization, Fluorescence. Male. Mice. Mice, Inbred C57BL. Mice, Transgenic. Reverse Transcriptase Polymerase Chain Reaction. Severity of Illness Index

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18048422.001).
  • [ISSN] 1460-2385
  • [Journal-full-title] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • [ISO-abbreviation] Nephrol. Dial. Transplant.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Extracellular Matrix Proteins; 0 / TRPP Cation Channels; 0 / polycystic kidney disease 2 protein; 63231-63-0 / RNA
  •  go-up   go-down


50. Nguyen RL, Tam LW, Lefebvre PA: The LF1 gene of Chlamydomonas reinhardtii encodes a novel protein required for flagellar length control. Genetics; 2005 Mar;169(3):1415-24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we describe the positional cloning and molecular characterization of the LF1 gene using a bacterial artificial chromosome (BAC) library.
  • Rescue of the lf1 phenotype upon transformation was obtained with clones containing the complete LF1 gene as well as clones that lack the last two exons of the gene, indicating that only the amino-terminal portion of the LF1 gene product (LF1p) is required for function.
  • Although LF1 helps regulate flagellar length, the LF1p localizes almost exclusively in the cell body, with <1% of total cellular LF1p localizing to the flagella.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 1999 Nov 26;274(48):34383-8 [10567416.001]
  • [Cites] Cell. 1998 Dec 11;95(6):829-37 [9865700.001]
  • [Cites] Biochim Biophys Acta. 2000 Jun 21;1492(1):1-14 [10858526.001]
  • [Cites] Traffic. 2000 Jan;1(1):29-34 [11208056.001]
  • [Cites] J Cell Biol. 2001 Apr 2;153(1):63-74 [11285274.001]
  • [Cites] J Cell Biol. 2001 Oct 29;155(3):405-14 [11684707.001]
  • [Cites] Mol Biol Cell. 2002 Nov;13(11):3859-69 [12429830.001]
  • [Cites] Trends Cell Biol. 2002 Dec;12(12):551-5 [12495842.001]
  • [Cites] Trends Genet. 2003 Mar;19(3):162-7 [12615011.001]
  • [Cites] Curr Opin Genet Dev. 2003 Apr;13(2):207-14 [12672499.001]
  • [Cites] Eukaryot Cell. 2003 Apr;2(2):362-79 [12684385.001]
  • [Cites] Mol Biol Cell. 2003 May;14(5):2041-56 [12802074.001]
  • [Cites] Curr Biol. 2003 Jul 1;13(13):1145-9 [12842015.001]
  • [Cites] J Cell Biol. 2003 Nov 10;163(3):597-607 [14610061.001]
  • [Cites] J Cell Biol. 1969 May;41(2):600-19 [5783876.001]
  • [Cites] J Cell Biol. 1972 Sep;54(3):507-39 [4558009.001]
  • [Cites] J Gen Microbiol. 1972 Aug;71(3):525-40 [4647471.001]
  • [Cites] Methods Enzymol. 1986;134:280-90 [3821567.001]
  • [Cites] EMBO J. 1987 Feb;6(2):313-8 [3556163.001]
  • [Cites] Genetics. 1988 Apr;118(4):637-48 [3366366.001]
  • [Cites] EMBO J. 1989 Oct;8(10):2803-9 [2583083.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Feb;87(3):1228-32 [2105499.001]
  • [Cites] J Cell Biol. 1993 Aug;122(3):653-61 [8335691.001]
  • [Cites] Genetics. 1993 Oct;135(2):375-84 [8244002.001]
  • [Cites] Mol Cell Biol. 1994 Jun;14(6):4011-9 [8196640.001]
  • [Cites] J Cell Sci. 1994 Mar;107 ( Pt 3):497-506 [7516341.001]
  • [Cites] Methods Cell Biol. 1995;47:163-9 [7476482.001]
  • [Cites] J Cell Biol. 1996 Feb;132(3):359-70 [8636214.001]
  • [Cites] Genetics. 1996 Oct;144(2):569-85 [8889521.001]
  • [Cites] Genetics. 1998 Feb;148(2):693-702 [9504917.001]
  • [Cites] Mol Biol Cell. 1998 Dec;9(12):3351-65 [9843574.001]
  • [Cites] Curr Biol. 2000 Feb 24;10(4):R149-51 [10704402.001]
  • (PMID = 15489537.001).
  • [ISSN] 0016-6731
  • [Journal-full-title] Genetics
  • [ISO-abbreviation] Genetics
  • [Language] ENG
  • [Databank-accession-numbers] GENBANK/ AY298951
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM034437; United States / NIGMS NIH HHS / GM / GM-34437
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Protozoan; 0 / Protozoan Proteins; 0 / RNA, Protozoan
  • [Other-IDs] NLM/ PMC1449559
  •  go-up   go-down


51. Na Z, Huipeng Y, Lipan L, Cuiping C, Umashankar ML, Xingmeng L, Xiaofeng W, Bing W, Weizheng C, Cenis JL: Efficient production of canine interferon-alpha in silkworm Bombyx mori by use of a BmNPV/Bac-to-Bac expression system. Appl Microbiol Biotechnol; 2008 Feb;78(2):221-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Efficient production of canine interferon-alpha in silkworm Bombyx mori by use of a BmNPV/Bac-to-Bac expression system.
  • The recombinant baculovirus harboring canine interferon gene was rapidly generated by the BmNPV/Bac-to-Bac system that was recently developed.
  • In B. mori-derived cell lines, the expression of the recombinant protein reached maximal levels around 72-96 h post-infection.
  • [MeSH-minor] Animals. Baculoviridae / genetics. Cell Line. Cell Survival. Chromatography, Affinity. Dogs. Electrophoresis, Polyacrylamide Gel. Genetic Vectors. Glycosylation. Larva / genetics. Larva / metabolism. Molecular Sequence Data. Rhabdoviridae Infections / immunology. Sequence Analysis, DNA. Vesiculovirus / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18066544.001).
  • [ISSN] 0175-7598
  • [Journal-full-title] Applied microbiology and biotechnology
  • [ISO-abbreviation] Appl. Microbiol. Biotechnol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ EF080825
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Interferon-alpha; 0 / Recombinant Proteins
  •  go-up   go-down


52. Aokage K, Ishii G, Yoshida J, Hishida T, Nishimura M, Nagai K, Ochiai A: Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma. Pathol Int; 2010 Dec;60(12):765-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma.
  • Histological typing based on the World Health Organization classification (bronchioloalveolar carcinoma, acinar, papillary, and solid subtype) was used to evaluate 234 metastases from the primary lung adenocarcinomas of 139 patients.
  • The predominant subtype of metastasis 3 mm or less in diameter was bronchioloalveolar carcinoma when the primary lesion was diagnosed as predominant bronchioloalveolar carcinoma, acinar, and papillary subtype.
  • These findings suggest that implanted cancer cells display lepidic growth in the early metastatic phase and recapitulate the morphological heterogeneity of the original tumor as the metastasis enlarges.
  • [MeSH-major] Adenocarcinoma / secondary. Lung Neoplasms / pathology. Lung Neoplasms / secondary. Neoplasm Metastasis / pathology
  • [MeSH-minor] Aged. Disease Progression. Female. Humans. Male. Middle Aged. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 The Authors. Pathology International © 2010 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.
  • (PMID = 21091834.001).
  • [ISSN] 1440-1827
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  •  go-up   go-down


53. Semba S, Iwaya K, Matsubayashi J, Serizawa H, Kataba H, Hirano T, Kato H, Matsuoka T, Mukai K: Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung. Clin Cancer Res; 2006 Apr 15;12(8):2449-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung.
  • PURPOSE: Highly invasive and metastatic cancer cells, such as adenocarcinoma of the lung cells, form irregular protrusions by assembling a branched network of actin filaments.
  • In mammalian cells, the actin-related protein 2 and 3 (Arp2/3) complex initiates actin assembly to form lamellipodial protrusions by binding to Wiskott-Aldrich syndrome (WASP)/WASP family verproline-homologous protein 2 (WAVE2).
  • In this study, colocalization of Arp2 and WAVE2 in adenocarcinoma of the lung was investigated to elucidate its prognostic value.
  • EXPERIMENTAL DESIGN: Immunohistochemical staining of Arp2 and WAVE2 was done on mirror sections of 115 adenocarcinomas of the lung from pathologic stage IA to IIIA classes.
  • Kaplan-Meier disease-free survival and overall survival curves were analyzed to determine the prognostic significance of the coexpression of Arp2 and WAVE2.
  • RESULTS: Immunoreactivity for both Arp2 and WAVE2 was detected in the same cancer cells in 78 (67.8%) of the 115 lung cancer specimens.
  • The proportion of cancer cells expressing both Arp2 and WAVE2 was significantly higher in cases with lymph-node metastasis (P = 0.0046), and significantly lower in bronchioloalveolar carcinomas (P < 0.0001).
  • The patients whose cancer cells coexpressed them had a shorter disease-free survival time (P < 0.0001) and overall survival time (P < 0.0001).
  • CONCLUSIONS: Coexpression of Arp2 and WAVE2 is correlated with poorer patient outcome, and may be involved in the mechanism of cancer metastasis.
  • [MeSH-major] Actin-Related Protein 2 / biosynthesis. Adenocarcinoma / pathology. Lung Neoplasms / pathology. Wiskott-Aldrich Syndrome Protein Family / biosynthesis
  • [MeSH-minor] Aged. Disease-Free Survival. Female. Humans. Immunohistochemistry. Male. Multivariate Analysis. Neoplasm Staging. Prognosis. Survival Analysis

  • Genetic Alliance. consumer health - Wiskott Aldrich syndrome.
  • Genetic Alliance. consumer health - WISKOTT-ALDRICH SYNDROME 2.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16638851.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ACTR2 protein, human; 0 / Actin-Related Protein 2; 0 / WASF2 protein, human; 0 / Wiskott-Aldrich Syndrome Protein Family
  •  go-up   go-down


54. Chen L, Li M, Li Q, Yang X, An X, Chen Y: Characterization of the bovine immunoglobulin lambda light chain constant IGLC genes. Vet Immunol Immunopathol; 2008 Aug 15;124(3-4):284-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To characterize the bovine immunoglobulin lambda light chain constant region (IGLC) genes, we have isolated a bacterial artificial chromosome (BAC) clone by a PCR based approach from a bovine genomic DNA library, constructed using a genital ridge cell line derived from a male Holstein fetus.
  • The positive BAC clone, containing the bovine IGLC genes, was fully sequenced and had a 138 kb insert.
  • This conclusion was further confirmed by a series of RT-PCR amplifications, which also showed that among these four genes the IGLC3 was preferentially expressed in cattle.
  • [MeSH-minor] Amino Acid Sequence. Animals. Base Sequence. Chromosomes, Artificial, Bacterial. Cloning, Molecular. DNA / chemistry. DNA / genetics. Gene Library. Immunoglobulin Joining Region / genetics. Immunoglobulin Joining Region / immunology. Male. Molecular Sequence Data. Phylogeny. Polymerase Chain Reaction / veterinary. Sequence Alignment

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18538861.001).
  • [ISSN] 0165-2427
  • [Journal-full-title] Veterinary immunology and immunopathology
  • [ISO-abbreviation] Vet. Immunol. Immunopathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Immunoglobulin Constant Regions; 0 / Immunoglobulin Joining Region; 0 / Immunoglobulin Light Chains; 0 / Immunoglobulin lambda-Chains; 9007-49-2 / DNA
  •  go-up   go-down


55. Emond MR, Jontes JD: Inhibition of protocadherin-alpha function results in neuronal death in the developing zebrafish. Dev Biol; 2008 Sep 1;321(1):175-87
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The pcdhalpha/CNR gene comprises a diverse array of neuronal cell-surface proteins of the cadherin superfamily, although very little is known about their role in neural development.
  • Using whole-mount immunocytochemistry and BAC-based expression of Pcdh1alpha-GFP fusion proteins, we find that Pcdh1alpha does not appear to form stable, synaptic puncta at early stages of synaptogenesis.
  • This cell death phenotype can be attenuated by the expression of a soluble Pcdh1alpha cytoplasmic domain.
  • [MeSH-minor] Animals. Cell Death. Central Nervous System / cytology. Central Nervous System / embryology. Embryo, Nonmammalian / metabolism. Protein Structure, Tertiary

  • COS Scholar Universe. author profiles.
  • SciCrunch. ZFIN: Data: Gene Expression .
  • ZFIN. ZFIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18602383.001).
  • [ISSN] 1095-564X
  • [Journal-full-title] Developmental biology
  • [ISO-abbreviation] Dev. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cadherins
  •  go-up   go-down


56. Williams LE, Detter C, Barry K, Lapidus A, Summers AO: Facile recovery of individual high-molecular-weight, low-copy-number natural plasmids for genomic sequencing. Appl Environ Microbiol; 2006 Jul;72(7):4899-906
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sequencing of the large (>50 kb), low-copy-number (<5 per cell) plasmids that mediate horizontal gene transfer has been hindered by the difficulty and expense of isolating DNA from individual plasmids of this class.
  • We report here that a kit method previously devised for purification of bacterial artificial chromosomes (BACs) can be adapted for effective preparation of individual plasmids up to 220 kb from wild gram-negative and gram-positive bacteria.
  • Adaptation of this BAC method for large plasmid isolation removes one major technical hurdle to expanding our knowledge of the natural plasmid gene pool.
  • [MeSH-major] DNA, Bacterial / isolation & purification. Genetic Techniques. Genome, Bacterial / genetics. Plasmids / isolation & purification. Sequence Analysis, DNA
  • [MeSH-minor] Chromosomes, Artificial, Bacterial / genetics. Corynebacterium / genetics. Escherichia coli / genetics. Magnetics. Microspheres. Molecular Sequence Data. Staphylococcus / genetics

  • COS Scholar Universe. author profiles.
  • REBASE - The Restriction Enzyme Database. gene/protein/disease-specific - REBASE ref# 9912 .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gene. 1977;2(2):95-113 [344137.001]
  • [Cites] Proc Natl Acad Sci U S A. 1967 May;57(5):1514-21 [5231757.001]
  • [Cites] J Bacteriol. 1979 Oct;140(1):167-81 [387721.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Jul;78(7):4041-5 [6270656.001]
  • [Cites] Microbiol Rev. 1988 Dec;52(4):433-51 [3070319.001]
  • [Cites] Plasmid. 1988 Sep;20(2):155-7 [2853395.001]
  • [Cites] J Mol Biol. 1990 Oct 5;215(3):403-10 [2231712.001]
  • [Cites] Antimicrob Agents Chemother. 1993 Apr;37(4):825-34 [8280208.001]
  • [Cites] Antimicrob Agents Chemother. 1993 Jun;37(6):1297-304 [8392309.001]
  • [Cites] J Mol Biol. 1994 Jun 24;239(5):623-63 [8014987.001]
  • [Cites] Nucleic Acids Res. 1994 Oct 25;22(21):4543-4 [7971285.001]
  • [Cites] Gene. 1995 Aug 30;162(1):157-8 [7557406.001]
  • [Cites] J Mol Biol. 1997 Aug 8;271(1):13-30 [9300052.001]
  • [Cites] Nucleic Acids Res. 1997 Oct 1;25(19):3959-61 [9380525.001]
  • [Cites] Appl Environ Microbiol. 1997 Nov;63(11):4494-503 [9361435.001]
  • [Cites] Genome Res. 1998 Mar;8(3):175-85 [9521921.001]
  • [Cites] Microbiol Mol Biol Rev. 1999 Sep;63(3):507-22 [10477306.001]
  • [Cites] Nat Rev Microbiol. 2005 Sep;3(9):679-87 [16138096.001]
  • [Cites] Nat Rev Microbiol. 2005 Sep;3(9):722-32 [16138100.001]
  • [Cites] J Antimicrob Chemother. 2006 Jan;57(1):31-8 [16339607.001]
  • [Cites] Nature. 2000 May 18;405(6784):299-304 [10830951.001]
  • [Cites] Biotechniques. 2000 Oct;29(4):786-8, 790, 792 [11056809.001]
  • [Cites] Genome Res. 2001 Jul;11(7):1269-74 [11435410.001]
  • [Cites] Plasmid. 2002 Sep;48(2):117-29 [12383729.001]
  • [Cites] Environ Sci Technol. 2003 Apr 15;37(8):1509-14 [12731831.001]
  • [Cites] Antimicrob Agents Chemother. 2003 Nov;47(11):3519-24 [14576111.001]
  • [Cites] Annu Rev Genet. 2003;37:283-328 [14616063.001]
  • [Cites] Genome Biol. 2004;5(2):R12 [14759262.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 4;101(18):7118-22 [15107498.001]
  • [Cites] Plasmid. 1978 Sep;1(4):584-8 [107540.001]
  • (PMID = 16820486.001).
  • [ISSN] 0099-2240
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ DQ364638/ DQ390454/ DQ390455/ DQ390456/ DQ390457/ DQ390458
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Bacterial
  • [Other-IDs] NLM/ PMC1489313
  •  go-up   go-down


57. Ingvardsen CR, Xing Y, Frei UK, Lübberstedt T: Genetic and physical fine mapping of Scmv2, a potyvirus resistance gene in maize. Theor Appl Genet; 2010 May;120(8):1621-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We fine mapped Scmv2 to a region of 0.28 cM, covering a physical distance of 1.3426 Mb, and developed six new polymorphic SSR markers based on publicly available BAC sequences within this region.
  • Analysis of the public B73 BAC library as well as the syntenic rice region did not reveal any similarity to known resistance genes.
  • [MeSH-minor] Chromosomes, Artificial, Bacterial. Chromosomes, Plant / genetics. DNA, Plant / metabolism. Expressed Sequence Tags. Genes, Plant. Genetic Markers. Models, Genetic. Mosaic Viruses / genetics. Oryza / genetics. Physical Chromosome Mapping. Plant Diseases / genetics. Polymorphism, Genetic

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Genet Genomics. 2005 Jul;273(6):450-61 [15891912.001]
  • [Cites] Mol Plant Microbe Interact. 2000 Oct;13(10):1130-8 [11043474.001]
  • [Cites] Trends Plant Sci. 2005 Aug;10(8):376-82 [16023398.001]
  • [Cites] Plant J. 2006 Nov;48(3):452-62 [17026540.001]
  • [Cites] Curr Opin Plant Biol. 2004 Dec;7(6):732-6 [15491923.001]
  • [Cites] Plant Physiol. 2001 Dec;127(4):1667-75 [11743111.001]
  • [Cites] Arch Virol. 1989;106(3-4):171-200 [2673154.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11856-61 [16880399.001]
  • [Cites] Theor Appl Genet. 2004 Dec;110(1):48-57 [15551042.001]
  • [Cites] Plant Physiol. 2004 Apr;134(4):1317-26 [15020742.001]
  • [Cites] Theor Appl Genet. 2003 Feb;106(3):485-93 [12589549.001]
  • [Cites] Plant Cell. 1999 May;11(5):781-92 [10330465.001]
  • [Cites] Genetics. 2004 Jan;166(1):493-503 [15020438.001]
  • [Cites] Theor Appl Genet. 2004 Aug;109(3):488-94 [15067509.001]
  • [Cites] Plant Cell. 1995 May;7(5):549-59 [7780307.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6157-62 [11959909.001]
  • [Cites] Protoplasma. 2008 Dec;234(1-4):51-64 [18810574.001]
  • [Cites] Theor Appl Genet. 2007 Jul;115(2):159-68 [17479240.001]
  • [Cites] Theor Appl Genet. 2003 May;106(7):1171-7 [12748766.001]
  • [Cites] Nature. 2002 Nov 21;420(6913):316-20 [12447439.001]
  • [Cites] Plant Physiol. 2002 Sep;130(1):138-46 [12226494.001]
  • [Cites] Mol Gen Genet. 1999 Apr;261(3):574-81 [10323240.001]
  • [Cites] Plant J. 2000 Jan;21(1):73-81 [10652152.001]
  • [Cites] Phytopathology. 1999 Aug;89(8):660-7 [18944678.001]
  • [Cites] Theor Appl Genet. 2002 Dec;105(8):1190-1195 [12582898.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):489-94 [10618445.001]
  • [Cites] Plant J. 2006 Aug;47(3):417-26 [16774645.001]
  • [Cites] J Virol. 2004 Jun;78(12):6102-11 [15163703.001]
  • [Cites] Plant J. 2002 Dec;32(5):655-67 [12472683.001]
  • [Cites] Virology. 1995 Feb 1;206(2):1007-16 [7856075.001]
  • [Cites] Genome Res. 2001 Oct;11(10):1660-76 [11591643.001]
  • [Cites] Theor Appl Genet. 2006 Feb;112(4):618-26 [16402192.001]
  • [Cites] Plant Cell. 2000 Apr;12(4):569-82 [10760245.001]
  • [Cites] Trends Plant Sci. 2004 Jan;9(1):33-41 [14729217.001]
  • [Cites] Theor Appl Genet. 2002 Aug;105(2-3):355-363 [12582538.001]
  • [Cites] Plant Mol Biol. 2003 Jul;52(5):1037-49 [14558663.001]
  • [Cites] Nature. 2005 Aug 11;436(7052):793-800 [16100779.001]
  • [Cites] Mol Plant Microbe Interact. 2002 Jul;15(7):717-27 [12118888.001]
  • [Cites] Theor Appl Genet. 2004 Jul;109(2):305-16 [14968304.001]
  • [Cites] Plant J. 1998 May;14(4):393-400 [9670556.001]
  • [Cites] Genome Res. 2005 Sep;15(9):1284-91 [16109971.001]
  • [Cites] Virology. 2006 Jan 5;344(1):169-84 [16364748.001]
  • [Cites] New Phytol. 2005 Oct;168(1):51-60 [16159320.001]
  • [Cites] Plant Cell. 2000 May;12(5):663-76 [10810142.001]
  • [Cites] Plant J. 2005 May;42(3):392-405 [15842624.001]
  • [Cites] Theor Appl Genet. 1995 Mar;90(3-4):341-6 [24173923.001]
  • [Cites] Cell. 1999 Jun 11;97(6):743-54 [10380926.001]
  • [Cites] J Virol. 1997 Nov;71(11):8624-31 [9343220.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11844-9 [17615239.001]
  • [Cites] Curr Opin Plant Biol. 2006 Apr;9(2):164-71 [16458573.001]
  • [Cites] Genome. 2006 Oct;49(10):1274-82 [17213909.001]
  • [Cites] Theor Appl Genet. 2005 Jul;111(2):347-59 [15912344.001]
  • [Cites] Trends Cell Biol. 2006 Oct;16(10 ):530-7 [16938456.001]
  • [Cites] Phytopathology. 2000 May;90(5):505-13 [18944557.001]
  • [Cites] Phytopathology. 2006 Feb;96(2):120-9 [18943914.001]
  • [Cites] Nat Rev Microbiol. 2005 Oct;3(10):789-98 [16132037.001]
  • [Cites] J Hered. 2002 Jan-Feb;93(1):77-8 [12011185.001]
  • [Cites] Plant J. 2005 Jun;42(6):912-22 [15941403.001]
  • [Cites] Curr Biol. 2002 Jun 25;12(12):1046-51 [12123581.001]
  • [Cites] Theor Appl Genet. 2003 Feb;106(3):411-22 [12589540.001]
  • [Cites] Theor Appl Genet. 2007 Aug;115(4):501-8 [17581735.001]
  • [Cites] Plant Cell. 2005 Feb;17(2):343-60 [15659640.001]
  • [Cites] Theor Appl Genet. 2003 Mar;106(5):840-5 [12647058.001]
  • [Cites] Trends Plant Sci. 2003 Nov;8(11):554-60 [14607101.001]
  • [Cites] Plant Physiol. 2003 Jul;132(3):1272-82 [12857809.001]
  • [Cites] Cell. 1994 Sep 23;78(6):1101-15 [7923359.001]
  • (PMID = 20155410.001).
  • [ISSN] 1432-2242
  • [Journal-full-title] TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik
  • [ISO-abbreviation] Theor. Appl. Genet.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA, Plant; 0 / Genetic Markers
  •  go-up   go-down


58. Pedrosa-Harand A, Kami J, Gepts P, Geffroy V, Schweizer D: Cytogenetic mapping of common bean chromosomes reveals a less compartmentalized small-genome plant species. Chromosome Res; 2009;17(3):405-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cytogenetic maps of common bean chromosomes 3, 4 and 7 were constructed by fluorescence in-situ hybridization (FISH) of BAC and a few other genomic clones.
  • Although all clones were selected with genetically mapped markers, mostly with single-copy RFLPs, a large subset of BACs, from 13 different genomic regions, contained repetitive sequences, as concluded from the regional distribution patterns of multiple FISH signals on chromosomes: pericentromeric, subtelomeric and dispersed.
  • Pericentromeric repeats were present in all 11 chromosome pairs with different intensities, whereas subtelomeric repeats were present in several chromosome ends, but with different signal intensities depending on the BAC, suggesting that the terminal heterochromatin fraction of this species may be composed of different repeats.
  • [MeSH-minor] Chromosome Mapping. Chromosomes, Artificial, Bacterial. In Situ Hybridization, Fluorescence. Recombination, Genetic

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Genetics. 2008 Nov;180(3):1319-28 [18791231.001]
  • [Cites] Genetics. 1996 Dec;144(4):1883-91 [8978071.001]
  • [Cites] Genetics. 2009 Feb;181(2):405-19 [19087965.001]
  • [Cites] Plant J. 2006 Sep;47(6):977-86 [16911585.001]
  • [Cites] Science. 1995 Oct 20;270(5235):480-3 [7570002.001]
  • [Cites] J Cell Sci. 2001 Dec;114(Pt 23):4207-17 [11739653.001]
  • [Cites] Genome. 1997 Feb;40(1):138-42 [18464813.001]
  • [Cites] Theor Appl Genet. 2003 Jan;106(2):251-61 [12582850.001]
  • [Cites] Plant J. 2001 Jul;27(1):49-58 [11489182.001]
  • [Cites] Genetics. 2005 Feb;169(2):955-65 [15489513.001]
  • [Cites] Genetics. 2006 Apr;172(4):2529-40 [16489216.001]
  • [Cites] Genetics. 1995 Oct;141(2):683-708 [8647403.001]
  • [Cites] Plant J. 1998 Mar;13(6):867-76 [9681023.001]
  • [Cites] Nature. 2005 Aug 11;436(7052):793-800 [16100779.001]
  • [Cites] Genetics. 2000 Jan;154(1):397-412 [10628998.001]
  • [Cites] Genome. 1999 Dec;42(6):1224-33 [10659791.001]
  • [Cites] Theor Appl Genet. 2003 Jan;106(2):205-12 [12582845.001]
  • [Cites] Theor Appl Genet. 2006 Apr;112(6):987-98 [16404584.001]
  • [Cites] Genetics. 2001 Apr;157(4):1749-57 [11290728.001]
  • [Cites] Chromosoma. 2001 Jul;110(3):203-13 [11513295.001]
  • [Cites] Theor Appl Genet. 2006 Mar;112(5):924-33 [16397788.001]
  • [Cites] Ann Bot. 2005 Jan;95(1):219-27 [15596469.001]
  • [Cites] Genetics. 1992 Jul;131(3):733-40 [1352759.001]
  • [Cites] Genome Res. 2001 Dec;11(12):2133-41 [11731505.001]
  • [Cites] Plant Physiol. 2005 Apr;137(4):1228-35 [15824285.001]
  • [Cites] Theor Appl Genet. 2007 Sep;115(5):675-82 [17632699.001]
  • [Cites] Theor Appl Genet. 2008 Feb;116(3):407-15 [18060540.001]
  • [Cites] Nature. 2000 Dec 14;408(6814):796-815 [11130711.001]
  • [Cites] DNA Res. 2008 Aug;15(4):227-39 [18511435.001]
  • [Cites] Chromosoma. 2004 Mar;112(6):288-99 [14986017.001]
  • [Cites] Genetics. 2008 Nov;180(3):1307-17 [18791232.001]
  • [Cites] Trends Genet. 1992 Nov;8(11):372-3 [1440872.001]
  • [Cites] Genetics. 2005 Dec;171(4):1963-76 [16143604.001]
  • [Cites] Cell. 2000 Feb 4;100(3):367-76 [10676818.001]
  • [Cites] Genetics. 2002 Aug;161(4):1661-72 [12196409.001]
  • (PMID = 19330455.001).
  • [ISSN] 1573-6849
  • [Journal-full-title] Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology
  • [ISO-abbreviation] Chromosome Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


59. Liu D, Kojima T, Ouchi M, Kuroda S, Watanabe Y, Hashimoto Y, Onimatsu H, Urata Y, Fujiwara T: Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer. Mol Cancer Ther; 2009 Apr;8(4):980-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer.
  • The present preclinical study investigates whether OBP-301 and a chemotherapeutic agent that is commonly used for lung cancer treatment, gemcitabine, are able to enhance antitumor effects in vitro and in vivo.
  • In vivo antitumor effects of intratumoral injection of OBP-301 in combination with systemic administration of gemcitabine were assessed on nu/nu mice s.c. xenografted with human lung tumors.
  • OBP-301 infection combined with gemcitabine resulted in very potent synergistic cytotoxicity in human lung cancer cells.
  • The three human lung cancer cell lines treated with OBP-301 for 24 hours tended to accumulate in S phase compared with controls.
  • Intratumoral injection of OBP-301 combined with systemic administration of gemcitabine showed therapeutic synergism in human lung tumor xenografts.
  • Our data suggest that the combination of OBP-301 and gemcitabine enhances the antitumor effects against human lung cancer.
  • We also found that the synergistic mechanism may be due to OBP-301-mediated cell cycle accumulation in S phase.
  • These results have important implications for the treatment of human lung cancer.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / therapy. Antimetabolites, Antineoplastic / therapeutic use. Carcinoma, Large Cell / therapy. Deoxycytidine / analogs & derivatives. Lung Neoplasms / therapy. Oncolytic Virotherapy. Telomerase / metabolism
  • [MeSH-minor] Adenovirus E1A Proteins / metabolism. Animals. Blotting, Western. Cell Proliferation / drug effects. Combined Modality Therapy. Drug Evaluation, Preclinical. Female. Humans. Immunoenzyme Techniques. Mice. Mice, Inbred BALB C. Mice, Nude. Ribonucleotide Reductases / antagonists & inhibitors. S Phase / drug effects. S Phase / physiology. Signal Transduction. Tumor Cells, Cultured. Virus Replication / drug effects. Xenograft Model Antitumor Assays

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19372571.001).
  • [ISSN] 1535-7163
  • [Journal-full-title] Molecular cancer therapeutics
  • [ISO-abbreviation] Mol. Cancer Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adenovirus E1A Proteins; 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine; EC 1.17.4.- / Ribonucleotide Reductases; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


60. Kaplan S, Prato CG: Impact of BAC limit reduction on different population segments: a Poisson fixed effect analysis. Accid Anal Prev; 2007 Nov;39(6):1146-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impact of BAC limit reduction on different population segments: a Poisson fixed effect analysis.
  • Over the past few decades, several countries enacted the reduction of the legal blood alcohol concentration (BAC) limit, often alongside the administrative license revocation or suspension, to battle drinking-and-driving behavior.
  • The present analysis focuses on the evaluation of the impact of BAC limit reduction on different population segments.
  • Model estimates demonstrate that, for alcohol-related single-vehicle crashes, (i) BAC laws are more effective in terms of reduction of number of casualties rather than number of accidents, (ii) women and elderly population exhibit higher law compliance with respect to men and to young adult and adult population, respectively, and (iii) the presence of passengers in the vehicle enhances the sense of responsibility of the driver.


61. Barnett NP, Wei J, Czachowski C: Measured alcohol content in college party mixed drinks. Psychol Addict Behav; 2009 Mar;23(1):152-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Standard drink equivalents were calculated and blood alcohol concentrations (BACs) for men and women were estimated.
  • Estimated BACs varied widely depending on drink alcohol concentration, but in most cases a heavy drinking episode for both men and women resulted in an estimated BAC at or above .08.

  • MedlinePlus Health Information. consumer health - Alcohol.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ETHANOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19290700.001).
  • [ISSN] 0893-164X
  • [Journal-full-title] Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
  • [ISO-abbreviation] Psychol Addict Behav
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 3K9958V90M / Ethanol
  •  go-up   go-down


62. Makushkin EO, Korsunov VM, Pavlova II: [The biomass of microbial communities in different types of alluvial soils in the upper reach of the Selenga River estuary]. Izv Akad Nauk Ser Biol; 2009 Jan-Feb;(1):100-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The bacterial complex predominated at the beginning of July; actinomycete and spore-fungal complexes, at the end of August; and spore-fungal and actinomycete complexes, at the beginning of October.

  • MedlinePlus Health Information. consumer health - Molds.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19239119.001).
  • [ISSN] 1026-3470
  • [Journal-full-title] Izvestiia Akademii nauk. Seriia biologicheskaia
  • [ISO-abbreviation] Izv. Akad. Nauk. Ser. Biol.
  • [Language] RUS
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


63. Kowalski W, Mierzwa T, Grabiec M, Laskowski R, Walentowicz M: [Problems in diagnosing breast cancer in women younger than 25 years old]. Ginekol Pol; 2006 May;77(5):376-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Problems in diagnosing breast cancer in women younger than 25 years old].
  • OBJECTIVES: There are several challenges in the diagnosis of breast cancer in young women.
  • Special consideration must be given to the woman's fertility and body image issues, but the difficulty in distinguishing benign from malignant lesions in this group of patients still exists.
  • The aim of our study was to show five cases of breast cancer in young women.
  • MATERIALS AND METHODS: Based on 5 cases of breast cancer in women younger than 25, several methods used in diagnosis in this group of patients were discussed.
  • The role of USG and BAC was analyzed.
  • RESULTS: Diagnosing and treatment of young patients with breast cancer should be performed in specialized oncological centers experienced in dealing with breast cancer in very young women.
  • Because of the possibility of breast cancer in women under 25 years old, each case of breast tumor should be precisely diagnosed, especially by ultrasonography and biopsy (BAC) 2.
  • Each case suspected of breast cancer in young women should be diagnosed in highly equipped and specialized medical center.
  • [MeSH-major] Breast Neoplasms / diagnosis
  • [MeSH-minor] Adult. Age Factors. Combined Modality Therapy. Diagnosis, Differential. Female. Humans. Mammography / methods

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16958227.001).
  • [ISSN] 0017-0011
  • [Journal-full-title] Ginekologia polska
  • [ISO-abbreviation] Ginekol. Pol.
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


64. Rösch C, Eilmus S, Bothe H: Approaches to assess the biodiversity of bacteria in natural habitats. Biochem Soc Trans; 2006 Feb;34(Pt 1):169-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Any attempt to characterize a bacterial community and their functional genes coding for enzymes of the nitrogen cycle is faced with its extreme biodiversity.
  • Computer-based assignment tools have now been developed utilizing terminal restriction fragments obtained from digestions with multiple restriction enzymes.
  • Such programs allow the gross characterization of bacterial life in any complex bacterial community with confidence.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16417513.001).
  • [ISSN] 0300-5127
  • [Journal-full-title] Biochemical Society transactions
  • [ISO-abbreviation] Biochem. Soc. Trans.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Ribosomal, 16S
  • [Number-of-references] 37
  •  go-up   go-down


65. McCartt AT, Blackman K, Voas RB: Implementation of Washington State's zero tolerance law: patterns of arrests, dispositions, and recidivism. Traffic Inj Prev; 2007 Dec;8(4):339-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The present study examined effects of the ZT law on arrests and case dispositions among underage offenders as a function of blood alcohol concentration (BAC) and post-law patterns of recidivism.
  • RESULTS: There was a substantial increase in arrests of underage drivers beginning immediately after implementation of the ZT law, especially among drivers with low BACs.
  • Underage offenders with lower BACs became far more likely to receive alcohol-related convictions and/or license suspensions.
  • However, the percentage of underage offenders with higher BACs receiving DUI convictions declined as some of these offenders received the lesser ZT disposition.
  • After the ZT law, underage offenders with BACs of 0.10 g/dL or higher were more likely to recidivate than those with lower BACs, but appreciable proportions of drivers were re-arrested for another alcohol offense, whatever the BAC and however they were penalized.
  • However, recidivism remains an issue as more than one in four underage drivers arrested with low BACs subsequently were re-arrested.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17994486.001).
  • [ISSN] 1538-9588
  • [Journal-full-title] Traffic injury prevention
  • [ISO-abbreviation] Traffic Inj Prev
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


66. Kim YK, Kwon JT, Choi JY, Jiang HL, Arote R, Jere D, Je YH, Cho MH, Cho CS: Suppression of tumor growth in xenograft model mice by programmed cell death 4 gene delivery using folate-PEG-baculovirus. Cancer Gene Ther; 2010 Nov;17(11):751-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Suppression of tumor growth in xenograft model mice by programmed cell death 4 gene delivery using folate-PEG-baculovirus.
  • Cancer gene therapy using tumor suppressor genes is considered to be an attractive approach for arresting cell growth and inducing apoptosis.
  • Programmed cell death 4 (Pdcd4) is a tumor suppressor gene, which prevents tumorigenesis and tumor progression.
  • Folate-PEG-baculovirus containing Pdcd4 gene (F-P-Bac-Pdcd4) was constructed by attachment of F-PEG to the baculovirus surface using chemical modification.
  • The F-P-Bac-Pdcd4 showed enhanced transduction efficiency, efficiently expressed PDCD4 protein, and induced apoptosis in human epidermal carcinoma (KB) cells as compared with an unmodified baculovirus.
  • In a tumor xenograft study, injection of F-P-Bac-Pdcd4 into tumors established from the KB cell line by subcutaneous implantation significantly suppressed tumor growth and induced apoptosis.
  • Thus, this study shows a new baculovirus-mediated tumor suppressor gene delivery system for cancer therapy.
  • [MeSH-major] Apoptosis Regulatory Proteins / metabolism. Baculoviridae / genetics. Carcinoma / therapy. Genes, Tumor Suppressor. RNA-Binding Proteins / metabolism. Transduction, Genetic
  • [MeSH-minor] Animals. Cell Line, Tumor. Folic Acid / analogs & derivatives. Folic Acid / metabolism. Gene Expression Regulation, Neoplastic. Genetic Therapy. Humans. Male. Mice. Mice, Inbred BALB C. Mice, Nude. Polyethylene Glycols. Xenograft Model Antitumor Assays

  • Hazardous Substances Data Bank. FOLIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20539318.001).
  • [ISSN] 1476-5500
  • [Journal-full-title] Cancer gene therapy
  • [ISO-abbreviation] Cancer Gene Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Apoptosis Regulatory Proteins; 0 / Pdcd4 protein, mouse; 0 / RNA-Binding Proteins; 0 / poly(ethylene glycol)-folate; 30IQX730WE / Polyethylene Glycols; 935E97BOY8 / Folic Acid
  •  go-up   go-down


67. Duruisseaux M, Cadranel J, Biron E, Pérol M, Guérin JC, Arpin D: Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features. Lung Cancer; 2009 Sep;65(3):385-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.
  • Bronchioloalveolar carcinoma (BAC) and adenocarcinoma mixed subtype with bronchioloalveolar features (ADC-WBF) represent a unique anatomo-clinical entity accounting for some 20% of non-small cell lung cancers (NSCLC).
  • After treatment arrest, the two patients experienced progressive disease but responded to retreatment with pemetrexed.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / pathology. Adenocarcinoma, Bronchiolo-Alveolar / drug therapy. Antimetabolites, Antineoplastic / therapeutic use. Bone Neoplasms / drug therapy. Bone Neoplasms / secondary. Glutamates / therapeutic use. Guanine / analogs & derivatives. Lung Neoplasms / drug therapy. Lung Neoplasms / pathology
  • [MeSH-minor] Aged. Cough. Disease Progression. Dyspnea. Folic Acid / administration & dosage. Humans. Male. Neoplasm Staging. Neutropenia. Pemetrexed. Remission Induction. Renal Insufficiency. Smoking. Tomography, X-Ray Computed. Vitamin B 12 / administration & dosage

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. PEMETREXED .
  • Hazardous Substances Data Bank. FOLIC ACID .
  • Hazardous Substances Data Bank. CYANOCOBALAMIN .
  • Hazardous Substances Data Bank. GUANINE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19346028.001).
  • [ISSN] 1872-8332
  • [Journal-full-title] Lung cancer (Amsterdam, Netherlands)
  • [ISO-abbreviation] Lung Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Glutamates; 04Q9AIZ7NO / Pemetrexed; 5Z93L87A1R / Guanine; 935E97BOY8 / Folic Acid; P6YC3EG204 / Vitamin B 12
  •  go-up   go-down


68. Juárez P, Walters ST, Daugherty M, Radi C: A randomized trial of motivational interviewing and feedback with heavy drinking college students. J Drug Educ; 2006;36(3):233-46
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • At an eight-week follow-up, all groups reduced their consumption, peak BAC, consequences, and dependence symptoms.

  • MedlinePlus Health Information. consumer health - Alcohol.
  • MedlinePlus Health Information. consumer health - College Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17345916.001).
  • [ISSN] 0047-2379
  • [Journal-full-title] Journal of drug education
  • [ISO-abbreviation] J Drug Educ
  • [Language] eng
  • [Grant] United States / NIAAA NIH HHS / AA / T32-AA07465
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


69. Safár J, Simková H, Kubaláková M, Cíhalíková J, Suchánková P, Bartos J, Dolezel J: Development of chromosome-specific BAC resources for genomics of bread wheat. Cytogenet Genome Res; 2010 Jul;129(1-3):211-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of chromosome-specific BAC resources for genomics of bread wheat.
  • Its complexity can, however, be reduced by using flow cytometry to isolate individual chromosomes, and these can be exploited to construct chromosome-specific BAC libraries.
  • Each chromosome (arm)-specific library is composed of a manageable number of clones, and so represents a practical tool in the area of wheat genomics.
  • [MeSH-major] Chromosomes, Artificial, Bacterial / genetics. Chromosomes, Plant / genetics. Triticum / genetics

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 S. Karger AG, Basel.
  • (PMID = 20501977.001).
  • [ISSN] 1424-859X
  • [Journal-full-title] Cytogenetic and genome research
  • [ISO-abbreviation] Cytogenet. Genome Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / DNA, Plant; 0 / Genetic Markers
  •  go-up   go-down


70. Tokiwa H, Sera N, Nakanishi Y: Involvement of alveolar macrophages in the formation of 8-oxodeoxyguanosine associated with exogenous particles in human lungs. Inhal Toxicol; 2005 Oct;17(11):577-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Involvement of alveolar macrophages in the formation of 8-oxodeoxyguanosine associated with exogenous particles in human lungs.
  • Lung specimens were collected from 161 non-smoking male patients with carcinoma to determine the deposition of carbon particles and oxidative damage in lung tissues.
  • Morphologically, carbon particles deposited in human lungs with carcinoma were similar to those of diesel exhaust like particles, and mass of particles showed a significant increase with the increasing age of the patients.
  • An increasing age of patient with carcinomas was also associated with 8-oxodeoxy-guanosine (8-oxo-dG) formation, which was analyzed using the HPLC-electrochemical detector method.
  • To determine whether particles in lung tissues were associated with 8-oxo-dG formation, carbon particles deposited in lung tissues were partially purified by cycling of alkali fusion with 1 M KOH; mutagenic chemicals in particles were extracted and excluded by removal with an equal volume of benzene/methanol and dichloromethane.
  • These results were also demonstrated by the occurrence of alveolar macrophages and neutrophils after intratracheal instillation of particles.
  • These observations suggest that small particles from lung cancer patients further promote oxidative damage when used to treat the mouse lung.
  • [MeSH-major] Carbon / administration & dosage. Deoxyguanosine / analogs & derivatives. Lung / metabolism. Macrophages, Alveolar / metabolism
  • [MeSH-minor] Adenocarcinoma / metabolism. Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Animals. Cell Line. Child. Dose-Response Relationship, Drug. Female. Humans. Lung Neoplasms / metabolism. Male. Mice. Mice, Inbred BALB C. Mice, Inbred ICR. Microscopy, Electron, Scanning. Middle Aged. Monocytes / drug effects. Monocytes / metabolism. Particle Size. Pyrenes / chemistry. Pyrenes / metabolism

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. 1-NITROPYRENE .
  • Hazardous Substances Data Bank. CARBON .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16033753.001).
  • [ISSN] 0895-8378
  • [Journal-full-title] Inhalation toxicology
  • [ISO-abbreviation] Inhal Toxicol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Pyrenes; 5522-43-0 / 1-nitropyrene; 7440-44-0 / Carbon; 88847-89-6 / 8-oxo-7-hydrodeoxyguanosine; G9481N71RO / Deoxyguanosine
  •  go-up   go-down


71. Ahsan B, Kobayashi D, Yamada T, Kasahara M, Sasaki S, Saito TL, Nagayasu Y, Doi K, Nakatani Y, Qu W, Jindo T, Shimada A, Naruse K, Toyoda A, Kuroki Y, Fujiyama A, Sasaki T, Shimizu A, Asakawa S, Shimizu N, Hashimoto S, Yang J, Lee Y, Matsushima K, Sugano S, Sakaizumi M, Narita T, Ohishi K, Haga S, Ohta F, Nomoto H, Nogata K, Morishita T, Endo T, Shin-I T, Takeda H, Kohara Y, Morishita S: UTGB/medaka: genomic resource database for medaka biology. Nucleic Acids Res; 2008 Jan;36(Database issue):D747-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This database provides basic genomic information, such as predicted genes, expressed sequence tags (ESTs), guanine/cytosine (GC) content, repeats and comparative genomics, as well as unique data resources including (i) 2473 genetic markers and experimentally confirmed PCR primers that amplify these markers, (ii) 142,414 bacterial artificial chromosome (BAC) and 217,344 fosmid end sequences that amount to 15.0- and 11.1-fold clone coverage of the entire genome, respectively, and were used for draft genome assembly, (iii) 16,519,460 single nucleotide polymorphisms (SNPs), and 2 859 905 insertions/deletions detected between two medaka inbred strain genomes and (iv) 841 235 5'-end serial analyses of gene-expression (SAGE) tags that identified 344 266 transcription start sites on the genome.
  • [MeSH-minor] Animals. Chromosomes, Artificial, Bacterial. Gene Expression. Genetic Markers. Genetic Variation. Internet. Plasmids / genetics. Polymorphism, Single Nucleotide. Transcription Initiation Site. User-Computer Interface

  • National BioResource Project. culture/stock collections - NBRP resources .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cytometry. 2000 Feb 1;39(2):91-5 [10679726.001]
  • [Cites] Nat Rev Genet. 2002 Jan;3(1):53-64 [11823791.001]
  • [Cites] Nature. 2002 May 30;417(6888):559-63 [12037570.001]
  • [Cites] Mech Dev. 2004 Jul;121(7-8):619-28 [15210171.001]
  • [Cites] Mech Dev. 2004 Jul;121(7-8):647-58 [15210174.001]
  • [Cites] Nature. 2007 Jun 7;447(7145):714-9 [17554307.001]
  • [Cites] J Mol Biol. 1997 Apr 25;268(1):78-94 [9149143.001]
  • [Cites] Sci Total Environ. 1999 Aug 15;233(1-3):211-20 [10492907.001]
  • [Cites] Genomics. 2007 Jan;89(1):124-33 [17067776.001]
  • [Cites] Nucleic Acids Res. 2007 Jan;35(Database issue):D668-73 [17142222.001]
  • [Cites] Nucleic Acids Res. 2007 Jan;35(Database issue):D610-7 [17148474.001]
  • [Cites] Nat Biotechnol. 2004 Sep;22(9):1146-9 [15300261.001]
  • (PMID = 17932069.001).
  • [ISSN] 1362-4962
  • [Journal-full-title] Nucleic acids research
  • [ISO-abbreviation] Nucleic Acids Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Genetic Markers
  • [Other-IDs] NLM/ PMC2238888
  •  go-up   go-down


72. Tischer BK, Kaufer BB, Sommer M, Wussow F, Arvin AM, Osterrieder N: A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. J Virol; 2007 Dec;81(23):13200-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9.
  • In order to facilitate the generation of mutant viruses of varicella-zoster virus (VZV), the agent causing varicella (chicken pox) and herpes zoster (shingles), we generated a full-length infectious bacterial artificial chromosome (BAC) clone of the P-Oka strain.
  • Subsequently, mini-F-containing recombinant virus was generated from overlapping cosmid clones, and full-length VZV DNA recovered from the recombinant virus was established in Escherichia coli as an infectious BAC.

  • COS Scholar Universe. author profiles.
  • Addgene Non-profit plasmid repository. clones/clone libraries - Get Article's Plasmids - Addgene (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 2006 May 15;203(5):1307-17 [16651385.001]
  • [Cites] J Virol. 2002 Feb;76(4):1537-47 [11799148.001]
  • [Cites] J Virol. 2002 Feb;76(4):1959-70 [11799190.001]
  • [Cites] Virology. 2002 Feb 15;293(2):356-67 [11886256.001]
  • [Cites] Vet Microbiol. 2002 Apr 22;86(1-2):69-88 [11888691.001]
  • [Cites] J Virol. 2002 Jul;76(13):6729-42 [12050386.001]
  • [Cites] Trends Microbiol. 2002 Jul;10(7):318-24 [12110210.001]
  • [Cites] J Virol. 2002 Aug;76(16):8208-17 [12134026.001]
  • [Cites] Antiviral Res. 2002 Oct;56(1):1-11 [12323395.001]
  • [Cites] J Virol. 2002 Nov;76(22):11447-59 [12388706.001]
  • [Cites] Biotechnol Prog. 2003 Mar-Apr;19(2):373-9 [12675574.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12697-702 [10535985.001]
  • [Cites] J Virol. 2000 Aug;74(15):6964-74 [10888635.001]
  • [Cites] J Gen Virol. 2000 Sep;81(Pt 9):2219-30 [10950980.001]
  • [Cites] J Virol. 2000 Dec;74(23):11088-98 [11070004.001]
  • [Cites] Mol Genet Metab. 2001 Jan;72(1):15-26 [11161824.001]
  • [Cites] Genomics. 2001 Apr 1;73(1):56-65 [11352566.001]
  • [Cites] J Virol. 2001 Dec;75(23):11307-18 [11689611.001]
  • [Cites] J Virol. 2002 Jan;76(2):774-82 [11752167.001]
  • [Cites] Curr Opin Microbiol. 2006 Aug;9(4):423-9 [16814597.001]
  • [Cites] J Virol. 2006 Oct;80(19):9481-96 [16973553.001]
  • [Cites] Herpes. 2006 Nov;13(3):75-80 [17147912.001]
  • [Cites] J Virol. 2007 Jan;81(2):761-74 [17079304.001]
  • [Cites] Mol Phylogenet Evol. 2007 Jun;43(3):1066-75 [17196839.001]
  • [Cites] J Virol. 2007 Oct;81(20):10924-32 [17670820.001]
  • [Cites] J Virol. 2003 May;77(10):6062-5 [12719598.001]
  • [Cites] J Virol. 2003 Dec;77(23):12891-900 [14610211.001]
  • [Cites] Science. 2004 Apr 30;304(5671):734-6 [15118162.001]
  • [Cites] Vaccine. 2004 Sep 28;22(29-30):4069-74 [15364458.001]
  • [Cites] J Virol. 2004 Nov;78(22):12406-15 [15507627.001]
  • [Cites] Lancet. 1974 Nov 30;2(7892):1288-90 [4139526.001]
  • [Cites] J Invest Dermatol. 1984 Jul;83(1 Suppl):42s-47s [6330220.001]
  • [Cites] J Gen Virol. 1986 Sep;67 ( Pt 9):1759-816 [3018124.001]
  • [Cites] Mol Cell Biol. 1985 Aug;5(8):1997-2008 [3018543.001]
  • [Cites] J Virol. 1988 Jun;62(6):2191-5 [2835520.001]
  • [Cites] J Virol. 1988 Dec;62(12):4622-6 [2460638.001]
  • [Cites] J Virol. 1988 Dec;62(12):4819-23 [2846893.001]
  • [Cites] Biochimie. 1988 Aug;70(8):1031-43 [2852507.001]
  • [Cites] J Virol. 1992 Jan;66(1):258-69 [1309245.001]
  • [Cites] J Infect Dis. 1992 Aug;166 Suppl 1:S7-12 [1320653.001]
  • [Cites] J Virol. 1992 Sep;66(9):5298-304 [1323696.001]
  • [Cites] J Gen Virol. 1994 Jun;75 ( Pt 6):1245-58 [8207391.001]
  • [Cites] J Virol. 1995 Jun;69(6):3863-7 [7745736.001]
  • [Cites] J Virol. 1996 Aug;70(8):5466-75 [8764058.001]
  • [Cites] Infect Dis Clin North Am. 1996 Sep;10(3):457-68 [8856347.001]
  • [Cites] J Gen Virol. 1997 Jun;78 ( Pt 6):1399-403 [9191936.001]
  • [Cites] Virology. 1997 Jul 7;233(2):382-91 [9217061.001]
  • [Cites] J Virol. 1997 Sep;71(9):6913-20 [9261418.001]
  • [Cites] J Virol. 1997 Nov;71(11):8279-88 [9343180.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14759-63 [9405686.001]
  • [Cites] J Virol. 1998 Feb;72(2):1542-51 [9445058.001]
  • [Cites] J Bacteriol. 1998 Apr;180(8):2063-71 [9555887.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8245-50 [9653172.001]
  • [Cites] Nat Genet. 1998 Oct;20(2):123-8 [9771703.001]
  • [Cites] J Infect Dis. 1998 Nov;178 Suppl 1:S22-6 [9852968.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):127-32 [9874783.001]
  • [Cites] J Virol. 1999 Aug;73(8):6405-14 [10400733.001]
  • [Cites] J Virol. 1999 Oct;73(10):8320-9 [10482582.001]
  • [Cites] J Virol. 2005 Apr;79(8):4730-43 [15795259.001]
  • [Cites] J Virol. 2005 Aug;79(15):9735-45 [16014935.001]
  • [Cites] J Virol. 2006 Mar;80(6):2609-20 [16501071.001]
  • [Cites] Vet Microbiol. 2006 Mar 31;113(3-4):163-9 [16330166.001]
  • [Cites] Biotechniques. 2006 Feb;40(2):191-7 [16526409.001]
  • [Cites] Nat Rev Microbiol. 2006 Apr;4(4):283-94 [16541136.001]
  • [Cites] Virus Res. 2006 Apr;117(1):90-104 [16490275.001]
  • (PMID = 17913822.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R21 AI061412; United States / NIAID NIH HHS / AI / 1R21AI061412
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Viral Structural Proteins
  • [Other-IDs] NLM/ PMC2169085
  •  go-up   go-down


73. Cadranel J, Lavolé A, Gounant V, Wislez M: [Clinical types of thoracic cancer. Bronchiolo-alveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum]. Rev Mal Respir; 2006 Nov;23(5 Pt 3):16S158-16S163
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical types of thoracic cancer. Bronchiolo-alveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum].
  • [Transliterated title] Formes cliniques des cancers thoraciques. Carcinome bronchiolo-alvéolaire (CBA) et adénocarcinome pulmonaire avec composante bronchiolo-alvéolaire (ADC-CBA): un continuum anatomo-clinique.
  • Bronchioloalveolar carcinoma (BAC) is a primary pulmonary adenocarcinoma (ADC) arising in the cells of the terminal respiratory unit.
  • Although stage IIIB and IV tumours were excluded from the strict WHO definition of BAC the first international workshop on this tumour in 2004 emphasised the clinico-pathological continuum that exists between BAC as defined by WHO and ADC with BAC features (ADC-BAC).
  • BAC and ADC-BAC are distinguished from other non-small cell carcinomas by an increased incidence in women, non-smokers and Asians.
  • Surgery offers the best treatment for localised disease.
  • The high frequency of epidermal growth factor receptor (EGFR) expression and amplification and/or mutation of its gene, as well as the finding in some cases of a major response to EGFR tyrosine-kinase inhibitors, have lead to several therapeutic trials of these drugs.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / pathology. Lung Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17268353.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 30
  •  go-up   go-down


74. Yang Z, Zhang Y: [The application of nuclear medicine imaging in bronchioloalveolar carcinoma.]. Zhongguo Fei Ai Za Zhi; 2009 Oct 20;12(10):1123-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The application of nuclear medicine imaging in bronchioloalveolar carcinoma.].

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20723354.001).
  • [ISSN] 1999-6187
  • [Journal-full-title] Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • [ISO-abbreviation] Zhongguo Fei Ai Za Zhi
  • [Language] chi
  • [Publication-type] Journal Article
  • [Publication-country] China
  •  go-up   go-down


75. Tinianow JN, Gill HS, Ogasawara A, Flores JE, Vanderbilt AN, Luis E, Vandlen R, Darwish M, Junutula JR, Williams SP, Marik J: Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET. Nucl Med Biol; 2010 Apr;37(3):289-97
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The amino group of desferrioxamine B was acylated by bromoacetyl bromide, N-hydroxysuccinimidyl iodoacetate, or N-hydroxysuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate to obtain thiol reactive reagents bromoacetyl-desferrioxamine (Df-Bac), iodoacetyl-desferrioxamine (Df-Iac) and maleimidocyclohexyl-desferrioxamine (Df-Chx-Mal), respectively.
  • Df-Bac and Df-Iac alkylated the free thiol groups of thio-trastuzumab by nucleophilic substitution forming Df-Ac-thio-trastuzumab, while the maleimide reagent Df-Chx-Mal reacted via Michael addition to provide Df-Chx-Mal-thio-trastuzumab.
  • RESULTS: The chemoselective reagents were obtained in 14% (Df-Bac), 53% (Df-Iac) and 45% (Df-Chx-Mal) yields.
  • Site-specific conjugation of Df-Chx-Mal to thio-trastuzumab was complete within 1 h at pH 7.5, while Df-Iac and Df-Bac respectively required 2 and 5 h at pH 9.
  • Each Df modified thio-trastuzumab was chelated with (89)Zr in yields exceeding 75%. (89)Zr-Df-Ac-thio-trastuzumab and (89)Zr-Df-Chx-Mal-thio-trastuzumab were stable in mouse serum and exhibited comparable PET imaging capabilities in a BT474M1 (HER2-positive) breast cancer model reaching 20-25 %ID/g of tumor uptake and a tumor to blood ratio of 6.1-7.1.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Hazardous Substances Data Bank. ZIRCONIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20346868.001).
  • [ISSN] 1872-9614
  • [Journal-full-title] Nuclear medicine and biology
  • [ISO-abbreviation] Nucl. Med. Biol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Radioisotopes; 0 / Radiopharmaceuticals; C6V6S92N3C / Zirconium
  •  go-up   go-down


76. Liu T, Mao D, Zhang S, Xu C, Xing Y: Fine mapping SPP1, a QTL controlling the number of spikelets per panicle, to a BAC clone in rice (Oryza sativa). Theor Appl Genet; 2009 May;118(8):1509-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine mapping SPP1, a QTL controlling the number of spikelets per panicle, to a BAC clone in rice (Oryza sativa).
  • Finally, it was narrowed down to a bacterial artificial chromosome clone spanning 107 kb; 17 open reading frames have been identified in the region.
  • [MeSH-major] Chromosomes, Artificial, Bacterial. Genes, Plant. Oryza / genetics. Physical Chromosome Mapping. Quantitative Trait Loci

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Plant Cell. 1991 Jul;3(7):677-684 [12324609.001]
  • [Cites] Planta. 2006 Jan;223(2):315-28 [16208486.001]
  • [Cites] Genetics. 1997 Feb;145(2):453-65 [9071598.001]
  • [Cites] Theor Appl Genet. 2002 Dec;105(8):1137-1145 [12582891.001]
  • [Cites] Nat Genet. 2008 Jun;40(6):761-7 [18454147.001]
  • [Cites] Nat Genet. 2007 May;39(5):623-30 [17417637.001]
  • [Cites] Theor Appl Genet. 2002 Apr;104(5):772-778 [12582636.001]
  • [Cites] Theor Appl Genet. 2003 May;106(8):1467-72 [12750790.001]
  • [Cites] Science. 2005 Jul 29;309(5735):741-5 [15976269.001]
  • [Cites] Nucleic Acids Res. 1980 Oct 10;8(19):4321-5 [7433111.001]
  • [Cites] Genetics. 1989 Jan;121(1):185-99 [2563713.001]
  • [Cites] Theor Appl Genet. 2003 Nov;107(8):1419-32 [14513215.001]
  • [Cites] Nat Genet. 2005 Oct;37(10):1141-6 [16155566.001]
  • [Cites] Genome Res. 2001 Aug;11(8):1441-52 [11483586.001]
  • [Cites] Plant Physiol. 1995 Oct;109(2):445-55 [7480341.001]
  • [Cites] Planta. 2004 Jan;218(3):388-95 [14534788.001]
  • [Cites] Plant Mol Biol. 1999 Jul;40(4):615-22 [10480385.001]
  • [Cites] Mol Plant Microbe Interact. 1996 May;9(4):233-42 [8634476.001]
  • [Cites] DNA Res. 2002 Feb 28;9(1):11-7 [11939564.001]
  • [Cites] Plant J. 2004 Feb;37(4):517-27 [14756760.001]
  • [Cites] Plant J. 2007 Dec;52(6):1027-40 [17916112.001]
  • [Cites] Genes Dev. 2006 May 15;20(10):1250-5 [16648463.001]
  • [Cites] Genetics. 2004 Dec;168(4):2187-95 [15611185.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9226-31 [11038567.001]
  • [Cites] J Plant Physiol. 2004 Apr;161(4):449-58 [15128032.001]
  • [Cites] Theor Appl Genet. 2006 Jul;113(2):361-8 [16791702.001]
  • [Cites] Theor Appl Genet. 2002 Aug;105(2-3):248-257 [12582526.001]
  • [Cites] Theor Appl Genet. 2006 Aug;113(4):619-29 [16770601.001]
  • [Cites] Plant Mol Biol. 1994 Dec;26(5):1357-77 [7858195.001]
  • [Cites] Mol Gen Genet. 1993 Oct;241(1-2):225-35 [7901751.001]
  • [Cites] Theor Appl Genet. 2008 Apr;116(6):789-96 [18219477.001]
  • [Cites] Biochem J. 1999 Apr 1;339 ( Pt 1):193-9 [10085244.001]
  • [Cites] Plant Cell. 1994 Oct;6(10):1485-93 [7994180.001]
  • [Cites] Plant Cell Rep. 2006 Nov;25(11):1133-7 [16676184.001]
  • [Cites] DNA Res. 2002 Dec 31;9(6):199-207 [12597276.001]
  • [Cites] Genetics. 2000 Feb;154(2):885-91 [10655238.001]
  • [Cites] Theor Appl Genet. 2006 Apr;112(6):1164-71 [16453132.001]
  • [Cites] Plant Cell Physiol. 1999 Feb;40(2):231-7 [10202817.001]
  • [Cites] Theor Appl Genet. 2003 Aug;107(4):679-90 [12920521.001]
  • (PMID = 19266175.001).
  • [ISSN] 1432-2242
  • [Journal-full-title] TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik
  • [ISO-abbreviation] Theor. Appl. Genet.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA, Plant; 0 / Genetic Markers
  •  go-up   go-down


77. Prior K, Hautefort I, Hinton JC, Richardson DJ, Rowley G: All stressed out. Salmonella pathogenesis and reactive nitrogen species. Adv Microb Physiol; 2009;56:1-28
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Bacterial pathogens must overcome a range of challenges during the process of infecting their host.
  • The ability of a pathogen to sense and respond appropriately to changes in host environment is vital if the pathogen is to succeed.
  • Mammalian defense strategies include the use of barriers like skin and epithelial surfaces, the production of a chemical arsenal, such as stomach acid and reactive oxygen and nitrogen species, and a highly coordinated cellular and humoral immune response.
  • Here we focus on the interplay which occurs between Salmonella and the host during the infection process, with particular emphasis on the complex bacterial response to reactive nitrogen species produced by the host.
  • We discuss recent advances in our understanding of the key mechanisms which confer bacterial resistance to nitrogen species, which in response to nitric oxide include the flavohemoglobin, HmpA, the flavorubredoxin, NorV, and the cytochrome c nitrite reductase, NrfA, whilst in response to nitrate include a repertoire of nitrate reductases.

  • MedlinePlus Health Information. consumer health - Salmonella Infections.
  • Hazardous Substances Data Bank. NITRIC OXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 Elsevier Ltd. All rights reserved.
  • (PMID = 20943123.001).
  • [ISSN] 2162-5468
  • [Journal-full-title] Advances in microbial physiology
  • [ISO-abbreviation] Adv. Microb. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Reactive Nitrogen Species; 31C4KY9ESH / Nitric Oxide; EC 1.7.- / Nitrite Reductases
  •  go-up   go-down


78. Sziksz E, Tibor Kozma G, Komlósi ZI, Pállinger E, Kardos M, Szebeni B, Losonczy G, Falus A, Szabó A, Tulassay T, Vannay A: Increased synthesis of vascular endothelial growth factor in allergic airway inflammation in histidine decarboxylase knockout (HDC(-/-)) mice. Exp Lung Res; 2010 Sep;36(7):420-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • VEGF mRNA expression and protein level were determined in the lung.
  • Number of VEGF-positive immune cells of bronchoalveolar lavage (BAL) and their intracellular VEGF content were measured by flow cytometry.
  • VEGF protein level in the lung and in the BAL cells was increased in OVA treated (HDC(-/-)(ova) as well as in WT(ova)) animals compared to their controls.
  • However, there was no difference in the VEGF levels between HDC(-/-) or WT animals, either in the lung or in the BAL cells.
  • In conclusion, increased VEGF production of the lung or BAL immune cells can be induced by allergen provocation independently from the genetic background of the animals.
  • [MeSH-minor] Animals. Bronchoalveolar Lavage Fluid / cytology. Female. Lung / drug effects. Lung / enzymology. Lung / pathology. Mice. Mice, Knockout. Ovalbumin

  • MedlinePlus Health Information. consumer health - Asthma.
  • Hazardous Substances Data Bank. HISTAMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20715981.001).
  • [ISSN] 1521-0499
  • [Journal-full-title] Experimental lung research
  • [ISO-abbreviation] Exp. Lung Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Vascular Endothelial Growth Factors; 820484N8I3 / Histamine; 9006-59-1 / Ovalbumin; EC 4.1.1.22 / Histidine Decarboxylase
  •  go-up   go-down


79. Chen WY, Pulukkunat DK, Cho IM, Tsai HY, Gopalan V: Dissecting functional cooperation among protein subunits in archaeal RNase P, a catalytic ribonucleoprotein complex. Nucleic Acids Res; 2010 Dec;38(22):8316-27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dissecting functional cooperation among protein subunits in archaeal RNase P, a catalytic ribonucleoprotein complex.
  • Biochemical studies on the bacterial holoenzyme, composed of one catalytic RNase P RNA (RPR) and one RNase P protein (RPP), have helped understand the pleiotropic roles (including substrate/Mg(2+) binding) by which a protein could facilitate RNA catalysis.
  • Exploiting our previous finding that these archaeal RPPs function as two binary RPP complexes (POP5•RPP30 and RPP21•RPP29), we prepared recombinant RPP pairs from three archaea and established interchangeability of subunits through homologous/heterologous assemblies.
  • Our finding that archaeal POP5•RPP30 reconstituted with bacterial and organellar RPRs suggests functional overlap of this binary complex with the bacterial RPP and highlights their shared recognition of a phylogenetically-conserved RPR catalytic core, whose minimal attributes we further defined through deletion mutagenesis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] FEBS Lett. 2010 Jan 21;584(2):287-96 [19931535.001]
  • [Cites] J Mol Biol. 2010 Feb 5;395(5):1019-37 [19917291.001]
  • [Cites] Nucleic Acids Res. 1996 Dec 1;24(23):4775-82 [8972865.001]
  • [Cites] Biochemistry. 1997 May 27;36(21):6317-25 [9174346.001]
  • [Cites] Biochemistry. 1998 Feb 24;37(8):2393-400 [9485387.001]
  • [Cites] Science. 1998 May 1;280(5364):752-5 [9563955.001]
  • [Cites] J Mol Biol. 1998 Jun 19;279(4):773-93 [9642060.001]
  • [Cites] Biochemistry. 1998 Jul 14;37(28):10126-33 [9665718.001]
  • [Cites] Nucleic Acids Res. 1999 Jan 1;27(1):314 [9847214.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15212-7 [9860948.001]
  • [Cites] Biochemistry. 1999 Jul 6;38(27):8612-20 [10393536.001]
  • [Cites] J Mol Biol. 1999 Jul 9;290(2):433-45 [10390342.001]
  • [Cites] Protein Expr Purif. 2001 Feb;21(1):224-34 [11162410.001]
  • [Cites] RNA. 2001 Feb;7(2):220-32 [11233979.001]
  • [Cites] RNA. 2001 Aug;7(8):1153-64 [11497433.001]
  • [Cites] J Mol Biol. 2003 Jan 24;325(4):661-75 [12507471.001]
  • [Cites] RNA. 2003 Jun;9(6):734-45 [12756331.001]
  • [Cites] Biochem Biophys Res Commun. 2003 Jul 4;306(3):666-73 [12810070.001]
  • [Cites] Anal Biochem. 2003 Aug 1;319(1):78-87 [12842110.001]
  • [Cites] Biochemistry. 2003 Nov 25;42(46):13541-50 [14622001.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15398-403 [14673079.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Jul 2;319(3):787-94 [15184052.001]
  • [Cites] Biochemistry. 2004 Aug 17;43(32):10547-59 [15301552.001]
  • [Cites] J Mol Biol. 2010 Feb 12;396(1):195-208 [19932118.001]
  • [Cites] EMBO J. 2010 Feb 17;29(4):761-9 [20075859.001]
  • [Cites] J Mol Biol. 1988 Aug 20;202(4):835-48 [2459398.001]
  • [Cites] FASEB J. 1993 Jan;7(1):188-95 [7678561.001]
  • [Cites] Biochemistry. 1993 May 25;32(20):5273-81 [8499432.001]
  • [Cites] Nucleic Acids Res. 1994 Oct 11;22(20):4087-94 [7524035.001]
  • [Cites] EMBO J. 1994 Oct 17;13(20):4870-6 [7525271.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12510-4 [8618931.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3001-6 [8610158.001]
  • [Cites] Nucleic Acids Res. 1996 Apr 1;24(7):1252-9 [8614627.001]
  • [Cites] RNA. 1996 May;2(5):452-62 [8665412.001]
  • [Cites] RNA. 1996 Jun;2(6):551-63 [8718684.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8924-8 [8799129.001]
  • [Cites] RNA. 2004 Sep;10(9):1423-32 [15317976.001]
  • [Cites] Cell. 1983 Dec;35(3 Pt 2):849-57 [6197186.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7803-8 [10393902.001]
  • [Cites] RNA. 1999 Aug;5(8):1021-33 [10445877.001]
  • [Cites] Biochemistry. 2004 Nov 9;43(44):14128-38 [15518563.001]
  • [Cites] Archaea. 2004 Oct;1(4):247-54 [15810434.001]
  • [Cites] RNA. 2005 May;11(5):739-51 [15811915.001]
  • [Cites] Biosci Biotechnol Biochem. 2005 Jun;69(6):1209-12 [15973057.001]
  • [Cites] Biochemistry. 2005 Sep 13;44(36):12086-93 [16142906.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13392-7 [16157868.001]
  • [Cites] Nature. 2005 Sep 22;437(7058):584-7 [16113684.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):873-8 [16418270.001]
  • [Cites] J Mol Biol. 2006 Mar 24;357(2):583-91 [16430919.001]
  • [Cites] Crit Rev Biochem Mol Biol. 2006 Mar-Apr;41(2):77-102 [16595295.001]
  • [Cites] Trends Biochem Sci. 2006 Jun;31(6):333-41 [16679018.001]
  • [Cites] RNA. 2006 Sep;12(9):1661-70 [16894220.001]
  • [Cites] EMBO J. 2006 Sep 6;25(17):3998-4007 [16932744.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16147-52 [17053064.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2062-7 [17284611.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2031-2 [17287341.001]
  • [Cites] J Mol Biol. 2007 Oct 5;372(5):1149-64 [17719605.001]
  • [Cites] RNA. 2007 Oct;13(10):1648-55 [17717080.001]
  • [Cites] Mol Microbiol. 2007 Nov;66(3):801-13 [17919279.001]
  • [Cites] Nucleic Acids Res. 2008 Jul;36(12):4172-80 [18558617.001]
  • [Cites] Biochemistry. 2008 Nov 11;47(45):11704-10 [18922021.001]
  • [Cites] J Mol Biol. 2008 Dec 19;384(3):652-62 [18929577.001]
  • [Cites] Nucleic Acids Res. 2009 Jan;37(1):231-42 [19036794.001]
  • [Cites] RNA. 2009 Feb;15(2):224-34 [19095620.001]
  • [Cites] RNA. 2009 Aug;15(8):1565-77 [19549719.001]
  • [Cites] J Mol Biol. 2009 Nov 13;393(5):1043-55 [19733182.001]
  • (PMID = 20705647.001).
  • [ISSN] 1362-4962
  • [Journal-full-title] Nucleic acids research
  • [ISO-abbreviation] Nucleic Acids Res.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM067807
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Archaeal Proteins; 0 / Protein Subunits; 0 / RNA Precursors; 9014-25-9 / RNA, Transfer; EC 3.1.26.5 / Ribonuclease P
  • [Other-IDs] NLM/ PMC3001054
  •  go-up   go-down


80. Bosnjak B, Ivetić Tkalcević V, Durić K, Belamarić D, Cuzić S, Ferencić Z, Brajsa K, Glojnarić I, Antolović R, Hrvacić B: Intranasal challenge with increasing ovalbumin doses differently affects airway hyperresponsiveness and inflammatory cell accumulation in mouse model of asthma. Inflamm Res; 2009 Nov;58(11):773-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intranasal challenge with increasing ovalbumin doses differently affects airway hyperresponsiveness and inflammatory cell accumulation in mouse model of asthma.
  • OBJECTIVE: To investigate whether challenge with increasing allergen doses could differently affect allergen-induced airway hyperresponsiveness (AHR) and inflammatory cell accumulation in mouse model of asthma, providing an experimental model to investigate their relationship.
  • MATERIAL AND METHODS: AHR and accumulation of inflammatory cells in bronchoalveolar lavage fluid (BALF) and into the lungs were compared in ovalbumin-sensitized mice that were challenged intranasally with 2.5, 10, 25 or 100 microg of ovalbumin/mouse.
  • RESULTS: Both AHR and inflammatory cell accumulation were proportional to the ovalbumin dose used for challenge.
  • [MeSH-minor] Animals. Bronchoalveolar Lavage Fluid / cytology. Bronchoalveolar Lavage Fluid / immunology. Cytokines / immunology. Disease Models, Animal. Eosinophil Peroxidase / metabolism. Eosinophils / immunology. Humans. Interleukin-13 / immunology. Lung / cytology. Lung / immunology. Lung / pathology. Male. Mice. Mice, Inbred BALB C

  • Genetic Alliance. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Allergy. 2007 Oct;62(10):1101-10 [17845579.001]
  • [Cites] Inhal Toxicol. 2004 May;16(5):259-69 [15371179.001]
  • [Cites] Am Rev Respir Dis. 1989 Oct;140(4):917-23 [2572192.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):721-30 [11254531.001]
  • [Cites] J Allergy Clin Immunol. 1988 Nov;82(5 Pt 1):764-70 [3192861.001]
  • [Cites] Am J Respir Crit Care Med. 1997 May;155(5):1515-21 [9154851.001]
  • [Cites] Thorax. 1987 Apr;42(4):302-8 [3616989.001]
  • [Cites] Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):766-75 [9309991.001]
  • [Cites] Clin Exp Allergy. 2008 May;38(5):701-3 [18307532.001]
  • [Cites] Am J Respir Cell Mol Biol. 2002 Feb;26(2):202-8 [11804871.001]
  • [Cites] Science. 1998 Dec 18;282(5397):2258-61 [9856949.001]
  • [Cites] Chest. 2006 Jul;130(1 Suppl):21S-28S [16840365.001]
  • [Cites] Am J Respir Cell Mol Biol. 2004 Jun;30(6):837-43 [14742296.001]
  • [Cites] Science. 2004 Sep 17;305(5691):1776-9 [15375268.001]
  • [Cites] Clin Exp Allergy. 1992 Feb;22(2):219-25 [1571815.001]
  • [Cites] Int Arch Allergy Immunol. 2004 Jan;133(1):84-100 [14726635.001]
  • [Cites] J Allergy Clin Immunol. 1992 Apr;89(4):850-7 [1560168.001]
  • [Cites] Am J Respir Crit Care Med. 2000 May;161(5):1720-45 [10806180.001]
  • [Cites] J Allergy Clin Immunol. 2006 Sep;118(3):551-9; quiz 560-1 [16950269.001]
  • [Cites] J Immunol Methods. 1985 Nov 7;83(2):209-15 [3840509.001]
  • [Cites] Clin Exp Allergy. 2003 Jan;33(1):119-31 [12534560.001]
  • [Cites] Clin Exp Allergy. 2008 May;38(5):829-38 [18070158.001]
  • [Cites] Am J Respir Cell Mol Biol. 1997 Mar;16(3):325-34 [9070618.001]
  • [Cites] Toxicology. 2005 Apr 1;209(1):77-89 [15725516.001]
  • [Cites] Am J Respir Crit Care Med. 1994 May;149(5):1167-74 [8173756.001]
  • [Cites] J Allergy Clin Immunol. 1995 Oct;96(4):435-40 [7560652.001]
  • [Cites] J Immunol. 1999 May 15;162(10):6233-7 [10229869.001]
  • [Cites] Chest. 2003 Mar;123(3 Suppl):411S-6S [12629006.001]
  • (PMID = 19440656.001).
  • [ISSN] 1420-908X
  • [Journal-full-title] Inflammation research : official journal of the European Histamine Research Society ... [et al.]
  • [ISO-abbreviation] Inflamm. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Cytokines; 0 / Interleukin-13; 9006-59-1 / Ovalbumin; EC 1.11.1.- / Eosinophil Peroxidase
  •  go-up   go-down


81. Sipos R, Székely AJ, Palatinszky M, Révész S, Márialigeti K, Nikolausz M: Effect of primer mismatch, annealing temperature and PCR cycle number on 16S rRNA gene-targetting bacterial community analysis. FEMS Microbiol Ecol; 2007 May;60(2):341-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of primer mismatch, annealing temperature and PCR cycle number on 16S rRNA gene-targetting bacterial community analysis.
  • In the attempt to explore complex bacterial communities of environmental samples, primers hybridizing to phylogenetically highly conserved regions of 16S rRNA genes are widely used, but differential amplification is a recognized problem.
  • The distortion of the template-to-product ratio was measured using predefined template mixtures and environmental samples by terminal restriction fragment length polymorphism analysis.
  • As a result of additional tests on environmental samples, the use of a low annealing temperature is recommended in order to significantly reduce preferential amplification while maintaining the specificity of PCR.
  • [MeSH-minor] DNA, Bacterial / chemistry. DNA, Bacterial / genetics. Ecosystem. Electrophoresis, Capillary. Environmental Microbiology. Molecular Sequence Data. Polymorphism, Restriction Fragment Length. Sequence Analysis, DNA. Temperature

  • SILVA. SILVA SSU Database .
  • StrainInfo. culture/stock collections - online strain list (subscription/membership/fee required).
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17343679.001).
  • [ISSN] 0168-6496
  • [Journal-full-title] FEMS microbiology ecology
  • [ISO-abbreviation] FEMS Microbiol. Ecol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ DQ207728/ DQ207729/ DQ207730/ DQ207731
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Bacterial; 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


82. Portnoï D, Sertour N, Ferquel E, Garnier M, Baranton G, Postic D: A single-run, real-time PCR for detection and identification of Borrelia burgdorferi sensu lato species, based on the hbb gene sequence. FEMS Microbiol Lett; 2006 Jun;259(1):35-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lyme borreliosis is the most important vector-borne disease caused by spirochetes within the Borrelia burgdorferi sensu lato (B. burgdorferi sl) complex.
  • There is strong evidence that different species of this group of genetically diverse spirochetes are involved in distinct clinical manifestations of the disease.
  • In order to differentiate species within this bacterial complex, we developed a real-time-PCR protocol, which targets the hbb gene.
  • We designed a fluorescein-labeled probe specific of a region of this gene harboring a polymorphism linked to species.
  • [MeSH-major] Bacterial Proteins / genetics. Borrelia burgdorferi Group / classification. Borrelia burgdorferi Group / isolation & purification. DNA-Binding Proteins / genetics. Polymerase Chain Reaction / methods
  • [MeSH-minor] Animals. Bacterial Typing Techniques. DNA Primers. DNA, Bacterial / analysis. DNA, Bacterial / isolation & purification. Reproducibility of Results. Sensitivity and Specificity. Ticks / microbiology. Transition Temperature

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16684099.001).
  • [ISSN] 0378-1097
  • [Journal-full-title] FEMS microbiology letters
  • [ISO-abbreviation] FEMS Microbiol. Lett.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / DNA Primers; 0 / DNA, Bacterial; 0 / DNA-Binding Proteins; 0 / Hbb protein, Borrelia burgdorferi
  •  go-up   go-down


83. Macfarlane S, Woodmansey EJ, Macfarlane GT: Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl Environ Microbiol; 2005 Nov;71(11):7483-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The human large intestine is covered with a protective mucus coating, which is heavily colonized by complex bacterial populations that are distinct from those in the gut lumen.
  • The establishment of bacterial communities in mucin gels was investigated by selective culture methods, scanning electron microscopy, and confocal laser scanning microscopy, in association with fluorescently labeled 16S rRNA oligonucleotide probes.
  • Mucin gels were rapidly colonized by heterogeneous bacterial populations, especially members of the Bacteroides fragilis group, enterobacteria, and clostridia.
  • Intestinal bacterial populations growing on mucin surfaces were shown to be phylogenetically and metabolically distinct from their planktonic counterparts.

  • MedlinePlus Health Information. consumer health - Bowel Movement.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gut. 2001 Feb;48(2):198-205 [11156640.001]
  • [Cites] Infect Immun. 2001 Feb;69(2):1120-6 [11160009.001]
  • [Cites] Br J Nutr. 2003 May;89(5):597-606 [12720580.001]
  • [Cites] Gut. 2004 Apr;53(4):523-9 [15016746.001]
  • [Cites] Clin Infect Dis. 2004 Jun 15;38(12):1690-9 [15227614.001]
  • [Cites] Adv Appl Microbiol. 2004;54:261-89 [15251284.001]
  • [Cites] Gut. 2004 Nov;53(11):1610-6 [15479681.001]
  • [Cites] Br Med Bull. 1978 Jan;34(1):79-82 [342054.001]
  • [Cites] Infect Immun. 1979 Jan;23(1):128-32 [370006.001]
  • [Cites] Microbiol Rev. 1979 Jun;43(2):260-96 [390357.001]
  • [Cites] Gastroenterology. 1981 Oct;81(4):751-8 [7262519.001]
  • [Cites] Infect Immun. 1981 Oct;34(1):234-40 [7298185.001]
  • [Cites] Infect Immun. 1981 Oct;34(1):241-9 [7298186.001]
  • [Cites] Infect Immun. 1983 Apr;40(1):62-9 [6339411.001]
  • [Cites] Appl Environ Microbiol. 1983 Mar;45(3):1025-33 [6847178.001]
  • [Cites] Gastroenterology. 1983 Sep;85(3):589-95 [6873605.001]
  • [Cites] Appl Environ Microbiol. 1984 Aug;48(2):449-50 [6486788.001]
  • [Cites] Nahrung. 1984;28(6-7):627-34 [6493320.001]
  • [Cites] Infect Immun. 1986 Jul;53(1):141-8 [2873103.001]
  • [Cites] Clin Gastroenterol. 1986 Oct;15(4):815-37 [3536210.001]
  • [Cites] J Gen Microbiol. 1986 Jun;132(6):1647-56 [3543210.001]
  • [Cites] Infect Immun. 1988 Sep;56(9):2209-17 [3044995.001]
  • [Cites] Infect Immun. 1988 Oct;56(10):2610-4 [3417352.001]
  • [Cites] J Appl Bacteriol. 1989 Nov;67(5):520-7 [2480341.001]
  • [Cites] J Appl Bacteriol. 1990 Feb;68(2):179-87 [2318746.001]
  • [Cites] Appl Environ Microbiol. 1990 Jun;56(6):1919-25 [2200342.001]
  • [Cites] FEMS Microbiol Lett. 1991 Jan 15;61(2-3):289-93 [1903753.001]
  • [Cites] FEMS Microbiol Lett. 1991 Nov 15;68(2):151-6 [1778437.001]
  • [Cites] J Appl Bacteriol. 1992 Jan;72(1):57-64 [1541601.001]
  • [Cites] Biochem Biophys Res Commun. 1992 Mar 16;183(2):506-13 [1372502.001]
  • [Cites] Infect Immun. 1992 Oct;60(10):3971-8 [1398908.001]
  • [Cites] Gut. 1993 Jan;34(1):63-7 [8432454.001]
  • [Cites] Microbiology. 1994 Dec;140 ( Pt 12):3407-12 [7881558.001]
  • [Cites] Appl Environ Microbiol. 1995 Aug;61(8):3069-75 [7487040.001]
  • [Cites] Microbiology. 1996 May;142 ( Pt 5):1097-106 [8704951.001]
  • [Cites] J Med Microbiol. 1997 Jan;46(1):85-91 [9003751.001]
  • [Cites] Adv Dent Res. 1997 Apr;11(1):59-68 [9524443.001]
  • [Cites] Proc R Soc Lond B Biol Sci. 1955 Jan 27;143(911):147-58 [14371602.001]
  • [Cites] J Biol Chem. 1959 Aug;234(8):1971-5 [13672998.001]
  • (PMID = 16269790.001).
  • [ISSN] 0099-2240
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Culture Media; 0 / Fluorescent Dyes; 0 / Mucins; 0 / Oligonucleotide Probes; 0 / RNA, Ribosomal, 16S
  • [Other-IDs] NLM/ PMC1287682
  •  go-up   go-down


84. Gearhardt AN, Corbin WR: Body mass index and alcohol consumption: family history of alcoholism as a moderator. Psychol Addict Behav; 2009 Jun;23(2):216-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BMI, family history of alcoholism, gender, and race/ethnicity were assessed as predictors of typical drinking frequency and estimated blood alcohol concentration (BAC).

  • MedlinePlus Health Information. consumer health - Alcohol.
  • MedlinePlus Health Information. consumer health - Alcoholism and Alcohol Abuse.
  • MedlinePlus Health Information. consumer health - Family Issues.
  • MedlinePlus Health Information. consumer health - Obesity.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 APA, all rights reserved.
  • (PMID = 19586138.001).
  • [ISSN] 0893-164X
  • [Journal-full-title] Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
  • [ISO-abbreviation] Psychol Addict Behav
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


85. Misfeldt AM, Boyle SC, Tompkins KL, Bautch VL, Labosky PA, Baldwin HS: Endocardial cells are a distinct endothelial lineage derived from Flk1+ multipotent cardiovascular progenitors. Dev Biol; 2009 Sep 01;333(1):78-89
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To distinguish endocardium from other vasculature, we generated an NFATc1-nuc-LacZ BAC transgenic mouse line capable of labeling this specific endothelial subpopulation at the earliest stages of cardiac development.
  • Endocardium is specified as a cardiac cell lineage, independent from other vascular populations, responding to BMP and Wnt signals that enhance cardiomyocyte differentiation.
  • [MeSH-major] Cell Lineage / physiology. Embryonic Stem Cells / physiology. Endocardium / embryology. Endothelial Cells / physiology. Multipotent Stem Cells / physiology. Myocytes, Cardiac / physiology. Vascular Endothelial Growth Factor Receptor-2 / metabolism
  • [MeSH-minor] Animals. Antigens, Differentiation / metabolism. Cell Differentiation / physiology. Cells, Cultured. Hematopoietic Stem Cells / cytology. Hematopoietic Stem Cells / physiology. Mesoderm / cytology. Mesoderm / embryology. Mice. Mice, Transgenic. Muscle, Smooth, Vascular / cytology. Muscle, Smooth, Vascular / embryology. Myocytes, Smooth Muscle / cytology. Myocytes, Smooth Muscle / physiology. NFATC Transcription Factors / genetics

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19576203.001).
  • [ISSN] 1095-564X
  • [Journal-full-title] Developmental biology
  • [ISO-abbreviation] Dev. Biol.
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / RL1 HL092551; United States / NHLBI NIH HHS / HL / RL1HL0952551-01; United States / NIGMS NIH HHS / GM / T32 GM07347
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Differentiation; 0 / NFATC Transcription Factors; 0 / Nfatc1 protein, mouse; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-2
  •  go-up   go-down


86. Shi JJ, Cai DH, Chen XJ, Sheng HZ: Cloning and characterization of the rabbit POU5F1 gene. DNA Seq; 2008 Feb;19(1):56-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The rabbit POUSF1 gene was mapped to chromosome 12q1.1 by PCR amplification of DNA from two putative POU5F1-containing BAC clones, which were previously mapped to chromosome 12q1.1.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17852331.001).
  • [ISSN] 1042-5179
  • [Journal-full-title] DNA sequence : the journal of DNA sequencing and mapping
  • [ISO-abbreviation] DNA Seq.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ EF062856/ EF194086
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Octamer Transcription Factor-3
  •  go-up   go-down


87. Titus TA, Selvig DR, Qin B, Wilson C, Starks AM, Roe BA, Postlethwait JH: The Fanconi anemia gene network is conserved from zebrafish to human. Gene; 2006 Apr 26;371(2):211-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fanconi anemia (FA) is a complex disease involving nine identified and two unidentified loci that define a network essential for maintaining genomic stability.
  • To test the hypothesis that the FA network is conserved in vertebrate genomes, we cloned and sequenced zebrafish (Danio rerio) cDNAs and/or genomic BAC clones orthologous to all nine cloned FA genes (FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL), and identified orthologs in the genome database for the pufferfish Tetraodon nigroviridis.
  • Evolutionarily conserved regions identified functionally important domains, since many amino acid residues mutated in human disease alleles or shown to be critical in targeted mutagenesis studies are identical in zebrafish and human.
  • [MeSH-minor] Amino Acid Sequence. Animals. Chromosomes, Artificial, Bacterial. Humans. Molecular Sequence Data. Sequence Homology, Amino Acid

  • Genetic Alliance. consumer health - Fanconi Anemia.
  • Genetic Alliance. consumer health - Anemia.
  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • ZFIN. ZFIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16515849.001).
  • [ISSN] 0378-1119
  • [Journal-full-title] Gene
  • [ISO-abbreviation] Gene
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD22486; United States / NCRR NIH HHS / RR / R01RR10715
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Fanconi Anemia Complementation Group D2 Protein
  •  go-up   go-down


88. Suzuki C, Daigo Y, Ishikawa N, Kato T, Hayama S, Ito T, Tsuchiya E, Nakamura Y: ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res; 2005 Dec 15;65(24):11314-25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
  • Gene expression profile analysis of non-small cell lung cancers (NSCLC) and subsequent functional analyses revealed that human ANLN, a homologue of anillin, an actin-binding protein in Drosophila, was transactivated in lung cancer cells and seemed to play a significant role in pulmonary carcinogenesis.
  • Immunohistochemical staining of nuclear ANLN on lung cancer tissue microarrays was associated with the poor survival of NSCLC patients, indicating that this molecule might serve as a prognostic indicator.
  • Our data imply that up-regulation of ANLN is a common feature of the carcinogenetic process in lung tissue, and suggests that selective suppression of ANLN could be a promising approach for developing a new strategy to treat lung cancers.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / metabolism. Contractile Proteins / metabolism. Lung Neoplasms / metabolism. Phosphatidylinositol 3-Kinases / metabolism. Proto-Oncogene Proteins c-akt / metabolism. rhoA GTP-Binding Protein / metabolism
  • [MeSH-minor] Actins / metabolism. Adenocarcinoma / genetics. Adenocarcinoma / metabolism. Adenocarcinoma / pathology. Adenocarcinoma, Bronchiolo-Alveolar / genetics. Adenocarcinoma, Bronchiolo-Alveolar / metabolism. Adenocarcinoma, Bronchiolo-Alveolar / pathology. Adult. Aged. Aged, 80 and over. Blotting, Western. Carcinoma, Adenosquamous / genetics. Carcinoma, Adenosquamous / metabolism. Carcinoma, Adenosquamous / pathology. Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / metabolism. Carcinoma, Squamous Cell / pathology. Cell Movement. Enzyme Activation. Female. Flow Cytometry. Humans. Lung / metabolism. Lung / pathology. Male. Middle Aged. Prognosis. RNA, Small Interfering / pharmacology. Reverse Transcriptase Polymerase Chain Reaction. Signal Transduction. Survival Rate. Tissue Array Analysis. Tumor Cells, Cultured. Wound Healing

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16357138.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Contractile Proteins; 0 / RNA, Small Interfering; 0 / anillin; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 3.6.5.2 / rhoA GTP-Binding Protein
  •  go-up   go-down


89. Moore S, Shepherd J, Perham N, Cusens B: The prevalence of alcohol intoxication in the night-time economy. Alcohol Alcohol; 2007 Nov-Dec;42(6):629-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHOD: A random sample of 893 people were interviewed and breathalysed in 24 repeated, cross-sectional surveys over the course of a year in the city centre streets of a European capital city between 11.00 pm and 3.00 am.
  • RESULTS: Median blood alcohol concentration (BAC) in men was 0.13% (min = 0%, max = 0.33%) and in women was 0.09% (min = 0%, max = 0.27%)-which were below the threshold used to indicate 'at risk BAC' (0.15%; for men t = 9.32, P < 0.001 and for women t = 17.54, P < 0.001).
  • Men provided higher BACs than women (t = 7.17, P < 0.001).
  • The relationship between age and BAC for men described an inverted 'u', peaking at 29 years, but for women the relationship was positive and linear.
  • BAC was inversely related to the ability to remember and report the evening's consumption (z = 4.76, P < 0.001).
  • Reported consumption predicted only 12% (P < 0.001) of the variance in BAC for men and 10% (P < 0.001) for women.
  • The probability for respondents to recall past consumption diminished as BAC increased suggesting self-report data are not suitable to assess consumption in heavy drinkers.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17660522.001).
  • [ISSN] 1464-3502
  • [Journal-full-title] Alcohol and alcoholism (Oxford, Oxfordshire)
  • [ISO-abbreviation] Alcohol Alcohol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


90. Philipp U, Quignon P, Scott A, André C, Breen M, Leeb T: Chromosomal assignment of the canine melanophilin gene (MLPH): a candidate gene for coat color dilution in Pinschers. J Hered; 2005;96(7):774-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate the genetic cause of the coat color dilution in Pinschers, we isolated BAC clones containing the canine ortholog of the known murine color dilution gene Mlph.
  • RH mapping of the canine MLPH gene was performed using an STS marker derived from BAC sequences.
  • Additionally, one MLPH BAC clone was used as probe for FISH mapping, and the canine MLPH gene was assigned to CFA25q24.

  • SciCrunch. OMIA - Online Mendelian Inheritance in Animals: Data: Gene Expression .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15958794.001).
  • [ISSN] 0022-1503
  • [Journal-full-title] The Journal of heredity
  • [ISO-abbreviation] J. Hered.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteins
  •  go-up   go-down


91. Quoix E: [Recent development of the standards of treatment of lung cancer]. Rev Prat; 2007 Feb 15;57(3):239-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Recent development of the standards of treatment of lung cancer].
  • [Transliterated title] Evolutions récentes des traitements de référence du cancer bronchique primitif.
  • Non-small cell lung cancer (NSCLC) knows important changes with the development of the use of chemotherapy not only in the advanced forms but also in a perioperative setting.
  • In early stage disease, a wedge resection seems to be sufficient in the tumours with a diameter less than 2 cm and presenting as ground-glass opacity.
  • Targeted therapies have been the real novelty in the treatment of non-small cell lung cancer.
  • However, they have proved useful in second line setting and in first line setting in diffuse bronchioloalveolar carcinoma.
  • Regarding small-cell lung cancer, there has been no real novelty, the standard treatment remains unchanged.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / surgery. Neoadjuvant Therapy
  • [MeSH-minor] Adenocarcinoma, Bronchiolo-Alveolar / surgery. Carcinoma, Small Cell / surgery. Chemotherapy, Adjuvant. Humans. Pneumonectomy. Radiotherapy, Adjuvant


92. Wang YJ, Jiang YL, Tang HF, Zhao CZ, Chen JQ: Zl-n-91, a selective phosphodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model. Int Immunopharmacol; 2010 Feb;10(2):252-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chronic obstructive pulmonary disease (COPD) is defined as a disease state characterized by poorly reversible airflow limitation induced by cigarette smoking and/or other noxious particle and gases.
  • Phosphodiesterase (PDE) 4 inhibitors are known to elevated cAMP concentrations in inflammatory cells, leading to inhibition of inflammatory response, relaxation of smooth muscle in the airway, and modulation of sensory nerves in the lung as well.
  • To investigate whether Zl-n-91, a new selective PDE4 inhibitor, could decrease inflammation and improve lung function in a COPD-like rat model, male Sprague-Dawley rats are used to challenge with lipopolysaccharide (LPS) and cigarette smoking (CS) exposure to induce COPD-like animal model.
  • Administration of Zl-n-91 at different dosages results in decreases of inflammatory cell in bronchoalveolar lavage fluid (BALF) as compared with vehicle treatment.
  • [MeSH-major] Anti-Inflammatory Agents, Non-Steroidal / therapeutic use. Furans / therapeutic use. Phenyl Ethers / therapeutic use. Phosphodiesterase 4 Inhibitors. Phosphodiesterase Inhibitors / therapeutic use. Pulmonary Disease, Chronic Obstructive / drug therapy
  • [MeSH-minor] Animals. Cyclic Nucleotide Phosphodiesterases, Type 4 / immunology. Disease Models, Animal. Lipopolysaccharides / immunology. Lung / drug effects. Lung / immunology. Lung / physiopathology. Male. Matrix Metalloproteinase 9 / immunology. Matrix Metalloproteinase Inhibitors. Neutrophils / drug effects. Neutrophils / immunology. Peroxidase / drug effects. Peroxidase / immunology. Rats. Rats, Sprague-Dawley. Smoking / adverse effects. Smoking / immunology

  • MedlinePlus Health Information. consumer health - COPD.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier B.V. All rights reserved.
  • (PMID = 19914404.001).
  • [ISSN] 1878-1705
  • [Journal-full-title] International immunopharmacology
  • [ISO-abbreviation] Int. Immunopharmacol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; 0 / Furans; 0 / Lipopolysaccharides; 0 / Matrix Metalloproteinase Inhibitors; 0 / Phenyl Ethers; 0 / Phosphodiesterase 4 Inhibitors; 0 / Phosphodiesterase Inhibitors; 0 / Zl-n-91 compound; EC 1.11.1.7 / Peroxidase; EC 3.1.4.17 / Cyclic Nucleotide Phosphodiesterases, Type 4; EC 3.4.24.35 / Matrix Metalloproteinase 9
  •  go-up   go-down


93. Arenberg D, American College of Chest Physicians: Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest; 2007 Sep;132(3 Suppl):306S-13S
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
  • OBJECTIVES: To review the current evidence on special issues relating to the diagnosis, imaging, prognosis, and treatment of bronchioloalveolar carcinoma (BAC).
  • METHODS: This guideline focuses on aspects of BAC that are unique and ways in which BAC differs importantly from other forms of non-small cell lung cancer (NSCLC).
  • The author reviewed published literature reporting on BAC using key words "histology," "CT scans," "fluorodeoxyglucose positron emission tomography scan," "sensitivity," "specificity," "surgical resection," "sublobar resection," and "epidermal growth factor receptor tyrosine kinase inhibitor" and selected references from published review articles.
  • Also included was a review of the 1999 World Health Organization (WHO) revised classification system for lung tumors, which established a more restrictive definition of BAC to tumors with a pure lepidic spreading pattern and no evidence of stromal, vascular, or pleural invasion.
  • RESULTS: With the notable exception of a lower likelihood of a positive positron emission tomography finding in the presence of BAC, staging, diagnosis, and treatment are the same as for other histologic subtypes of NSCLC, but additional treatment options that may prove to be equivalent, if not more effective, for more patients exist (eg, epidermal growth factor receptor tyrosine kinase inhibitor therapy, sublobar resection).
  • CONCLUSIONS: BAC is a form of adenocarcinoma with unique clinical, radiologic, and epidemiologic features.
  • The diagnosis of BAC should be reserved for tumors that meet the WHO criteria.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / diagnosis. Adenocarcinoma, Bronchiolo-Alveolar / therapy. Lung Neoplasms / diagnosis. Lung Neoplasms / therapy


94. Garfield DH, Cadranel JL, Wislez M, Franklin WA, Hirsch FR: The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases. J Thorac Oncol; 2006 May;1(4):344-59
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.
  • Bronchioloalveolar carcinoma (BAC) develops from terminal bronchiolar and acinar epithelia, growing along alveolar septa but without evidence of vascular or pleural involvement.
  • A final diagnosis of BAC can only be achieved from a surgical specimen.
  • Problematically, BAC may exhibit multifocal involvement by means of diffuse aerogenous metastatic spread, making this definition inapplicable for patients with stage IIIB to IV disease from whom only small size biopsy or cytological specimens are obtained.
  • The recent interest and potential importance of BAC and the related peripheral adenocarcinoma (ADC), mixed subtype, is attributable to mounting evidence that some, perhaps many, of what are called peripheral ADCs have arisen from and often contain BAC.
  • BAC, in turn, appears to arise from smaller peripheral nodules, called atypical adenomatous hyperplasia.
  • Interest also stems from the observation that advanced ADC, often with BAC features, are responding in surprising fashion to tyrosine kinase inhibitors.
  • Clinical characteristics often differ from other types of non-small cell lung cancers.
  • These include frequent female occurrence, especially in East Asians; no or less smoking history; an often indolent course; distinctive chest computed tomographic findings; frequent presentation as an asymptomatic, sometimes small, peripheral nodule(s)/mass; multifocal/synchronous primary tumors; and less frequently as pneumonic-type consolidation or diffuse, inoperable lesions, the latter two often with bronchorrhea, and with chest-only disease.
  • Because of frequent lung-only recurrences, lung transplantation, although performed rarely, may hold promise.
  • [MeSH-major] Adenocarcinoma / therapy. Adenocarcinoma, Bronchiolo-Alveolar / therapy. Lung Neoplasms / therapy
  • [MeSH-minor] Female. Humans. Lung Transplantation. Male. Neoplasm Invasiveness. Neoplasm Staging. Positron-Emission Tomography. Prognosis. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] J Thorac Oncol. 2006 Jun;1(5):405
  • (PMID = 17409882.001).
  • [ISSN] 1556-1380
  • [Journal-full-title] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • [ISO-abbreviation] J Thorac Oncol
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P50 CA 058187
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 207
  •  go-up   go-down


95. Cupp JS, Wrede JE, Cherry AM, Arber DA, George TI: Chromosomal aberrations in a case of synchronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type and bronchogenic adenocarcinoma. Appl Immunohistochem Mol Morphol; 2008 May;16(3):296-300
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chromosomal aberrations in a case of synchronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type and bronchogenic adenocarcinoma.
  • We present the chromosomal aberrations in a case of synchronous extranodal marginal zone B-cell lymphoma and bronchogenic adenocarcinoma with bronchioloalveolar features.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18301237.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunoglobulin Heavy Chains; 0 / Neoplasm Proteins; EC 3.4.22.- / Caspases; EC 3.4.22.- / MALT1 protein, human
  •  go-up   go-down


96. Tischer BK, Smith GA, Osterrieder N: En passant mutagenesis: a two step markerless red recombination system. Methods Mol Biol; 2010;634:421-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Bacterial artificial chromosomes are used to maintain and modify large sequences of different origins in Escherichia coli.
  • Since foreign sequences, such as antibiotic resistance genes as well as frt- or loxP-sites are often unwanted in mutant BAC clones, we developed a Red-based technique that allows for the scarless generation of point mutations, deletions, and insertion of smaller and larger sequences.
  • [MeSH-minor] Chromosomes, Artificial, Bacterial

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20677001.001).
  • [ISSN] 1940-6029
  • [Journal-full-title] Methods in molecular biology (Clifton, N.J.)
  • [ISO-abbreviation] Methods Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Xian HQ, Werth K, Gottlieb DI: Promoter analysis in ES cell-derived neural cells. Biochem Biophys Res Commun; 2005 Feb 4;327(1):155-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Promoter analysis in ES cell-derived neural cells.
  • Neural cells derived from ES cells in cell culture (ESNCs) have many of the properties of normal neural cells and provide a model of "neurogenesis-in-a-dish."
  • ES cells are transfected with bacterial artificial chromosomes (BACs) containing Olig2, a gene with a key role in neural fate choice.
  • One BAC is modified by recombineering to insert a reporter gene and a gene for selecting stably transfected clones.
  • Another BAC contains a deletion of a suspected Olig2 promoter.
  • The combination of ESNCs and BAC recombineering will have broad application for analyzing gene transcription in the nervous system and will be applicable to human ES cells.
  • The general approach should also be applicable to the many other cell lineages that can now be derived from mouse and human ES cells in culture.
  • [MeSH-minor] Animals. Basic Helix-Loop-Helix Transcription Factors. Cell Differentiation. Cell Line. Chromosomes, Artificial, Bacterial / genetics. Gene Expression. Mice. Nerve Tissue Proteins / genetics. Phenotype. Sequence Deletion / genetics. Transgenes / genetics. Up-Regulation / genetics

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15629444.001).
  • [ISSN] 0006-291X
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Grant] United States / NINDS NIH HHS / NS / NS045809; United States / NINDS NIH HHS / NS / P01 NS39577-03
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Basic Helix-Loop-Helix Transcription Factors; 0 / Nerve Tissue Proteins; 0 / Olig2 protein, mouse
  •  go-up   go-down


98. Chouahnia K, Brechot JM, Des-Guetz G, Saintigny P, Morere JF, Breau JL: [Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer]. Rev Mal Respir; 2006 Apr;23(2 Pt 1):149-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer].
  • [Transliterated title] Géfitinib et méningite carcinomateuse d'un carcinome bronchique non à petites cellules (CBNPC).
  • BACKGROUND: Carcinomatous meningitis is a major complication in Non Small Cell Lung Cancer (NSCLC).
  • OBSERVATION: We report a case of a female non-smoker with adenocarcinoma with bronchoalveolar features presenting with carcinomatous meningitis three years after the diagnosis of her primary tumour.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / drug therapy. Antineoplastic Agents / therapeutic use. Carcinoma, Non-Small-Cell Lung / drug therapy. Chemotherapy, Adjuvant. Lung Neoplasms / pathology. Meningitis / drug therapy. Protein Kinase Inhibitors / therapeutic use. Quinazolines / therapeutic use

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Meningitis.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • Hazardous Substances Data Bank. VINORELBINE .
  • Hazardous Substances Data Bank. VINBLASTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16788439.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Neoplasm Proteins; 0 / Protein Kinase Inhibitors; 0 / Quinazolines; 5V9KLZ54CY / Vinblastine; BG3F62OND5 / Carboplatin; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; P88XT4IS4D / Paclitaxel; Q20Q21Q62J / Cisplatin; Q6C979R91Y / vinorelbine; S65743JHBS / gefitinib
  •  go-up   go-down


99. Shao CW, Chen SL, Scheuring CF, Xu JY, Sha ZX, Dong XL, Zhang HB: Construction of two BAC libraries from half-smooth tongue sole Cynoglossus semilaevis and identification of clones containing candidate sex-determination genes. Mar Biotechnol (NY); 2010 Oct;12(5):558-68
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Construction of two BAC libraries from half-smooth tongue sole Cynoglossus semilaevis and identification of clones containing candidate sex-determination genes.
  • Two bacterial artificial chromosome (BAC) libraries for C. semilaevis, with large, high-quality inserts and deep coverage, were constructed in the BamHI and HindIII sites of the vector pECBAC1.
  • The two libraries contain a total of 55,296 BAC clones arrayed in 144 384-well microtiter plates and correspond to 13.36 haploid genome equivalents.
  • Thus, the two BAC libraries of C. semilaevis provided a readily useable platform for genomics research, illustrated by the isolation of sex determination gene(s).
  • [MeSH-major] Chromosomes, Artificial, Bacterial / genetics. Cloning, Molecular. Fisheries / methods. Flatfishes / genetics. Gene Expression Regulation / genetics. Gene Library. Sex Determination Processes / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mar Biotechnol (NY). 2009 Nov-Dec;11(6):699-709 [19214631.001]
  • [Cites] Cytometry A. 2003 Feb;51(2):127-8; author reply 129 [12541287.001]
  • [Cites] Mar Biotechnol (NY). 2008 Jul-Aug;10(4):358-65 [18283517.001]
  • [Cites] Mar Biotechnol (NY). 2009 Mar-Apr;11(2):243-51 [18779997.001]
  • [Cites] Mech Dev. 2004 Jul;121(7-8):639-45 [15210173.001]
  • [Cites] Genetics. 2001 Aug;158(4):1711-24 [11514457.001]
  • [Cites] Mol Reprod Dev. 2002 Sep;63(1):5-16 [12211055.001]
  • [Cites] Trends Genet. 2003 Apr;19(4):196-9 [12683972.001]
  • [Cites] Nature. 2002 May 30;417(6888):559-63 [12037570.001]
  • [Cites] Sex Dev. 2007;1(2):85-99 [18391519.001]
  • [Cites] Mar Biotechnol (NY). 2010 Apr;12(2):141-9 [19585170.001]
  • [Cites] Anim Genet. 2006 Aug;37(4):321-6 [16879340.001]
  • [Cites] Anim Genet. 2006 Oct;37(5):526 [16978191.001]
  • [Cites] Genetica. 2001;111(1-3):43-58 [11841186.001]
  • [Cites] Mar Biotechnol (NY). 2000 Nov;2(6):571-6 [14961180.001]
  • [Cites] Genetics. 2001 Nov;159(3):1231-42 [11729165.001]
  • [Cites] Anim Genet. 2003 Oct;34(5):379-83 [14510676.001]
  • [Cites] Biochim Biophys Acta. 2000 Sep 7;1493(1-2):180-7 [10978520.001]
  • [Cites] Nucleic Acids Res. 1998 Nov 1;26(21):4901-9 [9776751.001]
  • [Cites] Nature. 1990 Jul 19;346(6281):240-4 [1695712.001]